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ABSTRACT 
The effects of clinically important antimycobacterial drugs on Mycobacterium 
tuberculosis at the single cell level using cytochemical indicators of cellular activity were 
studied. Procedures based on rhodamine 123 (R 123) uptake as an indicator of 
cytoplasmic membrane energisation, propidium iodide (PI) exclusion and 
iodonitrophenyltetrazolium chloride (INT) reduction were established. Some cells in 
every preparation were found to resist labelling by all of the procedures applied. This 
proportion was highest in broth culture (up to 70%) and lowest in cell suspensions 
prepared from agar spread plates. R123 uptake in growing cells was reversibly sensitive 
to carbonylcyanide m-chlorophenylhydrazone (CCCP), an uncoupler of oxidative 
phosphorylation. Several tuberculocidal treatments (70°C/30 min, 70% ethanol and 4% 
formaldehyde) lead to development of uncoupler insensitive R 123 labelling of dead cells, 
demonstrating the requirement for a physiologically validated procedure where labelling 
was unambiguously attributed to membrane energisation. All antimycobacterial drug 
treatments (isoniazid, rifampicin, ethambutol, streptomycin and capreomycin) produced 
an excess of between 1 and 4 orders of magnitude of uncoupler sensitive R 123 labelling 
cells over culturable units. Thus, large populations of active but nonculturable (ABNC) 
cells were produced by antimycobacterial drugs commonly used in the treatment of 
tuberculosis. Non-labelling and ABNC cell populations were further investigated using a 
GFP reporter strain and by exposure to the lytic mycobacteriophage D29. In addition to 
demonstrating many of the potential pitfalls that may be encountered when the results of 
cellular activity/integrity assays are equated with viability/nonviability, these studies 
illustrate the heterogeneous nature of M tuberculosis cultures and the extent to which 
bulk analysis may give a misleading picture of cellular composition and physiology. 
Although the significance of the non-labelling and ABNC cells observed remains to be 
established, we speculate that these populations may have implications for the 
chemotherapy of tuberculosis. 
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1. INTRODUCTION 
CHAPTER 1 INTRODUCTION 
1.1 GENERAL INTRODUCTION 
In spite of forty years of effective chemotherapy for tuberculosis, the disease has never 
ceased to be a global health problem. Tuberculosis remains the major causative factor in 
3 million deaths worldwide each year. Much of the recent attention that this disease has 
received can be attributed to the resurgence of tuberculosis in developed countries and the 
emergence of multi-drug resistant strains of the causative agent Mycobacterium 
tuberculosis. However, tuberculosis remains the foremost cause of death from a single 
infectious agent in developing countries where 95% of all cases occur. A particularly 
worrying aspect of the current re-emergence of tuberculosis is the association with the 
Acquired Immunodeficiency Syndrome (AIDS) pandemic SInce Human 
Immunodeficiency Virus (HIV) infection has emerged as the strongest known risk factor 
for the development of tuberculosis and has produced and epidemic within an epidemic. 
The demanding, expenslve and lengthy reglmens required to cure tuberculosis are 
recognised as a significant obstacle to the control of this resurgent disease. However, the 
biological basis for the slow response to chemotherapy is not clearly established. While 
host factors may contribute to the problem by sequestering the organism at sites where the 
effects of antimicrobial agents are marginal, little is known about the physiological 
properties of the disease which could render it refractory to eradication. 
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1.2 THE GENUS MYCOBACTERIUM 
Members of the genus Mycobacterium are considered to be aerobic, non-motile, non-
sporeforming, rod-shaped bacteria, 0.2-0.7 x 1.0-10.0 J.lm in size (Murray et al., 1990). 
They are included in the aggregate group of Actinomycetales called the nocardioform 
actinomycetes which includes organisms classified in the genera Caseobacter, 
Corynebacterium, Mycobacterium, Nocardia, Rhodococcus and the "aurantiaca" 
(Goodfellow et aI., 1984). Mycobacteria are weakly Gram-positive and are characterised 
by their staining property of acid-fastness. When stained with one of the basic dyes such 
as carbol fuchsin, they resist decolourisation with mineral acids or acidified organic 
solvents. 
When the generic name Mycobacterium was introduced in 1896 (Lehmann and Neuman, 
1896), the genus only contained two species, M tuberculosis and Mycobacterium leprae, 
respectively the causative agents of tuberculosis and leprosy. It became apparent that 
other types of acid-fast bacilli were present in the environment and new mycobacterial 
species were placed into groups according to their speed of growth and pigmentation 
(Runyon, 1959). Group I contained slowly growing photochromogenic species (yellow 
pigment produced by culture after exposure to light), Group 11 was made up of the 
scotochromogenic slow-growers (yellow pigment produced without exposure to light) 
and Group III the non-chromogenic slow growers which included M tuberculosis. Group 
IV consisted of the rapidly growing mycobacteria. Slow-growers require over 7 days at 
optimal temperature on nutritionally rich medium to form easily visible single colonies, 
whereas fast-growers achieve this in 7 days or less. Although several recognised 
mycobacterial species are cultivated only with great difficulty, M leprae is unique 
amongst them, as it is not cultivable in vitro. The taxonomy of mycobacteria is now 
sufficiently complete to attach species names and Runyon group classification is rarely 
used. Currently, there are 78 recognised or proposed species of Mycobacterium (Wayne 
and Kubica, 1986; Shinnickand Good, 1994; Koukilakahkola et aI., 1995; Kleespies et 
3 
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al., 1996; Domenech et al., 1997; Schroder et al., 1997; Shojaei et al., 1997; Reischl et 
al., 1998; Vuorio et aI., 1999). 
More than 25 mycobacterial species other than M tuberculosis have been found in human 
clinical specimens, although the true pathogenicity of some is questionable (Table 1.1) 
(Heifets and Good, 1994). Non-tuberculous mycobacterial disease is more common in 
patients with pre-disposing conditions such as previously damaged lungs and 
immunosuppression. The Mycobacterium avium complex has become the second most 
important group of organisms among the mycobacterial species causing either 
disseminated infection in AIDS patients and localised pulmonary disease in non-AIDS 
patients (Heifets, 1994). 
Table 1.1: Mycobacteria-other-than-tubercle bacilli which have been associated with human disease 
(Shin nick, 1994) 
Slow-growers 
Mycobacterium asiaticum 
Mycobacteriun aviumlintracellulare 
Mycobacterium celatum 
Mycobacterium genavense 
Mycobacterium haemophilum 
Mycobacterium interjectum 
Mycobacterium intermedium 
Mycobacterium kansasii 
Mycobacterium /eprae 
Mycobacterium malmoense 
Mycobacterium marinum 
Mycobacterium scrofulaceum 
Mycobacterium shimoidei 
Mycobacterium simiae 
Mycobacterium szulgai 
Mycobacterium ulcerans 
Mycobacterium xenopi 
Rapid-growers 
Mycobacterium flavescens 
Mycobacterium fortuitum complex 
Mycobacterium gordonae 
Mycobacteria have unusually high lipid content, greater than 25% (in dry weight) in 
contrast to 0.5% in Gram-positive and 3% in Gram-negative bacteria (Smith, 1982). The 
lipids form an integral part of the distinct mycobacterial cell envelope, where they 
account for about 60% of the dry weight. The model of the mycobacterial cell wall, 
proposed by Minnikin (1982) and subsequently elaborated by McNeil and Brennan 
(1991), shows it to be among the most complex found in the microbial world. A 
schematic representation of the cell wall of M tuberculosis is shown in Figure 1.1. 
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The innermost layer of the envelope is the cytoplasmic membrane, which is similar to that 
found in other bacteria. External to this is a layer of conventional peptidoglycan that is 
linked to arabinogalactan (a branched polysaccharide composed of arabinose and 
galactose). The terminal arabinose units on the sidechains are covalently bound by 
esterification to a group of long chain fatty acids, termed mycolic acids. Mycolic acids 
are high molecular weight 3-hydroxy-2-alkyl branched fatty acids and mycobacteria differ 
from other mycolate-containing actinomycetes in the complexity of the types of mycolic 
acids present. The mycolic acids of mycobacteria have between 60 and 90 carbon atoms 
whereas those of the other members of nocardioform actinomycetes are smaller in size, 
ranging from 30 to 60 carbon atoms. The outer layer is composed of a heterogeneous 
group of complex free lipids with medium-chain fatty acids (e.g. the mycocerosates of the 
phenolic glycolipids) and short-chain fatty acids (e.g. phospholipids). 
CElL W AlJ.. PR.01'EIN UPOARABINOMANNAN 
GL YCOUI'IDS 
MYCOUCACID 
ARABINOOALACTAN 
PEPTID()()L YCAN 
CELL MEMBRANE PR.01'EINS 
Figure 1.1: A schematic representation of the ceU wall of M. tuberculosis (not to scale) (after 
Minnildn, 1982; McNeil et aL, 1991). 
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Minnikin (1982) proposed that the mycolic acids bound to arabinogalactan are arranged 
with their main and branched chains parallel, producing a parallel binding region which 
offers hydrophobic anchoring sites for the long acyl componemts of the complex free 
lipids. Essentially this produces a double membrane system analogous to the outer 
membrane of Gram-negative bacteria. Indeed, electron-microscopic studies of the 
mycobacterial cell wall show alternating zones of electron density and transparency 
similar to that of the Gram-negative cell wall (Brennan and Draper, 1994; Paul and 
Beveridge, 1994). 
McNeil and Brennan (1991) adapted Minnikin's earlier model to include 
lipoarabinmannan (LAM), which protrudes through the cell envelope from a covalent 
phospholipid anchor in the cytoplasmic membrane bilayer. It is thought that LAM has an 
important role to play in the interaction of the pathogen with the host, possibly 
contributing to the ability of M tuberculosis to survive within macrophages (Brennan and 
Besra, 1997; Besra and Chaterjee, 1994). 
The high proportion of cell envelope lipids and associated complex lipids constitutes a 
physical barrier that results in low permeability to a variety of solutes (Nikaido and 
Jarlier, 1991). This low permeability combined with the unique mycobacterial wall 
structure are thought to play important roles in the intrinsic resistance of these bacteria to 
most antibiotics, to chemical injury and attack by lytic enzymes. 
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1.3 TUBERCULOSIS 
1.3.1 Mycobacterium tuberculosis 
Tuberculosis in humans is caused by members of the M tuberculosis complex, which 
includes the subspecies M tuberculosis, M tuberculosis Asian variant, M tuberculosis 
African variant I, M tuberculosis African variant 11 and Mycobacterium bovis. M bovis 
rarely causes disease in areas of the world where animal husbandry includes TB screening 
and milk pasteurisation. The M tuberculosis complex also includes Mycobacterium 
microtti, a rarely encountered pathogen of voles and other small mammals which 
produces tubercles but is not naturally virulent for man. 
Although the M tuberculosis complex constitutes a relatively homogeneous group of 
bacteria, members of the group can be separated by several phenotypic and 
epidemiological characteristics (Shinnick and Good, 1994). In addition, vanous 
repetitive DNA elements that contribute to strain variation have been discovered. Two of 
these are insertion sequences and the remainder are short repetitive DNA sequences with 
no known function or phenotype (Small and van Embden, 1994). IS6110 is found in a 
variable number of copies and at different loci in the genomes of M tuberculosis strains. 
Locations of these copies in the genome are different in epidemiologically unrelated 
isolates, and this characteristic is utilised for the typing of M tuberculosis strains and in 
studies of tuberculosis transmission. 
1.3.2 Transmission and pathogenesis of disease 
Most cases of human tuberculosis result from inhalation of infected airborne droplets 
expectorated from a person with infectious pulmonary or laryngeal disease (Smith and 
Moss, 1994). These droplets are created following sneezing or coughing, dry to form 
droplet nuclei and can remain suspended in air currents for hours. Following the 
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inhalation of virulent microorganisms, the bacilli enter and proliferate intracellularly 
within alveolar macrophages (Fenton and Vermeulen, 1996). 
Primary infection occurs when phagocytic defences fail locally and bacilli proliferate in 
macrophages, usually in discrete alveolar foci. Bacilli are transported to regional lymph 
nodes, where additional foci of disease develop. Lesions developing at the implantation 
site and in the lymph nodes constitute the primary complex. Bacilli spread beyond this 
complex by the lymphatics and bloodstream, and lodge in many organs of the body. 
Primary infection may give rise to mild fever and malaise, particularly when the regional 
lymph nodes are involved, but most cases are asymptomatic. 
The possible course of events following primary infection by M tuberculosis largely 
reflects the host's immune response and is summarised in Figure 1.2 (Grange, 1998). 
Where the immune system is competent, cell mediated immunity develops, macrophages 
infiltrate the lesion, which becomes surrounded by epithelioid cells, and granuloma 
develop. Subsequent caseation of dead macrophages and tubercle bacilli in the centre and 
the deposition of collagen in the outer layers make up the characteristic tuberculous 
granuloma or 'tubercle' which contains the infection. M tuberculosis bacilli persist to an 
unknown extent, quiescent but viable in the tubercles. 
In about 95% of infected individuals the primary complex resolves spontaneously and 
therefore usually passes unnoticed. In the remainder, particularly in some children, the 
primary complex causes serious complications. These include pulmonary disease, 
nonpulmonary disease (meningeal, bone and joint or renal tuberculosis) and miliary 
tuberculosis (when foci of infection erode into major blood vessels, resulting in 
dissemination of bacteria and the production of numerous small lesions throughout the 
body). 
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Figure 1.2: The possible course of events following primary infection by M. tuberculosis (Grange, 
1998). 
In the absence of these complications the infection becomes quiescent as stated and 
usually remains latent for the rest of the person's life. However, infected individuals have 
a 10% lifetime risk of developing post-primary tuberculosis (Hopewell, 1994). 
Conditions predisposing to reactivation include old age, malnutrition, malignant disease, 
corticosteroid therapy, immunosuppressive drugs and disease, including HIV infection. 
Post-primary tuberculosis may also occur from exogenous infection in communities 
where the disease is highly prevalent. 
Post-primary tuberculosis tends to occur in the apices of the lungs irrespective of the site 
of the primary complex. Post-primary pulmonary lesions differ from primary lesions in 
that the necrotic element is much more evident, very large lesions occur and the 
surrounding tissues often liquefy. Local progression is much more marked and the 
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development of secondary lesions is common. Lesions may rupture into the bronchi and 
discharge their necrotic contents, thereby forming pulmonary cavities. Such patients are 
infectious and are said to have open tuberculosis. Bleeding can be serious when a 
bronchial artery is eroded. In contrast to primary tuberculosis, post-primary tuberculosis 
is more localised and contained as lymphatic or haematogenous spread of disease is rare. 
The pathologic and inflammatory processes produce the characteristic weakness, chest 
pain, fever, cough and bloody sputum of TB. 
1.3.3 Dormancy of M. tuberculosis 
There is currently renewed interest in the concept that M tuberculosis is capable of 
adapting to prolonged periods of dormancy during infection (Parrish et al., 1998; 
Gangadharam, 1995; Wayne, 1994; Grange, 1992). The existence of dormant tubercle 
bacilli (persistors) for long periods after chemotherapy was shown by McCune and his 
colleagues in 1966 (McCune et al., 1966). The physiological state and nature of these 
persistors is unknown but it is widely thought that these bacteria are in a state of 
dormancy which renders them functionally resistant to many of the anti-tuberculosis 
drugs. Persistors may be responsible for the endogenous reactivation of tuberculosis 
years or even decades after the primary infection in so-called latently infected individuals. 
Reports of non-acid-fast forms of M tuberculosis in persistent human infection, which 
are suggestive of a spore-like resting state, have remained controversial for nearly a 
century (Stanford, 1987). In 1907 and 1908 Hans Much described spore-like granules of 
M tuberculosis present in tuberculous tissues and abscesses that were not properly acid 
fast, not easily cultured, were just large enough to be resolved by light microscopy but 
small enough through porcelain filters then used (Much, 1907; 1908). Ultra-fine forms of 
M tuberculosis were again described by Khomenko (1987) who observed that the 
proportion of ultra-fine forms increased during anti-tuberculosis chemotherapy, by the 
third month of treatment he detected them in 82% of patients with open cavities. These 
ultra-fine forms were 20 times smaller than the typical acid-fast bacteria, passed through 
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fine-porous filters, were spherical with dense electron opaque shells when examined by 
electron microscopy and reverted to typical forms of M tuberculosis by passage in liquid 
culture medium. 
The presence of homologs of Streptomyces coelicolor and Bacillus subtilus sporulation 
genes in M tuberculosis provides further evidence that the organism may have a spore-
like metabolically inactive form that may respond to activating signals (De Maio et at., 
1996). Although transcription of these genes is induced in stationary phase and is 
virtually undetected in exponential phase cultures, further molecular genetic studies are 
necessary to determine their true function in mycobacteria. 
Recent work suggests that dormancy may be the result of metabolic adaptation to 
anaerobiosis, in response to conditions that the bacteria are exposed to in the human host 
such as in sealed-off tubercles. Wayne and Lin (1982) have shown that although very 
abrupt exposure to anaerobic conditions has a lethal effect on actively-growing cultures of 
M tuberculosis, incubation under conditions in which oxygen is depleted gradually leads 
to a shift down from active replication to dormancy. This orderly shutdown is essential to 
continued survival of M tuberculosis in a quiescent form. These workers found that M 
tuberculosis was resistant to the major antituberculosis drugs whilst in this dormant phase 
but were susceptible to metronidazole, a drug that acts almost exclusively on anaerobes 
(Wayne and Sramek, 1994). An understanding of the nature and physiological properties 
of persisters would be of great value as it could provide the key to the development of 
better preventive therapy and much shorter courses of chemotherapy (Grange, 1992). 
Cunningham and Spreadbury (1998) reported that there is a marked thickening of the cell 
wall outer electron-opaque layer in M tuberculosis and M bovis BCG when the bacteria 
were cultured under either microaerobic or anaerobic conditions. They speculated that 
the thickened walls act as a protective coat or mantle and help the bacilli to survive in 
oxygen deficient conditions in vivo and may offer protection against hostile environments 
such as the toxic conditions associated with granulomas. They found no evidence for a 
11 
CHAPTER 1 INTRODUCTION 
spore-like or coccoid morphology and speculated that the thickened cell wall might 
alleviate the necessity for these bacteria to sporulate. They also observed the 
upregulation of an a-crystallin homolog (16 kDa small heat protein) during adaptation to 
Iow-oxygen conditions which may play a role in stabilising cell structures during long-
term survival. 
1.3.4 Prevention of disease by vaccination 
The BaciIle Calmette-Guerin (BCG) vaccine was developed by Calmette and Guerin in 
1921 from an attenuated strain of M bovis that had been through 231 serial cultures over 
13 years and that had lost its pathogenicity in animals (Calmette, 1927; Guerin, 1957). 
BCG is globally the most widely used vaccine with over 3 billion doses having been 
administered in the past four decades and more than 70% of the world's children now 
receiving BCG (Fine and Rodrigues, 1990). However, the protective efficacy of the BCG 
vaccine has always been the subject of controversy (Bloom and Fine, 1994). A critical 
review of eight controlled BCG trials concluded that trials had a range of observed 
efficacy and protection varied from - 57% to over 75% (Clemens et aI., 1983). Although 
several explanations for BCG's variable efficacy have been proposed (different vaccine 
strains and doses; influence of exposure to environmental mycobacteria; differences in 
virulence between M tuberculosis strains; and genetic differences within and between 
human populations), there is still no general agreement on the basis for the variation. 
There is no evidence that BCG vaccination can prevent the establishment of infection but 
it appears to limit the multiplication and dissemination of the bacilli and the development 
of lesions. Efficacy is greatest against disseminated disease in young children, reducing 
death rates from progressive pneumonic primary infection, miliary and meningeal 
tuberculosis. 
There is much research into improved vaccines for tuberculosis. Alternative vaccines 
include: recombinant BCG vaccines expressing protective antigens of M tuberculosis 
(Stover et aI., 1991), genetically attenuated M tuberculosis vaccines (Ganjam et al., 
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1991), atypical mycobacterial vaccines (Palmer and Long, 1966), auxotrophic or killed 
vaccines for use in immunocompromised recipients, and DNA vaccines (Ulmer et aI., 
1998). 
1.3.5 The return of an old nemesis 
The 20th century saw a gradual decline in the incidence of tuberculosis in industrialised 
countries (Snider et aI., 1994). This decline was associated with increases in living 
standards and accelerated by the introduction of effective chemotherapy in the 1950s. 
Statistics from the United States of America (USA) compiled between 1953 and 1984 
show an average decline of about 5.3% per year in the incidence of disease, and infection 
was typically associated with 100% cures (Centers for Disease Control and Prevention, 
1993). This significant reduction in tuberculosis was observed in other developed 
countries. Incidence rates reached a low plateau level of 10-12 per 100,000 in the USA, 
however, from 1985 an increase of 20% in the number of reported cases of tuberculosis 
was observed. 
In contrast to industrialised countries, tuberculosis remains the foremost cause of death 
from a single infectious agent in developing countries where 95% of all cases occur, 
accounting for more than 25% of avoidable adult deaths (Snider, 1994). The World 
Health Organisation (WHO) estimates that about one third (1.7 billion) of the world's 
population is infected with, or has been infected by M tuberculosis (WHO, 1998). This 
leads to about 9 million new cases of tuberculosis and 3 million deaths from the disease 
annually. A particularly worrying aspect of the current almost-global re-emergence of 
tuberculosis is the occurrence of a series of outbreaks caused by drug resistant strains. 
The re-emergence of tuberculosis as a significant public health problem in the developed 
world is particularly associated with immigrant groups from countries where tuberculosis 
is endemic, alcoholics and drug addicts, homelessness, malnutrition, and more recently 
with HIV infection and AIDS (Bloom and Murray, 1992). Because of the virus's ability 
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to disrupt the immune system, HIV has emerged as the most significant risk factor for 
progression of latent tuberculosis infection to clinical disease (Selwyn et al., 1989). In 
general, individuals who are infected by M tuberculosis have a 10% lifetime risk of 
developing clinically significant disease. For individuals coinfected with HIV, this risk 
rises to 5-10% per annum, along with greatly increased case fatality, even when the 
disease is properly treated. 
The impact of HIV on tuberculosis has been greatest in developing countries where 85% 
of the estimated 13 million adults and 1 million children infected with HIV live (WHO, 
1998). In many of these countries, tuberculosis has been reported in 20-40% of AIDS 
patients. Although HIV -associated disease accounts for a major part of the recent 
increase in tuberculosis incidence in the USA, HIV and tuberculosis are largely restricted 
to distinct populations in the United Kingdom (Rieder, 1998). 
1.3.6 The genome project 
Since its isolation from a human patient at New York's Trudeau Sanatorium in 1905, M 
tuberculosis strain H37Rv has been used extensively, in biomedical research in 
laboratories all over the world (Kubica et aI., 1972). It has retained full virulence in 
animal models of tuberculosis, is susceptible to drugs used in chemotherapy and IS 
amenable to genetic manipulation (Cole et al., 1998). 
The complete genomic sequence of M tuberculosis H37Rv has recently been determined 
and analysed (Cole et al., 1998). The genome consists of a single circular chromosome 
containing 4,411,529 base pairs, encodes approximately 4,000 genes, and has a very high 
guanine and cytosine content (65.6%) that is reflected in the biased amino acid content of 
the proteins. A large proportion of its coding capacity is devoted to the production of 
enzymes involved in lipogenesis and lipolysis. The genome is rich in repetitive 
deoxyribonucleic acid (DNA), particularly insertion sequences and in new multigene 
families and duplicated housekeeping genes. By using database comparisons, precise 
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functions have been attributed to about 40% of the predicted proteins and some 
information or similarity for another 44%. The remaining 16% resembled no known 
proteins and may account for specific mycobacterial functions. 
The wealth of information revealed from the systematic sequence analysis of the genome 
will undoubtedly fuel the next generation of research. The genome project will be used 
for a diverse range of purposes: deducing gene function by bioinformatics, reverse 
genetics and pathogenicity, new leads for chemotherapy, and immunoprophylaxis (Cole, 
1996). 
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1.4 CHEMOTHERAPY OF TUBERCULOSIS 
1.4.1 General principles 
Mitchison (1985) has proposed that the M tuberculosis population in an infected 
individual can be divided into four sub-populations distinguished by their location and 
metabolic activity. According to this hypothesis bacteria are either: (1) actively 
metabolising and relatively rapid growing, (2) semi dormant in an acidic environment 
(early acute inflammation sites or within the phagolysosomes of the macrophages), (3) 
semidormant in nonacidic environments with occasional spurts of metabolism or (4) in a 
dormant state. It is thought that tubercle bacilli are only vulnerable to bactericidal drugs 
when they are metabolically active and replicating. Therefore the putative sub-
populations of bacilli that are in groups 3 and 4 are not amenable to cidal action unless 
they become metabolically active. 
Five drugs are currently regarded as essential in the management of tuberculosis -
rifampicin, isoniazid, pyrazinamide, ethambutol and streptomycin (WHO, 1991). 
According to Mitchison, these drugs vary in their bactericidal action (ability to kill large 
numbers of actively metabolising bacilli rapidly), sterilising action (capacity to kill slowly 
or intermittently metabolising semi-dormant and persisting bacilli) and ability to prevent 
the emergence of acquired resistance by suppressing drug-resistant mutants in large 
bacterial populations (Mitchison, 1985). The relative activities of the mam anti-
tuberculosis drugs in each of these functions are summarised in Table 1.2. 
Table 1.2: Grading of activities of anti-tuberculosis drugs (Mitchison, 1985) 
Drug Sterilising action Early bactericidal Prevention of drug resistance 
Rifampicin Good Fair Good 
Pyrazinamide Good Poor Poor 
Isoniazid Fair Good Good 
Ethambutol Poor Fair Fair 
Streptomycin Poor Poor Fair 
Thiacetazone Poor Poor Poor 
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1.4.2 Drug resistance 
Drug resistance in mycobacteria results from selective growth of spontaneous resistant 
mutants in a wild population when exposed to a drug that can inhibit growth of sensitive 
organisms (Grange, 1988). Spontaneous mutations leading to drug resistance occurs in 
M tuberculosis with a frequency of approximately 1 x 10-6 to 1 x 10-8 depending on the 
drug (Table 1.3) (David, 1970). There is a high probability of resistant mutants emerging 
and becoming predominant in single drug regimens as bacterial populations in 
tuberculous cavities may be as high as 109 (Johnson and Sepkowitz, 1995). Therefore, it 
is considered essential during treatment to include two or more drugs to which the strain 
is sensitive so that the probability that one organism will simultaneously develop 
resistance to the drugs becomes negligible. 
Table 1.3: Mutant frequencies in unselected populations of M. tuberculosis (David, 1970) 
Drug ().tg mrl) Average mutant frequencl 
Rifampicin (I.O) 
Isoniazid (0.2) 
Ethambutol (5.0) 
Streptomycin (2.0) 
• Proportion of mutants observed in an unselected population. 
1.20 X 10.8 
3.50 X 1006 
3.10 X 10.5 
3.80 X 1006 
Although adequate regimens of anti-tuberculosis drugs are available, the incidence of 
drug-resistant and multi-drug resistant tuberculosis (MDR-TB) continues to increase. 
MDR-TB is usually defined as disease caused by bacteria that are resistant to two or more 
anti-tuberculosis agents including both isoniazid and rifampicin (WHO, 1997; Cohn et 
al., 1997). Disease produced by MDR-TB is expensive and difficult to cure with cure 
rates less than 50% (Houston and Fanning, 1994). 
Since the early 1990s, several outbreaks of MDR-TB have been reported in different 
regions of the world (Cohn et al., 1997). In many of these outbreaks, the emergence of 
new strains of M tuberculosis that are resistant to all current anti-tuberculosis agents has 
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raised the possibility of untreatable disease. This problem was documented in the New 
York City outbreak, where the evolution and dissemination of strain W, an extremely 
drug-resistant strain caused at least 22% of MDR-TB during the peak tuberculosis year of 
1992 (Agerton et al., 1999). Almost all the isolates of strain W were resistant to four 
first-line drugs and kanamycin. Most of the cases were associated with HIV-infected 
individuals and there was citywide nosocomial spread of W -strain TB among AIDS 
patients because the recommended four-drug therapy was not effective. 
1.4.3 Drug regimens 
Modern tuberculosis chemotherapy has had a profound effect on the outcome of 
tuberculosis in the individual (Houston and Fanning, 1994). The long-term mortality of 
active tuberculosis is well over 50% without treatment, while the cure rate of drug 
sensitive disease approaches 100% with optimal therapy. 
Several regImens of short-course chemotherapy of tuberculosis are recommended by 
WHO on the basis of extensive field trials (WHO, 1991). The 6-month regimen of daily 
isoniazid and rifampicin, supplemented by pyrazinamide for the first 2 months, is 
regarded as the most effective and consistently results in a combined rate of treatment 
failure and relapse of less than 5% in drug-sensitive tuberculosis (Home, 1990). The 
addition of a fourth drug to the initial phase is recommended in populations with a high 
incidence of primary resistance. 
The combination of these drugs during treatment produces an early bactericidal effect and 
most of the freely multiplying extracellular organisms are thought to be destroyed during 
the first few days of therapy (Jindani et al., 1980; Mitchison, 1985). The bactericidal 
effect is highest for isoniazid and is important in shortening the period during which the 
patient is most infectious to others. During the next two months, pyrazinamide and 
rifampicin, by virtue of their high "sterilising" activity, kill the bulk of the remaining 
bacteria. This powerful sterilising effect has apparently enabled shortening of the overall 
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period of tuberculosis chemotherapy to 6 months. Continued treatment with rifampicin is 
thought to ensure that dormant and near-dormant bacteria are eventually killed. The 
inclusion of two or more drugs throughout the treatment prevents the emergence of drug 
resistance. This regimen has become the therapy of choice for pulmonary tuberculosis in 
most countries in the developed world. 
In spite of this powerful regImen, treatment failure remains a problem. The most 
common causes are patients who discontinue their treatment too early or who take their 
drugs irregularly. Directly observed therapy (DOT) is used in many countries in order to 
control this problem, especially amongst "problem patients" who cannot be relied upon to 
self-administer therapy (WHO, 1997). Patients with relapsing or unresponsive disease 
are a priority for obtaining culture and drug sensitivities. Single drugs are never added to 
a failing regimen as this may in effect, result in single-drug treatment creating ideal 
conditions for the development of resistance to the new medication. In the absence of 
reliable sensitivity tests the WHO recommend an 8-month retreatment regimen. This 
consists of 3 drugs throughout (isoniazid, rifampicin and ethambutol) supplemented by 
pyrazinamide during the first 3 months and streptomycin during the first 2 months. 
Individuals who have failed the standard WHO retreatment regIOn, patients with 
resistance to at least isoniazid and rifampicin, and other patients who have received a 
variety of sub-optimal regimens outside national programmes require the use of second-
line drugs. These drugs are less effective and have more side effects. The initial regimen 
should consist of at least three drugs, preferably four or five, to which the bacilli are 
likely to be fully sensitive. 
1.4.4 Antimycobacterial drug activity 
The characteristics of the existing first and second line antimycobacterial drugs are 
summarised in Table 1.4 along with current understanding of their modes of action and 
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the genes responsible for the development of resistance (Chopra and Brennan, 1998; 
Evans, 1998). 
Table 1.4: Characteristics of the main anti-tuberculosis drugs (adapted from Evans, 1998) 
Year of Molecular target" Genes involved in Mutation 
introduction drug resistanceb rateC 
._----_ .. __ .. _-_. __ .. __ ._--_ .. _-_._--.--_ .. _---_._-_ .. - .... _ ... _--
First-line drugs 
Isoniazid 1952 Mycolic acid synthesis inhA, kasA, kalG 10-8 
Rifampicin 1965 RNA polymerase (p- rpoB 10- 10 
subunit) 
Pyrazinamide 1970 ? pncA 10-3 
Streptomycin 1944 30S ribosomal subunit rpoL, rrs, str A, S 12 10-8 
Ethambutol 1968 Cell wall polysaccharides embA, B, C 10-7 
Second-line drugs 
Ethionamide 1966 Mycolic acid synthesis (?) ? 10-3 
Kanamycin! 1957 30S ribosomal subunit ? 10-6 
Amikacin 
Cycloserine 1955 Cell wall synthesis A IrA 10- 10 
Capreomycin 1967 70S ribosomal subunit (?) ? 10-3 
Thioacetazone 1950 Mycolic acid synthesis (?) ? 10-3 
p-Aminosalicylic 1946 Folate biosynthesis! iron- ? 10-8 
acid (PAS) chelating mycobactin 
synthesis (?) 
Ofloxacin 1987 DNA gyrase gyrA, B ? 
• (?) indicates suspected molecular targets (Chopra and Brennan, 1998); b ? indicates where genes involved in drug resistance arc 
unknown; < mutation rate is defined as the rate of mutation per cell division at the gene(s) responsible for drug resistance. 
Isoniazid is highly active against M tuberculosis and is central to the treatment of 
disease. Although the drug was synthesised in 1912, it was not recognised as an anti-
tuberculosis drug for 40 years (Heifets, 1994). Its use is estimated to kill approximately 
90% of the bacterial population in tuberculous lesions during the first few days of 
chemotherapy (Mitchison, 1985). Efficacy of isoniazid is limited to M bovis and M 
tuberculosis, other pathogenic mycobacterial species are not susceptible to the drug 
(Mdluli et al., 1998). Isoniazid enters the mycobacterial cell as an inactive pro-drug and 
is not bactericidal until oxidised by catalase-peroxidase to a still unknown active form 
(Zhang et al., 1992; Zhang, 1993). The mode of action of isoniazid is usually associated 
with inhibition of mycolic acids biosynthesis (Winder, 1982). M tuberculosis bacilli 
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treated with isoniazid show evidence of cellular deformities and loss of acid-fast staining 
coincident with the shut-down of mycolic acid biosynthesis (Takayama et aI., 1973). 
Recent research by Jacobs and colleagues (Banerjee et aI., 1994; Quemard et aI., 1995) 
identified the inhA gene product (InhA) as the primary target. This enzyme catalyses the 
NADH-specific reduction of long chain substrates (12-24 carbons) during the early stages 
of mycolic acid biosynthesis. More recently, Mdluli et aI., (1998) have reported that the 
kasA gene product (KasA) may be the target for isoniazid. They have shown that 
inhibition of this keto acyl synthase results in the accumulation of long chain saturated 
fatty acids needed for mycolic acid biosynthesis. The evidence for several isoniazid 
targets has lead some researchers to speculate that the activated form of isoniazid may 
have multiple targets, each of which could possibly be lethal to the cell (Barry et al., 
1998). 
Rifampicin was introduced into anti-tuberculosis drug regimens m 1966 and is an 
essential element of modem short course « 1 year) regimens (WHO, 1997). It proves 
very effective in the inhibition of mycobacterial DNA-dependent RNA polymerase which 
in cell free systems is 1000 times more sensitive than the equivalent enzyme isolated 
from Escherichia coli (Nikaido and Jarlier, 1991). Rifampicin is an important 
bactericidal drug but is also an important sterilising drug because of its ability to kill 
semi-dormant bacilli capable of surviving the bactericidal effect of isoniazid (Mitchison, 
1985). Resistance to rifampicin occurs by mutations leading to an altered p-subunit of 
the polymerase (Russell and Chopra, 1996). 
Pyrazinamide is considered the third most important drug in modem therapy of 
tuberculosis (WHO, 1997). Its unique role for accelerating the sterilisation effect in 
combination with rifampicin and isoniazid is a key element that has enabled shortening of 
therapy form 9 to 6 months (Heifets, 1994). Pyrazinamide is only active in acidic 
environments (pH 5.8 optimum) and it is postulated that the drug is effective against 
bacterial subpopulations persisting in the low pH environments associated with acute 
inflammation sites and possibly within the phagolysosomes of macrophages (Mackaness, 
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1956; McDermott and Tompsett, 1954). Susceptible mycobacterial strains convert 
pyrazinamide to pyrazinoic acid and it has been suggested that this enzyme-generated 
product is responsible for the antibacterial activity of the drug (Chopra and Brennan, 
1998). Strains resistant to pyrazinamide do not produce pyrazinamidase and therefore are 
not vulnerable to this agent (Scorpio and Zhang, 1996). The bactericidal activity of 
pyrazinamide is said to be low (33-57% killing at twofold above the minimum inhibitory 
concentration (MIC)). Pyrazinamide is not very active during the later stages of treatment 
and consequently is only included in the first two months of drug regimens (Home, 
1990). 
Ethambutol is a synthetic compound and appears unrelated to the other anti-tuberculosis 
drugs. It produces a bacteriostatic effect and it is thought to be important in preventing 
the emergence of resistance to the principle antituberculosis drugs (Home, 1990). The 
effect of ethambutol is primarily on polymerisation steps in the biosynthesis of the 
arabinan component of the mycobacterial cell wall (Takayama and Kilbum, 1989; 
Brennan and Besra, 1997). The absence of the arabinan receptor, which acts as the 
mycolic acid anchor in the cell wall prevents the transfer of mycolic acids into the cell 
wall and explains the ethambutol-induced accumulation of trehalose monomycolate, 
trehalose dimycolate, and free mycolic acids in the culture medium. The 
arabinosyltransferase enzymes EmbA and EmbB appear to be the primary targets. Deng 
et aI., (1995) report that ethambutol also inhibits biosynthesis of the arabinan of 
lipoarabinomannan and that there is also evidence that the synthesis of galactan in the cell 
wall core is also strongly inhibited. More recently, Brennan and Besra (1997) suggest that 
the primary effect of ethambutol is on arabinogalactan, not lipoarabinomannan because of 
the different susceptibilities of the arabinosyltransferase enzymes involved in the different 
biosynthetic pathways. 
Streptomycin was the first drug shown to be effective against tuberculosis. It is an 
aminoglycoside antibiotic and inhibits prokaryotic protein synthesis by binding to the 30S 
ribosomal subunit (Russell and Chopra, 1996). It demonstrates potent anti-tuberculosis 
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activity against bacterial populations in cavities, but not intracellularly where the pH is 
low (Houston and Fanning, 1994). It is usually ranked third after isoniazid and 
rifampicin with regard to its early bactericidal activity but demonstrates poor sterilising 
activity on persisting bacteria (Mitchison, 1985). The other aminoglycosides have 
activity against M tuberculosis but often show cross-resistance with streptomycin. 
Capreomycin has many similarities to the aminogycoside antibiotics but has a chemically 
distinct structure (Russell and Chopra, 1996). There is no cross-resistance between 
capreomycin and streptomycin, and occasionally is used in the treatment of tuberculosis 
especially where streptomycin-resistant strains are encountered (Home, 1990). There is 
no direct information on the mode of action of capreomycin (Chopra and Brennan, 1998), 
but it is likely that the drug inhibits protein synthesis (Winder, 1982). 
Thiacetazone is an inexpensive antimycobacterial drug widely used in combined 
chemotherapy for tuberculosis in developing countries where the cost of treatment is an 
important factor (Home, 1990). It has low efficacy but is effective in preventing the 
development of isoniazid resistance when given in combination (WHO, 1991). The 
mode of action of the drug is unknown. However, since many thiacetazone-resistant 
strains of M tuberculosis exhibit cross-resistance to ethionamide (see below) it has been 
suggested that thiacetazone, like ethionamide might inhibit mycolic acid biosynthesis 
(Chopra and Brennan, 1998). 
Many of the new fluoroquinolones have good antimycobacterial activity with low MIC 
values (Houston and Fanning, 1994). The fluoroquinolones are synthetic derivatives of 
nalidixic acid and include ofloxacin, ciprofloxacin and sparfloxacin. They act by 
inhibiting DNA gyrase which catalyses the negative supercoiling of DNA necessary for 
processes dependent on DNA topology such as replication and transcription (Russell and 
Chopra, 1996). Ofloxacin is most active against M tuberculosis and is often used where 
the organism is resistant to one or more first-line drugs (Yew et ai., 1990). However, 
quinolone-containing regimens have demonstrated inferior sterilising ability (67% 
compared with 100% at 2 months) compared with the combination of pyrazinamide and 
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ethambutol (Kennedy et at., 1993). Results obtained to date are based on limited clinical 
data, and the role of fluoroquinolones in anti mycobacterial chemotherapy has yet to be 
fully established (Chopra and Brennan, 1998). 
Ethionamide is structurally similar to isoniazid, and it is now believed that its mechanism 
of action, inhibition of mycolic acid synthesis, is also similar (Blanchard, 1996). 
However, ethionamide is much less active against M tuberculosis than isoniazid (Heifets, 
1994). Cross-resistance between the two drugs does not appear to be common. 
D-cycloserine is a structural analogue of the amino acid D-alanine and inhibits cell wall 
synthesis in mycobacteria by competing with the amino acid during the biosynthesis of 
the mycolylarabinogalactan-peptidoglycan complex (David, 1970). Resistance is 
probably as a result of point mutations in the D-alanine racemase gene (Caceres, 1997). 
D-cycloserine is used in the combination therapy of disease caused by organisms resistant 
to one or more of the first line drugs principally to prevent the emergence of resistance to 
the other drugs in the regimen (WHO, 1997). 
The mode of action of para-aminosalicylic acid (PAS) is unclear but is likely that it 
competes with p-benzoic acid for mycobacterial dihydropteroate synthetase during folate 
biosynthesis (Winder, 1982; Chopra and Brennan, 1998). However, there is also 
evidence that PAS interferes with the salicylate-dependent biosynthesis of the Iron 
chelating mycobactins involved in iron assimilation (Brown and RatIedge, 1975). PAS 
exhibits a high level of activity against M tuberculosis and was widely used in 
combination with isoniazid to prevent the emergence of isoniazid-resistant organisms 
(Home, 1990). Following the introduction of modern short-course regimens, PAS is 
rarely used nowadays as a chemotherapeutic drug in industrialised countries but because 
it is inexpensive it remains an important drug in some developing countries. 
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1.5 DRUG SUSCEPTIBILITY TESTING 
1.5.1 Culture based phenotypic methods 
Drug susceptibility testing is essential for effective management of tuberculosis. There 
are three widely used methods for drug sensitivity testing of M tuberculosis on solid 
medium: the absolute concentration method, the resistance-ratio method and the 
proportion method (Inderlied, 1991). 
In the first method, resistance is defined as growth from a carefully controlled inoculum 
of the isolate (~ 2 x 103 CFU per ml) that is greater than a certain number of colonies 
(usually 20) at a particular drug concentration. In the resistance-ratio method the 
susceptibility test results are expressed in terms of the ratio of the minimal inhibitory 
concentration (MIC) of drug necessary to inhibit the growth of the test isolate of M 
tuberculosis to that of the standard M tuberculosis H37Rv strain. A resistance ratio of 2 
or less is defined as sensitive, while 8 or more is resistant. In the proportion method the 
bacilli are cultured on two media, one with and one without drug; the ratio of the number 
of colonies obtained on the drug-containing medium to the number of colonies obtained 
on the drug-free medium indicates the proportion of resistant bacteria. Drug resistance by 
this method is defined as more than 1 % of a popUlation of bacilli being resistant to a 
given drug. 
There is a clinical need for rapid tests of drug susceptibility to disease caused by M 
tuberculosis because of the extremely slow growth of the organism; even when cultured 
under optimum conditions the tubercle bacilli has a doubling time of 20-24 hours (Hatfull 
and Jacobs, 1994). It takes between 2 and 4 weeks to obtain bacterial colonies from a 
clinical sample that are large enough for further analysis and determination of whether the 
organism is present or not. It then requires at least a further 2 to 4 weeks to determine 
drug susceptibilities due principally to the slowness of colony development. By this time, 
the initial strain may well have acquired new resistance properties, especially in the face 
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of inadequate treatment or poor compliance (Heifets and Good, 1994). This problem is 
becoming more critical due to the emergence of drug-resistant strains of M tuberculosis 
(Cohn et aI., 1997). 
Techniques developed to shorten the turnaround time in mycobacterial susceptibility 
testing include a variety of culture-based phenotypic methods, culture-independent 
genotypic methods (Section 1.5.2) and a variety of colorimetric and bioluminescent 
cytological indicators of cellular viability and proliferation (Section 1.5.3) (Drobniewski 
and Wilson, 1998). The results of any new method for the assessment of drug activity 
should show good correlation with those from conventional methods (Gordon et a/., 
1996). 
A major improvement in the rapidity of testing was the development of the radiometric 
BACTEC system (Becton-Dickinson). The basis of this system is the evolution of 14C02 
from the metabolism of 14C-palmitic acid by mycobacterial clinical isolates. Growth is 
defined in terms of the growth index (Gl) and resistance or susceptibility is determined by 
comparison of the GI values of control bottles relative to values from bottles containing 
the drug of interest. Heifets (1991) reports that it is possible to determine M tuberculosis 
drug susceptibilities in less than two weeks using the BACTEC system and results show 
good agreement with the standard methods (Lee and Heifets, 1987). However, its 
widespread use is restricted because of cost and the generation of radioactive wastes. 
Further work by Becton Dickinson lead to the development of the non-radiometric 
Mycobacterium Growth Indicator Tube (MGIT) fluorometric assay which utilises an 
oxygen-sensitive fluorescent compound to detect growth. Mycobacterial growth removes 
dissolved oxygen from the medium and allows the compound to fluoresce, and this 
provides a means of growth detection. Although the system offers a rapid, non-invasive, 
non-radioactive method of detection and susceptibility testing of M tuberculosis it does 
not offer a significant saving in time over the BACTEC system, and some reports indicate 
that it may actually be less rapid (Pfuffer, 1995). 
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Recently, a novel phenotypic culture-based drug susceptibility assay that uses 
mycobacteriophage to identify viable M tuberculosis cells has been developed (Wilson et 
al., 1997). The PhaB assay (phage amplified biologically) is based on the ability of live 
tubercle bacilli to protect infecting mycobacteriophage from extracellular chemical 
inactivation. The protected mycobacteriophage then replicate within viable bacteria and, 
eventually cause the host mycobacteria to lyse and release a new generation of phage. 
The released mycobacteriophage are plated on to a lawn of the rapidly growing species 
M smegmatis and after overnight incubation are detected as plaques on the test plate. 
Hence, a viable bacterium in the original sample will lead to a plaque on the test plate. 
Drug susceptibility results of cultured MDR-TB isolates were obtained within 3-4 days 
and the assay is being further developed for direct testing on patients samples. 
1.5.2 Culture independent genotypic methods 
Genetic methods for assessing drug resistance in mycobacteria have been developed and 
offer potential advantages over conventional methods of susceptibility testing of M 
tuberculosis (Table 1.5) (Cockerill, 1999). Rapid detection of resistance would be 
produced as clinical samples could be directly tested thus avoiding the need for isolation 
of the organism by culture and the long wait required by conventional methods due to the 
slow growth of the organism. In addition, since the organism does not have to be 
propagated, associated biohazard risks are kept to a minimum. 
However, there are disadvantages particular to genetic methods: different assays are 
required for each anti mycobacterial drug tested; the genetic mechanism for resistance 
needs to be defined; and resistance to a specific antimicrobial agent may occur via 
different mechanisms associated with different resistance genes. Consequently, new 
forms of resistance produced by new mutations would not be detected. 
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Table 1.5: Application of genetic methods for assessing antimicrobial resistance in M. tuberculosis 
(Cockerill, 1999) 
Antimicrobial agent 
Isoniazid 
Rifampicin 
Ethambutol 
Streptomycin 
Pyrazinamide 
Fluoroquinolones 
Genetic changes associated with resistance 
Mutations in the catalase-peroxidase kalG gene 
account for 50-70% of resistant strains (30-
65% due to a single mutation [S315T] 
Examples of reported methods 
PCR-SSCP I, PCR-RFLP 2, PCR-
CFLP 3, PCR-DNA sequencing 
Mutations in the inhA locus account for 5-10% PCR-SSCP, PCR-DNA 
of resistant strains sequencing 
Mutations in promoter region of ahpC PCR-SSCP, PCR-DNA 
encoding the alkylhydroperoxide reductase sequencing 
gene account for 6-13% of resistant strains 
Mutations in rpoB gene, which encodes the p-
subunit of RNA polymerase 
Mutations in embB gene, which encodes 
polymerization of arabinose into 
arabinogalactan, account for -70% of resistant 
strains 
Mutations in genes encoding 16S rRNA (rrs) 
and ribosomal protein S 12 (rpsL) account for 
64-68% of resistant strains 
Mutations in the pncA gene, which encodes 
pyrazinamidase, accounts for -70% of 
resistance strains 
PCR-SSCP, PCR-ddF, PCR-HDP 
analysis, PCR-CFLP, PCR-LiPA, 
PCR-molecular beacon sequence 
analysis, PCR-DNA sequencing 
PCR-SSCP, PCR-DNA 
sequencing 
PCR-RFLP, PCR-DNA 
sequencing 
PCR-DNA sequencing 
Mutations in gyrA gene, which encodes the A PCR-SSCP, PCR-DNA 
subunit of DNA gyrase, accounts for -100% of sequencing 
resistant strains 
I single-strand conformation polymorphism; 2 restriction fragment length polymorphism analysis; 3 cleavage fragment polymorphism. 
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1.5.3 Colorimetric and bioluminescent cytological indicators of cellular viability 
In the past 20 years a variety of colorimetric and bioluminescent cytological indicators of 
cellular viability and proliferation have been developed as rapid tests for drug 
susceptibility of mycobacterial clinical isolates or as high-throughput screens for 
detecting novel antimycobacterial agents (Table 1.6). Many rely on a metabolic process 
such as enzymatic activity (esterase, peroxidase) or membrane potential to identify living 
cells. Viable bacteria contain ion pumps and channels which serve to maintain both the 
appropriate levels of internal ions and the potential difference across the cell's 
membranes. Functioning ion pumps are necessary for cell viability. 
Fluorescein diacetate (FDA) was first described as a fluorescent staining reagent for 
determining cytological activity of mycobacterial cells in 1980 (Jamagin and Luchsinger, 
1980). The relatively membrane-permeant FDA enters live and dead cells and is 
hydrolysed by various esterases to free fluorescein. Fluorescein is retained by cells with 
intact membranes to yield cytoplasmic green fluorescence. In a series of studies around 
this time, FDA was used to demonstrate activity in M smegmatis and M phlei (K vach 
and Veras, 1982), M lepraemurium (Tsukiyama et at., 1985), M leprae (Mor et aI., 
1988), M w and M tuberculosis H37Ra (Chitambar et at., 1988). The emphasis of much 
of this work was development of a drug susceptibility assay for the non-culturable M 
leprae. Although fluorescence after staining corresponded well with the ability of 
mycobacteria to multiply in culture, no correspondence was detected when death of the 
organisms occurred in vivo. Recently, there has been renewed interest in the development 
of a rapid FDA drug susceptibility assay for pathogenic mycobacteria using flow 
cytometry. Organisms investigated in these studies include M tuberculosis H37Ra 
(Norden et al., 1995; Kirk et al., 1998) M avium, M fortuitum, M gordonae and M 
marinum (Bownds et al., 1996). 
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Table 1.6: Cytological Methods that have been used to estimate mycobacterial "viability" or activity 
Method Assay 
Enzyme substrates Fluorescein diacetate 
Tetrazolium salt MTT·, NBT 2,NT 3, 
reduction INT 4 
Tellurite reduction Potassium tellurite 
Energisation-sensitive R 123 
probes 
Reporter systems Luciferase 
GFP 
I3-Galactosidase 
Assay Principle 
Membrane-permeant fluorescein diacetate is de-esterfied by 
esterases in live mycobacteria to yield cytoplasmic green 
fluorescence. 
Reduction of MTT by live M tuberculosis and M avium-
intracellulare to formazan deposits in rapid assay for rifampicin 
resistance. Cytochemical indicator of activity in M smegmatis. 
Reduction of potassium tellurite by (non-culturable) M leprae. 
Accumulation of Rl23 by pathogenic and non-pathogenic 
mycobacteria with energised cytoplasmic membranes. 
Luciferase reporter mycobacteriophages and luciferase producing 
strains of M tuberculosis for rapid testing of tuberculosis drug 
susceptibility. 
GFP reporter assays for high-throughput screening of compounds 
against M tuberculosis 
I3-Galactosidase reporter systems in M smegmatis and M aurum 
prepared for rapid screening of antimycobacterial compounds 
I methylthiazolyldiphenyl tetrazolium bromide;2 nitroblue tetrazolium chloride;3 neotetrazolium chloride;4 iodonitrophenyltetrazolium 
Reference 
Kvach and Veras, 1982; Tsukiyama et al., 
1985; Chitambar et ai., 1988; Mor et ai., 
1988; Jayapal et al., 1991; Norden et al., 
1995; Bownds et al., 1996; Kirk et al., 1998. 
Thorn et al., 1993; Gomez-Fores et al., 1995; 
Mshana et al., 1998. 
David et al., 1982; Mor et al., 1988. 
Matsuyama, 1984; Bercovier et al., 1987; 
Say1es, 1994; Ibrahim, 1996. 
Andrew et al., 1993; Cooksey et al., 1993; 
Jacobs et al., 1993; Gordon et al., 1996; 
Cooksey et al., 1995; Arain et al., 1996; 
Shawar et al., 1997; Carriere et al., 1997. 
Dhandayuthapani et al., 1995; Kremer et al., 
1995; Collins et al., 1998. 
Bar1etta et ai., 1992; Murray et al., 1992 
Table 1.6 continued over 
Table 1.6: Cytological Methods that have been used to estimate mycobacterial "viability" or activity 
Method 
Passive dye exclusion 
Nucleic acid staining 
Ratio of intrabacterial 
Na+ to K+ 
Radiolabelling 
Adenylate energy 
charges 
RNA amplification 
mRNAPCR 
Assay 
Ethidium bromide 
Molecular Probes 
Inc. SYTO stains 
Assay Principle 
Exclusion of nucleic acid labelling ethidium bromide by intact 
permeability barrier in live bacteria 
Live-cell permeant nucleic acid stain 
Mass spectrometric determination of the ratio ofthe intrabacterial 
concentrations ofNa+ and K+ of individual bacterial organisms 
H3 -Thymidine, Uracil Radiometric assay for determination of M /eprae and M aurum 
viability and drug susceptibility 
Monitoring of drug effects of cultivable mycobacteria and M 
lepae by determination of AEC 
16S ribosomal RNA detection in M smegmatis as a rapid 
assessment of viability 
M. leprae 71 kD heat shock protein 
Reference 
Kvach and Veras, 1982; Tsukiyama et al., 
1985; Chitambar et al., 1988; Jayapal et aI., 
1991. 
Ibrahim, 1996; Ibrahim et al., 1997. 
Prioli et al., 1985 
Van der Vliet et al., 1994. 
Patel et al., 1993. 
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Rhodamine 123 (RI23) is a water soluble, cationic, fluorescent dye, originally used for 
selectively labelling mitochondria in living cells but has also proved an indicator of 
cytological activity in a wide range of bacteria including M smegmatis, M bovis BCG 
and M tuberculosis (Matsuyama, 1984; Resnick et af., 1985; Bercovier et af., 1987). 
Bacterial accumulation of R 123 appears to be non-toxic and does not effect the viability 
of treated bacteria (Matsuyama, 1984). R123 accumulates down the electrochemical 
gradient (100-200 mV potential) of live bacteria in an energy dependent fashion. 
Kaprelyants and Kell (1992) demonstrated that R123 is concentrated in an uncoupler-
sensitive fashion, i.e. fluorescence is greatly diminished in bacteria that are exposed to 
uncoupler agents that dissipate the proton gradient across the bacterial cytoplasmic 
membrane. Bercovier et al., (1987) demonstrated that R123 could be used to measure the 
susceptibility of M tuberculosis H37Ra and M bovis BCG to rifampicin in as short a time 
as 24 hours. Work in this laboratory has shown that R123 can be used as an indicator of 
activity in a variety of live pathogenic mycobacteria including clinical isolates of M 
tuberculosis and M avium (D.R. Walker and M.R. Barer, unpublished data; Sayles, 1994; 
Ibrahim, 1996). 
Double staining methods may be used to assess the viability of cells by staining dead cells 
with one dye and live cells with another dye of different emission (Lopez-Amoros et af., 
1995). Dyes that are highly impermeant to membranes will stain only cells that are dead 
or have compromised membranes. The most commonly used stains for identifying dead 
cells are cell-impermeant DNA stains, although any cell impermeant dye can potentially 
be used. Ethidium bromide was used in many of the mycobacterial FDA studies to 
identify dead cells (K vach and Veras, 1982; Matsuo et af., 1984; and Chitambar et al., 
1988). Propidium iodide was used to identify dead mycobacteria by D.R. Walker and 
M.R. Barer (unpublished data), Sayles, (1994) and Ibrahim, (1996). 
Tetrazolium salts have been used extensively as cytochemical indicators of oxidative 
metabolism in a variety of bacteria including mycobacteria (Thorn et al., 1993). These 
agents capture electrons from oxidative metabolism and produce a localised formazan 
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deposit that can be detected by light microscopy. The relationship between capacity for 
tetrazolium salt reduction and cell viability is not clear but offers a rapid, culture-
independent means of detecting microbial activity and relative rate of reducing equivalent 
production in micro-organisms. Gomez-Flores et at., (1995) developed a colorimetric 
assay for drug susceptibility testing of M avium complex based on the ability of live 
bacilli to reduce 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) to 
formazan. More recently, Mshana et al., (1998) described a rapid test that used the ability 
of live M tuberculosis to reduce MTT to detect resistance to rifampicin. Both studies 
concluded that the inhibition of MTT reduction paralleled the reduction in the number of 
colony forming units. 
The reduction of potassium tellurite was used to investigate the effects of several 
substrates on the respiratory activity of M aurum, M smegmatis and M avium (David et 
at., 1982) and to detect activity in M lepraemurium and M leprae (Mor et at., 1988). 
However, although there appeared to be correspondence between tellurite reduction for 
M lepraemurium in vitro, correspondence with tellurite-reduction was not observed when 
death of M lepraemurium occurred in vivo. 
Jacobs and colleagues have demonstrated that drug susceptibility of tubercle bacilli in 
clinical samples could be measured with genetically modified mycobacteriophages 
containing the firefly lux or luciferase gene (Jacobs et aI., 1993; Cooksey, 1993, 1995). 
Drug-resistant mycobacteria growing in the presence of these drugs are able to express 
luciferase, which catalyses the reaction of luciferin with ATP to generate photons of light 
that can be detected in a lurninometer, while mycobacteria sensitive to the drug die, no 
A TP is produced, and there is a cessation of light production. To date, this method has 
not proved sensitive and requires an expensive luminometer (Wilson et at., 1997). 
Luciferase plasmid-based systems have also been developed as high-throughput screens 
for antimycobacterial drugs. Mycobacteria investigated include M smegmatis, M avium, 
M intracellulare, M bovis BCG and M tuberculosis (Cooksey et aI., 1993; Andrew and 
Roberts, 1993; Cooksey et at., 1995; Hickey et at., 1996; Shawar et at., 1997). 
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Systems for high-throughput screening of anti mycobacterial drugs usmg Aequorea 
victoria (jellyfish) green fluorescent protein (GFP) as reporter molecule have also been 
developed. Aequorea GFP fluorescence does not require substrates for fluorescence as 
the active chromophore is generated by the spontaneous cyclisation and oxidation of a 
serine-glycine trimer within a defined hexapeptide sequence of the protein. Kremer et aI., 
(1995) demonstrated that exposure of M bovis BCG to anti mycobacterial drugs produced 
a decrease in fluorescence, while fluorescence increased in drug-free controls. More 
recently, a GFP reporter microplate assay for screening compounds against M 
tuberculosis was described (Collins et al., 1998). 
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1.6 INTRODUCTION TO LIGHT MICROSCOPIC CYTOLOGICAL 
ANALYSES 
A central feature of this study has been the application of light microscope based 
techniques established in this laboratory to the investigation of mycobacterial physiology 
at the cellular level. Single cell cytological investigations of the types described in 
Section 1.5.3 can readily identify metabolically active but non-culturable cells in 
populations without significant cell division and thus reveal a great deal about their 
phenotypes. In addition, cytological analyses provide the opportunity to determine 
whether such phenotypes are heterogeneously distributed within a cell population and 
whether expression of the specific property is dependent on a spatial relationship. 
Investigations of the slowly growing pathogenic M tuberculosis using light microscopy 
also offers the advantage that small quantities of culture are sufficient for most 
investigations (e. g. a few milliliters of cell suspension containing 107 cells mr 1). 
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1.7 AIMS AND OBJECTIVES 
The overall aim of this study was to investigate the effects of antimycobacterial drugs on 
M tuberculosis at the single cell level using cytochemical indicators of cellular activity. 
The purpose was to learn more about the physiological response of M. tuberculosis to 
antimycobacterial drugs and therefore to understand better the properties which render the 
organism refractory to eradication and produce the characteristic slow response to 
chemotherapy ( 6-9 months). 
The specific objectives were: 
1. To establish a culture method for M tuberculosis that would be suitable for both 
cytochemical labelling and antimycobacterial drug studies. 
2. To evaluate and develop methods to study cytological activity in M tuberculosis 
suitable for light microscopy and quantitative image analysis. 
3. To investigate the effects of anti mycobacterial drugs on M tuberculosis using the 
techniques developed and to compare the results to those from conventional culture 
techniques. 
4. To assess what relevance the results of these experiments would have on the 
chemotherapy of tuberculosis. 
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2. MATERIALS AND METHODS 
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2.1 BACTERIAL STRAINS, PLASMIDS AND MYCOBACTERIOPHAGE 
The bacterial strains, plasmids and mycobacteriophage used in this study are summarised 
in Table 2.1. 
Table 2.1: Bacterial strains, plasmids, and mycobacteriophages used in this study 
Bacterial strains 
Mycobacterium tuberculosis H37Rv 
Mycobacterium smegmatis mc2 l55 
Escherichia coli DH5a 
Plasmids 
pMV26 I 
pG FP 
PGFMII 
Mycobacteriophage 
D29 
Description 
Type strain 
M smegmatis strain with high 
transformation phenotype 
SupE44 hsdRI7 recAI thi-l 
MacU 169( ?801acZAM 15) endA I 
gyrA96 relAI 
Mycobacterial cloning vector, KanR 
GFP cDNA source on pUCI9 derivative 
GFP-expressing mycobacterial cloning 
vector, KanR StrepR 
Lytic mycobacteriophage, infects both 
fast- and slow-growing mycobacteria 
Reference/source 
NCTC' 10942 
Snapper et aI., 1990 
Hanahan et al., 1983 
Stover et al., 1991 
Clontech Laboratories2 
Kremer et al., 1995 
Kindly provided by Dr. 
N.G. Stoker3 
I National Collection of Type Cultures, Central Public Health Laboratory, 61 Colindale Avenue, London. 
2 Clontech Laboratories Inc., 4030 Fabian Way, Palo Alto, CA 94303-4607, USA; http:\\GFP.CLONTECH.COM. 
3 Department oflnfectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London. 
SAFETY 
M tuberculosis is a hazardous pathogen, therefore all the work described here was done 
in a containment level 3 laboratory in compliance with established advice (Advisory 
Committee on Dangerous Pathogens, 1995). 
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2.2 GENERAL LABORATORY REAGENTS AND CULTURE MEDIA 
Unless otherwise stated, chemicals were obtained from Sigma-Aldrich Company Limited 
(Poole, Dorset, UK). 
Mycobacterial strains were grown on Middlebrook 7HlO agar (Difco Laboratories, 
Detroit, USA) containing 0.5% (v/v) glycerol and 10% oleic acid-albumin-dextrose-
catalase supplement (OADC), or in Middlebrook 7H9 broth (Difco) containing 0.2% 
(v/v) glycerol, 0.05% (w/v) Tween 80 and 10% albumin-dextrose-catalase (ADC) 
supplement. Mycobacteria transformed with E. coli-mycobacteria shuttle vectors were 
grown in the presence of kanamycin at 25 Ilg mr). Mycobacteria for mycobacteriophage 
studies were grown in Tween 80-free media. 
Middlebrook culture media were prepared according to the manufacturer's instructions 
and sterilised by autoclaving at 121°C at 15 psi for 15 min. The final pH of media was 
6.6 ± 0.2 at 25°C. Prepared media were kept in the dark and used within a week. 
Supplements were bought directly from Difco or prepared fortnightly in the laboratory. 
ADC supplement was prepared from 12.5 g bovine albumin fraction V, 5.0 g glucose, and 
10.0 mg catalase (from bovine liver, thymol-free) made up to 250 ml in distilled water. 
OADC supplement was prepared from 12.5 g bovine albumin fraction V, 5.0 g glucose, 
0.85 g NaCl, 0.05 g oleic acid (1 % solution prepared in 0.2 N NaOH), and 10.0 mg 
catalase made up to 250 ml in distilled water. When dissolved, supplements were filter-
sterilised, incubated overnight to check for contaminants and stored at 4°C for up to 2 
weeks. Supplements were aseptically added to media after autoclaving. 
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2.3 STOCK CULTURES 
M tuberculosis H37Rv was obtained directly as freeze dried culture from the National 
Collection of Type Cultures, Colindale, London, UK. A large seed pool of inoculum was 
prepared by subculturing freeze-dried culture through two passages of Middlebrook 7H9 
broth. The second culture was divided into 1 ml aliquots and stored at -70°C in clearly 
labelled double sealed storage containers. M smegmatis and E. coli were stored at -70°C 
in media containing 10% (v/v) glycerol as a cryoprotectant. 
The Bacto TB Fluorescent Stain Set T (Difco) was used to confirm the purity of M 
tuberculosis cultures during this study. Bacterial suspensions for acid-fast staining were 
smeared onto glass microscope slides, allowed to air dry, and heat fixed by passing the 
slide through the blue cone of a Bunsen flame three or four times. Heat fixed samples 
were stained with Bacto TB Auramine-Rhodamine T for 20 min at room temperature, 
washed with Bacto TB Decolouriser for 2 min and counterstained with Bacto TB 
Potassium Permanganate for 4 min. Slides were rinsed thoroughly with water after each 
treatment. After staining, slides were air dried and mounted in Citifluor immersion oil 
(Agar Scientific Limited, Essex, UK). Acid-fast bacteria were brightly fluorescent on a 
dark background when examined by epifluorescence microscopy. 
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2.4 GROWTH STUDIES 
2.4.1 Growth in liquid medium 
A 250 ml baffled polycarbonate conical flask (Nalgene, Fisher, Loughborough, UK) 
containing 50 ml of Middlebrook 7H9 broth was inoculated with 1 ml of thawed M 
tuberculosis stock and incubated for one week at 37°C in a rotary shaker-incubator at 180 
rpm. A sufficient amount of this first passage culture was added to 100 ml of 
Middlebrook 7H9 broth to yield a calculated optical density at 580 nm of 0.002. This 
culture was incubated at 37°C in a rotary shaker-incubator at 180 rpm, from which 
samples were taken daily for colony counts and optical density measurement. 
In one experiment, growth in liquid medium was assessed for comparison using the 
methods of Wayne (1994) and Mitchison and colleagues (Herbert et ai, 1996). With the 
first method, M tuberculosis culture was prepared as described but aerated with 50-mm 
Teflon-coated magnetic stirring bars in flasks (70 rpm) on magnetic stirrers (Heidolph 
MR 1000, Kelheim, Germany). With the second method, M tuberculosis was grown in 
10 ml of Middlebrook 7H9 broth in unshaken tubes for 7 days at 37°C. The total number 
of bacilli mrl in this culture was determined in a Thoma chamber (see Section 2.7), and 
appropriate amounts were inoculated into 250 ml flasks containing 100 ml of 
Middlebrook 7H9 broth to give 105 bacilli mrl. Cultures were incubated unshaken at 
37°C and sampled after 3 days growth. 
2.4.2 Enumeration of colony forming units 
Enumeration of colony forming units (CFU) was by a drop-plate modification of the 
Miles and Misra procedure (Hob en and Somasegaran, 1982). Serial tenfold dilutions of 
broth culture were prepared in Middlebrook 7H9 broth (containing Tween 80 but not 
supplement). Three 20 JlI samples from each dilution were plated out on duplicate pre-
dried Middlebrook 7HIO agar plates. Agar plates for colony counts were poured thickly 
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(25 ml) in 9 mm petri dishes to prevent desiccation during lengthy incubations. When the 
drops had dried, the plates were sealed with laboratory sealing film (Whatman, 
Maidstone, UK) and incubated, inverted in sealed plastic bags at 37°C. Colonies were 
counted weekly using a dissecting microscope (x 40 magnification) until counts had 
stabilised. Dilutions that yielded final counts of between 10 and 100 colonies were used 
to calculate the original number of CFUs. 
2.4.3 Optical density measurements 
Turbidity was determined by measuring the optical density (OD) of culture in a 
colorimeter (Jenway PCOI - Jenway Ltd., Dunmow, Essex, UK) at a wavelength of 580 
nm' Each measurement was made by transferring the growth culture into a 1.5 ml 
cuvette, which was sealed with laboratory sealing film and secured with tape. Where 
necessary, cultures were diluted to ODs in the range of 0.05-0.5. The OD measurement 
ofthe diluted culture was then multiplied by the dilution factor to give the actual OD. 
2.4.4 Preparation of inocula from agar 
A 50 ml culture of M tuberculosis in Middlebrook 7H9 broth was prepared from frozen 
stock as described in Section 2.4.1. Pre-dried Middlebrook 7HlO agar plates were 
inoculated with 100 JlI of subculture using the spread plate method. The plates were 
allowed to stand at room temperature for the inoculum to dry, sealed with laboratory 
sealing film and incubated in closed plastic bags at 37°C for 6-8 days. By this time the 
culture had grown to a sub-confluent lawn. One loopful of mycobacterial growth was 
transferred to a sterile glass tube and gently homogenised with the rounded end of a 
sterile glass rod until a smooth paste was obtained. Two 50 JlI portions of Middlebrook 
7H9 broth were added during homogenisation so that an even suspension was produced; 
the volume was made up to 1 ml and thoroughly mixed. Mycobacterial suspension 
prepared in this way, and adjusted to ODs8onm of 0.2 yielded between 5.0 x 107 and 1.0 x 
108 CFU mr). 
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2.5 MICROSCOPY 
Bacteria were immobilised for cell counting and to study their cytochemical properties at 
the single cell level. Previous work in this laboratory has employed a procedure 
involving 3-aminopropyltriethoxysilane (APS) coated coverslips (Barer and Entwistle, 
1991). The combination of APS-coated glass and centrifugation results in immobilised 
live cells to which analytical procedures may be applied. 
2.5.1 Aminopropyltriethoxysilane (APS) coating of coverslips 
APS-coated coverslips were prepared by leaving acetone-washed 19 mm circular 
coverslips (BDH, Poole, Dorset, UK) in a 2-3% (v/v) solution of APS in acetone 
overnight at room temperature. The following day the covers lips were washed twice in 
acetone, rinsed thoroughly in distilled water, gently blotted with tissue paper and dried at 
37°C. The APS-coated face was marked with permanent pen. Coverslips prepared in this 
way from fresh APS were stored in clean petri dishes and used for up to one month. 
2.5.2 Preparation of bacterial mono layers 
Cells were immobilised as a 'monolayer' on APS-coated covers lips by centrifugation 
using the microchamber system developed by Walker et al., (1994) (Figure 2.1). The 
silicone blocks with four sample wells and the teflon packing unit were made to 
specification for this laboratory by RAPRA Technology Limited (Billingham, Cleveland, 
UK; http://www.rapra.co.uk) and designed to fit in 30 ml disposable universals (Bibby 
Sterilin Limited, UK). 
Thirty microliters of cell suspension were added to each well and immobilised onto APS-
coated coverslips by centrifugation for 5 min at 1,000 x g. For pathogenic live 
mycobacteria the complete micro chamber was contained in sealed centrifuge buckets. 
The supematant was gently removed and the chamber assembly dismantled, taking care 
43 
CHAPTER 2 MATERIALS AND METHODS 
not to interfere with the deposited mono layers. Cytological labelling procedures were 
done before or after cell deposition as indicated. Coverslips were mounted, cell deposits 
face down, on microscope slides in an appropriate mountant (e.g. 20 ,.d silicone fluid, 
BDH) and sealed with clear nail varnish. The location of mono layers was marked with 
pennanent pen so that they were easily located during microscopy. 
Silicone block 
with sample wells 
APS-coated coverslip 
Packing Wlit 
Drilled universal cap 
30 ml disposable Wliversal 
Figure 2.1: Microehamber system used for the production ofbaderial monolayers 
The monolayers were observed using phase contrast, brightfield and/or epifluorescence 
microscopyas appropriate. Silicone blocks and packing units were autoclaved for reuse, 
drilled universal caps and centrifuge pots were left overnight in 70% ethanol, and the 30 
ml disposable universals were discarded. 
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2.5.3 Microscopy and recording of images 
Mounted cell preparations were viewed usmg a Nikon DIAPHOT -300 inverted 
microscope (Nikon UK Limited, Surrey, UK) equipped with standard epifluorescence 
attachments and a 100 W high-pressure mercury-vapour light source. Images were 
recorded using colour charge-coupled device (CCD) cameras (Sony DXC 390, Optivision 
Limited, York, UK or JVC KY -S55B, Foster Findlay and Associates, Newcastle upon 
Tyne, UK) and stored at 24-bit resolution in standard tagged image file fonnat (*.TIF). 
Camera fields of view were calibrated using a stage micrometer (Graticules Limited, 
Tonbridge, Kent, UK). The complete system as installed is displayed in Figure 2.2. 
VIDEO 
MONITOR 
lMAGESTORAGE 
PC 
••••••••• 
••••••••• 
MICROSCOPE 
Figure 2.2: Arrangement of equipment used for the microscopy of samples and recording of images. 
The spectral characteristics of the fluorophores used in the study and the appropriate filter 
sets used to examine the fluorescence of each are shown in Table 2.2. Citifluor 
immersion oil was used with oil-immersion lenses to keep background fluorescence a 
mmllDum. 
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Table 2.2: Characteristics of fluorescent compounds and filter sets used for viewing fluorescence 
Fluorophore characteristics) Filter set used2 
Excitation Emission 
maximum (nm) maximum (nm) 
Rhodamine 123 (RI23) 507 529 FITC/B-2A 
Propidium iodide (PI) 535 617 B-2A 
Ethidium homodimer 528 617 B-2A 
Auramine O-Rhodamine B 460/540 550/625 B-2A 
Green fluorescent protein (OFP) 395 509 FITC 
Cyanoditolyl tetrazolium chloride (CTC) 450 630 B-2A 
4' ,6-diamindino-2-phenylindole (DAPI) 358 461 UV-2A 
Bis-(l ,3-dibutylbarbituric acid) trimethine oxonal 493 516 B-2A 
Live/Dead BacLIGHT stain3, Reagent A NA NA B-2A 
Live/Dead BacLIOHT stain, Reagent B 535 617 B-2A 
J Spectral characteristics obtained from Molecular Probes Inc., Eugene, Oregon, USA (http:\\www.probes.com) and Polysciences Inc., 
Warrington, PA 18976, USA (http:\\www.polysciences.com). 
2 FITe specific filter block (excitation filter 420-490, barrier filter 530 ± 10, dichroic mirror 510); Nikon B-2A filter block (excitation 
filter 450-490, barrier filter 520-560, dichroic mirror 510); Nikon UV-2A filter block (excitation filter 330-380, barrier filter 420, 
dichroic mirror 400). 
J LIVE/DEAD BacLight bacterial viability consists of two nucleic acid stains. Reagent A is SYT09 whose spectral characteristics are 
not available (NA), Reagent B is propidium iodide. 
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2.6 IMAGE ANALYSIS 
Images acquired by microscopy were analysed usmg an in house developed, image 
analysis programme, 'Alpha' (Adaptrix Limited, Gateshead, Tyne and Wear, UK). The 
protocol for the analysis of paired mask and data images adopted during the present study 
is outlined below. The mask image was usually a phase contrast image from which 
binary masks of the profiles of cells for analysis were created. The binary mask provided 
the morphometric data. The data image was the corresponding fluorescence or 
brightfield-illuminated image from which densitiometric or fluorometric measurements 
were made. A more detailed description of image analysis using an earlier version of this 
software is given by Whiteley et al., (1998). 
Step 1 Pre-processing mask image. Mask and data image pairs were loaded together 
(Figure 2.3a). High quality mask images were created for accurate threshholding by 
applying contrast enhancement and smoothing functions (e.g. mean, median and gaussian 
filters) (Figure 2.3 b). 
Step 2 Thresholding. Binary images that closely represented the underlying image were 
created by thresholding (Figure 2.3c). Subsequent binary processing was usually 
necessary to create binary images that described the cells in the underlying image more 
precisely. These binary operators included opening, closing, erosion, dilation, thickening 
and thinning (Figure 2.3d). 
Step 3 Cell browsing and classification. Objects were then either accepted (valid cell), 
rejected (classified as not being a cell), and if clumped/clustered split as precisely as 
possible. If necessary, binary alignment for each object was performed to ensure that the 
origin of the object in the mask image corresponded to the origin of the object in the data 
image (Figure 2.3e). 
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(a) 
(b) 
Figure 2.3: Single cell image analysis using' Alpha' software. 
Windows show (a) loaded mask and data paired images, (b) mask image 
processing, (c) binary creation, (d) binary processing, (e) cell browsing and 
detection. Figure 2.3 continued over page. 
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(c) 
(d) 
80 ____ _ 
, 
(e) 
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Step 4 Cell measurement. Once the browsing classification step was complete the 
morphometric and intensity data were saved to disc as comma-separated text files (*.pm 
files). 
Step 5 Data export. Comma-separated text files were analysed usmg spreadsheet, 
statistical and graph-plotting computer programmes (e.g. Quattro Pro, Borland 
International, Inc.). 
Morphometric measurements obtained by image analysis included length, breath, area 
and perimeter of cells. Densitiometric measurements included integrated optical density 
(lOD) (sum of the optical weights of all pixels in an object) and mean optical density 
(MOD) (IOD divided by the number of pixels in object). Fluorometric measurements 
included integrated grey level (lOL) (sum of grey level values of all pixels in an object) 
and mean grey level (MOL) (lOL divided by the number ofpixels in object). 
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2. 7 TOTAL CELL COUNTS (TeC) 
Three methods of microscopic enumeration of cells were compared, a Thoma chamber, 
membrane filtration and staining, and phase contrast microscopy of bacteria immobilised 
on APS-coated coverslips. Samples for cell counts were mixed with equal volumes of 
8% formaldehyde to inactivate the mycobacteria. 
Counting chamber method (Koch, 1994) 
A Thoma ruled counting chamber (Hawskley Glass Limited, Lansing, UK) was filled 
with approximately 5 j.l.l of bacterial suspension. The slide was viewed by phase contrast 
microscopy (x 40 magnification) and sufficient squares were examined to ensure that 
more than 300 individual cells were counted. The total number of cells mr' of undiluted 
culture was calculated by use of the following formula: 
total bacteria counted x dilution factor x 4x 1 08 
number of small squares counted x filling depth (in micrometers) 
4',6-diamindino-2-phenylindole (DAPn membrane filter method (Kepner and Pratt, 
1994) 
A stock solution of 33 )lg mr' DAPI was prepared in SDW and stored at 4°C in the dark. 
One hundred microliters of DAPI staining solution, 100 j.l.l of mycobacterial suspension 
and 800 j.l.l SDW were mixed in a 1.5 ml centrifuge tube and incubated for 12 min in the 
dark at room temperature. Thirty microliters of well-mixed labelled cells were filtered 
onto 13 mm Nucleopore Polycarbonate filters (Costar Scientific Corporation, Bucks., 
UK) using a Millipore Swinney Stainless 13 mm filter holder (Millipore Corp., 
Massachusetts, USA). Filters were briefly dried, mounted on microscope slides between 
drops of citifluor immersion oil and covered with coverslips. Cells were viewed by 
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epifluorescence microscopy and sufficient fields were examined to ensure more than 200 
bacteria were counted. The total number of cells mr' of undiluted culture was calculated 
by use of the following formula: 
(total bacteria counted/number of fields) x (area of filter/area of field) x dilution factor 
3 X 10.2 
Direct counting of immobilised bacteria on APS-coated coverslips (Gribbon, 1996) 
Thirty microliters of well-mixed bacterial suspension were immobilised onto APS-coated 
coverslips by centrifugation and mounted on microscope slides as described in Section 
2.5.2. Monolayers were viewed by phase contrast microscopy and after confirming an 
even distribution of cells; sufficient fields were counted to ensure that at least 500 cells 
were counted. The total number of cells mr' of undiluted culture was calculated by use 
of the following formula: 
(total bacteria counted/number of fields) x (area of monolayer/area of field) x dilution factor 
3 X 10.2 
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2.8 METHODS USED TO ASSESS CELLULAR ACTIVITY 
2.8.1 Rhodamine 123 - Propidium Iodide labelling 
A stock solution of 6.5 mM rhodamine 123 (R123) was prepared in dimethyl sulphoxide 
(DMSO) and stored at -20°C. A working solution of 50 IlM was prepared in phosphate 
buffered saline (PBS) from completely thawed stock on each day of use. 
PBS was prepared by dissolving NaCI 8.0 g, KCI 0.2 g, Na2HP04 1.15 g, KH2P04 0.2 g 
in distilled water and making up to 1 L. The pH was adjusted to 7.3 prior to autoclaving. 
A stock solution of 7.5 mM propidium iodide (PI) was prepared in DMSO and stored at -
20°C. A working solution of 150 IlM was prepared in PBS from completely thawed 
stock on each day of use. 
Forty eight microliters of cell suspension was placed in a screw-topped 1.5 ml centrifuge 
tube. One microliter of R123 and PI working solutions were added to give final 
concentrations of 1 !J.M and 3 !J.M respectively. Suspensions were thoroughly mixed and 
incubated in a 37°C water-bath for 15 min. Bacteria were harvested by centrifugation 
(10,000 x g for 2 min), washed twice with PBS and re suspended in SDW. Bacterial 
monolayers were prepared and mounted on silicone oil as described in Section 2.5.2. 
When large numbers of samples were being processed it was more convenient to 
immobilise the bacteria prior to labelling. Thirty microliters of cell suspension was 
immobilised onto APS-coated coverslips by centrifugation. The coverslips were placed 
in 5 cm petri dishes (Bibby Sterilin Limited, UK) and covered with 5 ml of PBS 
containing the appropriate final concentrations of R 123 and PI. After 15 min, the 
labelling solution was removed and the coverslips gently washed twice with PBS and 
once with SDW. Coverslips were mounted on silicone oil. 
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The cells were viewed by phase contrast and epifluorescence microscopy. 
2.8.2 Uncoupler sensitivity studies 
A fresh stock solution of 7.5 mM carbonyl cyanide m-chlorophenyl hyrazone (CCCP) 
was prepared in ethanol when required. 
One microliter of stock solution was added to 49 !J.I of bacterial suspension in a 1.5 ml 
screw-topped centrifuge tube to give a final CCCP concentration of 150 !J.M. 
Suspensions were thoroughly mixed and incubated in a 37°C water-bath for 15 min. 
CCCP-treated bacteria were labelled with R123/PI as described. In experiments to show 
the uncoupler effect was reversible, CCCP-treated bacteria were harvested by 
centrifugation (10,000 x g for 2 min), washed twice with uncoupler-free Middlebrook 
7H9 broth and allowed to recover in a 37°C water-bath for IS min before labelling with 
RI 23/PI. 
2.8.3 Valinomycin studies 
A stock solution of I mM valinomycin was prepared in DMSO and stored at -20°C. 
Bacterial cultures were treated with valinomycin and labelled with R123 using an 
adaptation of the method by Porter at al., (1995). Cultures were washed twice in PBS 
before labelling, valinomycin was added at a final concentration of 5 !J.M and bacteria 
were labelled with RI23IPI as described in Section 2.8.1. 
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2.8.4 Tetrazolium salt reactions 
Iodonitrophenyl tetrazolium chloride (INT) 
A fresh stock solution of 10 mM INT was prepared in SOW. INT was completely 
dissolved if the suspension was heated to 55°C and briefly sonicated (IKASONIC U 50, 
IKA Labortechnik, Staufen, Germany). A 2 mM working solution was prepared by 
dilution in PBS and sterilised by filtration through a 0.22 ~m pore membrane. 
Mycobacterial suspensions for INT labelling were prepared in sterile PBS and adjusted to 
an ODS80nm of 0.4. Equal volumes of bacterial suspension and INT working solution 
were mixed and incubated at 37°C for one hour. Cells were harvested by centrifugation 
(10,000 x g for 2 min), washed twice with PBS and immobilised onto APS-coated 
covers lips. Coverslips were mounted in PBS and the edges sealed with clear nail varnish. 
Formazan deposits were observed using brightfield microscopy. 
Substrate-enhanced tetrazolium reduction (Gribbon and Barer, 1995) 
Working solutions of 1.0 M aspartate, a-ketoglutarate, pyruvate, cellobiose, malate, 
senne, fumarate, citrate, succinate, glucose and glutamate were prepared in distilled 
water. The solutions were adjusted to pH 7.0, sterilised by filtration through 0.22 ~m 
pore membranes and stored at 4°C. 
Mycobacterial suspensions for substrate-enhanced INT reduction were prepared in PBS 
as described. Equal volumes of bacterial suspension and appropriate INT solution 
supplemented with 100 mM substrate were mixed to give a final reaction concentration of 
50 mM substrate. Reaction tubes were mixed thoroughly and incubated at 37°C for 60 
min. Bacteria were harvested, washed, immobilised onto APS-coated coverslides and 
mounted in PBS. Formazan deposits were observed using brightfield microscopy. 
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Cyanoditolyl tetrazoliurn chloride (CTC) 
A stock solution of 20 mM CTC (Polysciences, Inc.) was prepared in sterile PBS. The 
solution was dispensed into 50 JlI aliquots and stored at -20°C. A working solution of 2 
mM was prepared in sterile PBS when required. 
Bacteria for labelling were harvested by centrifugation (l0,000 x g for 2 min), 
resuspended in 2 mM CTC working solution and incubated at 37°C for 30 min. After 
incubation, cells were washed with PBS, re suspended in SDW and immobilised onto 
APS-coated coverslips. When the mono layers were dry, the covers lips were mounted in 
silicone fluid and sealed with clear nail varnish. CTC deposits were observed by 
epifluorescence microscopy. 
2.8.5 Combined R123/PI labelling and INT reduction assays 
The INT reduction assay was combined with RI23/PI labelling to further investigate the 
cytological activity of M tuberculosis at the single cell level. In these experiments, R123 
and PI were added for the last 15 min of the INT step incubation at final concentrations of 
1 J..lM and 3 J..lM respectively. Bacteria were harvested by centrifugation (10,000 x g, 2 
min), washed in PBS and resuspended in SDW. Bacterial monolayers were prepared as 
described and mounted in silicone fluid on a microscope slide. Cells were observed by 
epifluorescence and brightfield microscopy. 
2.8.6 LivelDead BacLIGHT viability stains 
M tuberculosis was labelled with the Live/Dead BacLight viability stains (Molecular 
Probes, Inc.) according to the manufacturer's protocol. In summary, mycobacterial 
suspensions were washed with PBS and resuspended in SDW to an ODs8onm of 0.2. 
Equal volumes of reagents A and B were combined and mixed thoroughly. Three 
microliters of this solution were added to 1 ml of bacterial suspension in 1.5 ml 
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centrifuge tubes and incubated for 15 min, at room temperature in the dark. Bacteria 
were immobilised onto APS-coated coverslips as described, gently washed with SDW 
and mounted in silicone fluid. Labelled cells were observed by epifluorescence 
microscopy. 
2.8.7 Bis-(1,3-dibutylbarbituric acid) trimethine oxonol (DiBAC4) labelling 
M tuberculosis was labelled with DiBAC4 using an adaptation of the methods described 
by Mason et al., (1995) and Jepras et al., (1997). A sock solution of 5 mM DiBAC4 
(Molecular Probes, Inc.) was prepared in DMSO and stored at -20°C. Fresh working 
stocks of 50 ~M were prepared in PBS when required. 
Mycobacterial suspensions for labelling were prepared in PBS and adjusted to an ODs8onm 
of 0.2. One microliter of oxonol working stock was added to 49 ~l of bacterial 
suspension in 1.5 ml centrifuge tubes to give a final concentration of 1 IlM. Reaction 
tubes were thoroughly mixed and incubated at 37°C for 15 min in the dark. Bacteria were 
immobilised onto APS-coated cover slips by centrifugation as described, washed gently 
with PBS and water and mounted in silicone fluid. Cells were viewed by phase contrast 
and epifluorescence microscopy. 
2.8.8 SYT016 live cell nucleic acid stain 
A working solution of 250 ~M SYT016 (Molecular Probes, Inc.) was prepared in SDW 
from the 1 mM solution supplied and stored at -20°C. 
M tuberculosis cell suspensions were labelled using the method of Ibrahim et al., 1997. 
One microliter of SYT016 working solution was added to 50 ~L of cell suspension in 
SDW in 1.5 mL centrifuge tubes to give a final concentration of 5 ~M. The cell mixture 
was briefly vortexed and incubated for 10 min at 37°C. Cells were harvested by 
centrifugation at 10,000 x g for 2 min, washed once with SDW and resuspended in SDW. 
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Cells were immobilised onto APS-coated coverslips by centrifugation and mounted in 
silicone fluid as described previously. Cells were viewed by phase contrast and 
epifluorescence microscopy. 
2.8.9 Effect of cytological assays on colony counts 
The effect of routinely used cytological assays on mycobacterial colony counts was 
investigated. Mycobacterial suspensions were treated with R123, PI, CCCP and INT 
using conditions described in their staining procedures. Samples were taken for 
enumeration of colony forming units as described in Section 2.4.2 and compared to those 
from untreated controls. 
2.8.10 Heat, formaldehyde and ethanol treatments 
Cytochemical labelling was used to study the effect of heat, formaldehyde and ethanol on 
cultures of M tuberculosis. 
Heat treatment: Five milliliters of mycobacterial suspension in screw-capped pyrex test 
tubes (20 x 125 mm) were heat treated for 30 min in a 70°C water bath. The tubes were 
mixed thoroughly once or twice during heat treatment and afterwards were cooled to 
37°C for at least 2 hours before being utilised for staining. 
Formaldehyde treatment: Fresh 8% para-formaldehyde was prepared by dissolving 8 g 
para-formaldehyde in 100 ml PBS heated to 60°C on a heated magnetic stirrer and cooled 
to room temperature before use. Equal volumes of mycobacterial suspension and 8% 
formaldehyde solution were mixed thoroughly and incubated for 3 h or overnight. 
Ethanol treatment: Mycobacteria were harvested by centrifugation (4,000 x g for 5 min) 
and resuspended in an equal volume of 70% ethanol for 5 min. 
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Formaldehyde and ethanol treated bacteria were harvested by centrifugation (4,000 x g 
for 5 min), washed twice with fresh broth and re suspended in an equal volume of broth 
before being utilised for staining. Samples of mycobacteria after each of the bactericidal 
treatments were taken for colony counts and cytochemical labelling. 
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2.9 TREATMENT WITH ANTIMYCOBACTERIAL DRUGS 
2.9.1 Antimycobacterial drugs 
The anti mycobacterial drugs tested in the study were isoniazid, rifampicin, ethambutol 
HCI, streptomycin sulphate and capreomycin. Antibiotics were purchased from Sigma 
Chemical Company and stored as recommended by the manufacturer. Stock solutions 
were prepared according to Inderlied, (1991), sterilised by filtration through 0.22 Ilm pore 
membranes and stored at -70°C for up to 12 months. The diluents used and the stock 
concentrations are summarised in Table 2.3. 
Table 2.3: Preparation of stock, working stock and final concentrations of antimycobacterial drugs 
Drug Solvent· Diluent Stock Cone Working Concb 
(Ilg mr!) (/lg mr!) 
Rifampicin OMSO SOW 10,000 2.0 
Isoniazid SOW SOW 10,000 0.4 
Streptomycin SOW SOW 10,000 4.0 
Ethambutol SOW SOW 10,000 12.0 
Capreomycin SOW SDW 10,000 20.0 
a Rifampicin was dissolved in DMSO and decimally diluted in SDW before sterilisation by filtration. 
b "Working Concentration" was prepared by dilution in Middlebrook 7H9 broth. 
Final Conec 
(/lg mr!) 
1.0 
0.2 
2.0 
6.0 
10.0 
C "Final Concentration" was obtained by mixing equal volumes of "Working Concentration" and mycobacterial suspension. 
2.9.2 Drug exposure protocol 
Inocula for assessment of anti mycobacterial activity were prepared from sub-confluent 
lawns of M tuberculosis cultured on Middlebrook 7H 1 0 agar as described in Section 
2.4.4, adjusted to an ODs8onm of 0.4 in Middlebrook 7H9 broth and distributed into 5 ml 
aliquots in sterile screw-capped tubes (20 x 125 mm). Equal volumes of mycobacterial 
suspension and broth containing the 'Working Concentration(s), of the drug(s) to be 
tested were mixed to yield the final drug concentration(s) noted in Table 2.3. Drug-free 
control cultures were included in each assay. 
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Cultures were incubated without shaking at 37°C for 7 days and were thoroughly mixed 
before sampling. Daily samples were taken for colony counts and cytochemical labelling. 
Samples were taken at the end of the assay for Tee enumeration and Most Probable 
Number (MPN) estimation. 
2.9.3 Most Probable Number (MPN) estimates 
The MPN and colony count methods for estimating the number of propagules of M 
tuberculosis in anti mycobacterial drug treated cultures were compared. A five-tube, ten-
dilution MPN protocol was used. Diluent tubes were prepared aseptically by aliquoting 
1.8 ml of Middlebrook 7H9 broth into 5 ml plastic disposable bijoux (Bibby Sterilin Ltd., 
UK) and incubated overnight at 37°C to check for contaminants. Hence, fifty tubes were 
prepared for each estimate. 
Two millilitres of mycobacterial culture were sampled at day 7 of each drug assay and 
harvested by centrifugation (3000 x g for 5 min). The supematant was carefully 
discarded; the bacteria were washed once in Middlebrook 7H9 broth and thoroughly 
re suspended in 2 ml of Middlebrook 7H9 broth. Five replicas of serial tenfold dilutions 
(l0-1 - 10-1°) were prepared for each MPN estimate. The bijoux were sealed with 
parafilm to prevent evaporation and incubated at 37°C for 2 months. Turbidity was 
scored as a positive result and the number of positive tubes at each dilution was recorded. 
The combination of positive and negative tubes was used to calculate the MPN from 
standard MPN tables as described in Reports on Public Health and Medical Subjects, No. 
71 (1969). Random samples of turbid tubes were taken for acid-fast staining to check for 
contaminants. 
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2.10 MYCOBACTERIAL GREEN FLUORESCENT PROTEIN STUDIES 
GFP-expressing M tuberculosis were produced to further investigate the non-labelled 
sUb-population observed in broth culture and as a reporter assay to follow the effect of 
drugs during the anti mycobacterial drug assays. 
2.10.1 Construction of shuttle plasmid expressing the gfp gene 
The strategy was to clone the Aequorea victoria gfp gene into the E. coli-mycobacterial 
shuttle vector pMV261 downstream of the hsp60 promoter using the unique BamHI and 
EcoRI sites as shown schematically in Figure 2.4a. M tuberculosis was also transformed 
with the gfp expressing vector pGFM-l1 which was kindly supplied by Kremer et al., 
(1995). The structure of pG FM-I 1 is shown in Figure 2.4b. 
Plasmids and DNA manipulation 
All DNA manipulations were performed under standard conditions, as described by 
Sambrook et al., (1989). Restriction enzymes, T4 DNA polymerase and T4 DNA ligase 
were purchased from Boehringer Mannheim. 
All cloning steps were performed in E. coli DH5a. Preparation of electro-competent cells 
and electro-transfromation with plasmid DNA of E. coli DH5a was by the method of 
Dower et al., (1988). 
Preparation of electro-competent cells of E. coli DH5a 
One litre of Luria-Bertani broth* was inoculated with 11100 volume of a fresh overnight 
culture and incubated with vigorous shaking to OD600nm of 0.5-1.0. The culture was 
chilled on ice for 15-30 min and harvested by centrifugation at 4000 x g for 15 min at 
4°C. The pellet was resuspended in 1 L of chilled SDW and harvested by centrifugation. 
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The pellet was resuspended in 500 ml of chilled SDW and harvested by centrifugation. 
The pellet was resuspended in 20 ml of sterile chilled 10% (w/v) glycerol and harvested 
by centrifugation. The bacteria were carefully re suspended to a final volume of 2-3 ml in 
10% glycerol, divided into 50 JlI aliquots and snap-frozen in ethanol cooled to -70°C. 
The aliquots were stored at -70°C and used for up to 6 months. 
*Luria-Bertani broth contained: 10 g Bacto-tryptone, 5 g Bacto-yeast extract and 10 g 
NaCI made up to 1 L in SDW and and was sterilised by autoclaving (IS psi for 30 min). 
Luria-Bertani agar was solidified with 1.5% (w/v) agar. 
Procedure for high efficiency electro-transfromation of E. coli DH5a 
The cells were thawed at room temperature and placed on ice. Resuspended cells (40 JlL) 
were mixed with 1-2 JlI of DNA, vortexed and placed on ice for 1 min. The mixture was 
transferred to a cold 0.2 cm gap electroporation cuvette (Biorad) and electroporated 
(2.5kV, 25JlF, 2000) in a Gene Pulser (Biorad). Cells were immediately diluted with 1 
ml ofSOC* medium at room temperature, incubated at 37°C for 1 h and plated onto solid 
medium containing 25 Jlg mrl kanamycin. 
*SOC medium contained: 2% Bacto tryptone, 0.5% Bacto yeast extract, 10 mM NaCI, 
2.5 mM KCI, 10 mM MgCh, 10 mM MgS04 and 20 mM glucose in SDW. SOC medium 
was sterilised by filtration. 
Small scale extraction of plasmid DNA was by the STET buffer* method. Bacteria in 1.5 
ml of overnight culture were harvested by centrifugation (13,000 x g for 1 min), 
resuspened in 200 ml STET buffer and boiled for 1 min. Cell debris was pelleted by 
centrifugation (13,000 x g for 10 min) and removed with a tooth pick. The supernatant 
and 150 JlI isopropanol were thoroughly mixed and centrifuged for 15 min at 13,000 x g. 
The supematant was aspirated and the pellet dried under vacuum for 30 min. The pellet 
was resuspended in 50 JlI SDW and 1 JlI RNase. 
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*STET buffer contained: 40 g sucrose, 25 mL 10% (w/v) Triton X, 50 ml 0.5 M EDTA 
(PH 8.0), 25 ml Tris HCI (pH 8.0) in 500 ml SOW. 
The Qiagen Midi protocol (Qiagen Ltd., UK) was used for large scale extraction of 
plasmid DNA. Cloned genes were sequenced at the Facility for Molecular Biology at the 
University of Newcastle upon Tyne, UK. 
Expression studies were performed in M tuberculosis H37Ry. Preparation of electro-
competent cells and electro-transfromation with plasmid DNA of M tuberculosis H37Ry 
was carried out as described by Wards and CoBins, (1996). 
Preparation of electro-competent cells of M tuberculosis H37Rv 
A 250 ml conical flask containing 100 ).lL of Middlebrook 7H9 broth was inoculated with 
1 ml of M tuberculosis stock and incubated at 37°C in a rotary shaker-incubator at 180 
rpm for 7 days. Cells were harvested by centrifugation, washed twice with 10% glycerol 
and re suspended in approximately 1 ml 10% (w/v) glycerol (at room temperature). 
Procedure for high efficiency electro-transfromation of M tuberculosis H37Ry 
Aliquots of cells (200 ).lL) were mixed with 1 ).lg DNA in a 0.2 cm gap electroporation 
cuvette (Biorad) and electroporated (2.5 kV, 25 ).IF, 1000 Q) in a Gene Pulser (Biorad). 
Cells were immediately diluted with 1 ml fresh Middlebrook 7H9 broth at room 
temperature, incubated for 4-8 h at 37°C, and plated onto solid medium containing 25 ).lg 
mrl kanamycin. Once dried, the plates were sealed with parafilm, inverted and incubated 
at 37°C in sealed bags. 
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Figure 2.4a: Construction of the gfp expression vector pRPCl. 
The Aequorea victoria gfp gene was cloned into the E. coU-mycobacterial shuttle vector 
pMV261 downstream of the hsp60 promoter using the unique BamHI and EcoRI sites. 
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Figure 2.4b: Structure of the gfp expression vector pGFM-ll (reproduced from 
Kremer et aI., 1995). 
The vector contains 0.4 kb of the 5' end of the BCG hsp60 gene, including the promoter 
region, ribosome-binding site and the initiation codon, upstream of the g/jJ coding 
sequence. The vector also contains a kanamycin and streptomycin resistance cassette as 
well as a mycobacterial and an E. coli origin of replication. 
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2.10.2 Method for GFP detection 
Direct detection of gfp expression was by irradiation of colonies at 366 run with a long-
wave UV light source. For microscopical studies, bacteria were harvested from agar or 
broth culture and immobilised on APS-coated coverslips by centrifugation as described in 
Section 2.5.2. Coverslips were rinsed with PBS, mounted in PBS on microscope slides 
and sealed with clear nail varnish. Cells were viewed by phase contrast and 
epifluorescence microscopy. 
Colonies with the most intense GFP fluorescence were isolated and selected for study. 
Mycobacterial gfp transformants were cultured in Middlebrook 7H9 broth or on 
Middlebrook 7HIO agar containing 25 Ilg mrl kanamycin. 
2.10.3 Treatment with antimycobacterial drugs 
The effect of the antimycobacterial drugs on gfp expreSSIOn by M tuberculosis 
transformants was investigated. Drug assays were carried out as described in Section 
2.9.2, with the exception that each was supplemented with 25 Ilg mrl kanamycin. 
Cultures were incubated without shaking at 37°C and sampled at day 7 for CFU 
enumeration and microscopic assessment of OFP expression. 
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2.11 MYCOBACTERIOPHAGE D29 STUDIES 
2.11.1 Preparation of high-titre Iysates of mycobacteriophage 
High-titre lysates of mycobacteriophage D29 were prepared using the method described 
by Jacobs et al., (1991). M smegmatis for phage infection were prepared by inoculating 
25 ml of Middlebrook 7H9 broth with 1 00 ~l of starter culture in a 250 ml flask and 
incubated with shaking overnight at 37°C. Phage was decimally diluted in Phage Buffer* 
(PB) to obtain approximately 5 x 104 plaque forming units mrl. Two millilitres of M 
smegmatis cells were mixed with 1.0 ml of phage solution in 30 ml disposable universals 
and incubated for 30 min at 37°C to allow adsorption to occur. 0.3 ml of the phage-cell 
mixture was added to 3.0 ml of overlay agar (Tryptone Soya Broth (Difco) containing 
0.75% agar), mixed by gentle rotation and aseptically poured on top of prepoured agar 
plates (Tryptone Soya Broth containing 1.2% agar). The agar was allowed to solidify, 
inverted and incubated at 37°C for 24-36 h. Five plates were prepared for each lysate. 
After incubation, 5 ml of PB was pipetted onto each plate and the plates were set upright 
on a rocking table at 4°C overnight. As much liquid as possible was pipetted from each 
plate and combined. The lysates were centrifuged at 4°C at 3000 x g for 10 min, the 
supernatant was sterilised by filtration through 0.2 !lm membranes and stored at 4°C. 
*Phage Buffer contained: 10 mM Tris (pH 7.6), 100 mM NaCl, 10 mM MgS04, and 2 
mM eaCh in SDW and was sterilised by autoclaving (15 psi for 30 min). 
2.11.2 Plaque forming unit (PFU) enumeration / phage titres 
Enumeration of PFU was by the method described by Fullner and Hatfull, (1997). 
Bacterial lawns were prepared by addition of 3.0 ml of softened overlay agar to 0.3 ml of 
overnight culture of M smegmatis (OD600nm ~ 0.2) and the mixture poured onto 
prepoured agar plates and allowed to solidify. Mycobacteriophage D29 was decimally 
diluted in PB (to 10-10) and triplicate 1 0 ~l drops of each dilution were spotted, allowed to 
68 
CHAPTER 2 MATERIALS AND METHODS 
dry and incubated inverted at 37°C for 1-2 days. The dilution that produced discrete 
countable plaques was used for the enumeration of PFU mrl. 
2.11.3 Mycobacteriopbage infectivity studies 
The effect of mycobacteriophage D29 infection on broth culture and antimycobacterial 
drug treated cultures of M tuberculosis was investigated using R 123/PI cytochemical 
labelling. Mycobacterial cultures were infected with D29 as described by Fullner and 
Hatful (1997). Cultures were incubated for 24 h in Tween 80-free medium prior to D29 
infection because Tween 80 was shown to inhibit phage adsorption. 
Broth culture of M tuberculosis was prepared as described in Section 2.4.1. Bacteria 
were harvested by centrifugation (3000 x g for 10 min), resuspended in Tween 80-free 
Middlebrook 7H9 broth and incubated for with shaking for 24 h at 37°C. Cultures were 
then either infected with D29 (l ml of high titre phage solution to 9 ml culture) or PB 
control and incubated overnight. Samples were taken for CFU enumeration and R 123/PI 
labelling. 
M tuberculosis culture was treated with anti mycobacterial drugs as described in Section 
2.9.2. Bacteria were harvested by centrifugation (3000 x g for 10 min), re suspended in 
Tween 80-free Middlebrook 7H9 broth containing the appropriate antimycobacterial drug 
and incubated for 24 h. Cultures were then either infected with D29 (1 ml D29 to 9 ml 
culture) or PB control and incubated overnight. Samples were taken for CFU 
enumeration and R123IPI labelling. 
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2.12 ADAPTATION OF M. TUBERCULOSIS TO ANAEROBIOSIS 
Anaerobiosis was induced in M tuberculosis cultures usmg two different methods 
developed by Wayne and colleagues (Wayne and Lin, 1982; Wayne and Hayes, 1996). 
Cells were cultured in Dubos Tween-albumin broth prepared according to the 
manufacturer's instructions from Dubos broth base (Difco) and Dubos medium albumin 
(Difco) at a final pH of 6.6±0.2. Inocula were prepared in 250 ml baffled polycarbonate 
conical flask containing 50 ml of Dubos Tween-albumin broth and 1 ml of thawed M 
tuberculosis stock, which were incubated for one week at 37°C in a rotary shaker-
incubator at 180 rpm. By this time the culture contained approximately 1 x 107 CFU mr I. 
In the first method, cells were adapted by the slow settling of bacilli through a self-
generated oxygen gradient in unshaken tubes. Aliquots (10 ml) of Dubos Tween-albumin 
broth in 20-by-125-mm tubes fitted with screw-cap caps with latex liners were inoculated 
with 100 III of culture. The caps were tightly screwed down and the tubes incubated in an 
upright position without agitation, with care not to disturb the sediment that formed or to 
aerate the medium. Cells were sampled from the anoxic region in the sediment at the 
bottom of the tube and labelled with R123/PI as described in Section 2.8.1. 
In the second method, adaptation to anaerobiosis was achieved in slowly stirred sealed 
liquid cultures exposed to limited headspace volumes of air (one-half volume of initial 
headspace air per volume of media). Conical flasks with total fluid capacity of 600 ml 
containing 400 ml of Dubos Tween-albumin broth and 1 cm Teflon-coated magnetic 
stirrers were inoculated with 1 ml of culture. The flasks were tightly sealed with sterile 
rubber septa (Sigma) and incubated on magnetic stirrers (Heidolph MR 100, Germany) at 
37°C at the slowest magnetic stir. Samples of culture for cytochemical staining were 
taken using sterile syringes and needles. 
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Control cultures containing sterile methylene blue at a final concentration of 1.5 Ilg mrl 
were included in each experiment. Reduction and decolourisation of this dye served as a 
visual indication of oxygen depletion. 
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3.1 METHODOLOGICAL STUDIES 
A reliable method for obtaining consistent defined populations of M tuberculosis for use 
in cytochemical labelling and antimycobacterial drug assays was required early in this 
study. Considerable effort was invested in establishing growth in broth under defined 
conditions as the basis for these experiments. However, as will be seen, inocula produced 
from broth culture were unsuitable, as many cells proved recalcitrant to labelling. 
Therefore, cells from agar culture, although more difficult to describe in terms of 
recognised growth phases were used for most of the work. 
3.1.1 Growth characteristics in broth 
Representative growth characteristics of M tuberculosis in broth, incubated in a rotary 
shaker-incubator for two weeks are shown in Figure 3.1. An exponential increase in OD 
was observed for the first seven days after which little change occurred. Towards the end 
of the 2 week culture period a decrease in OD was observed. Colony counts were shown 
to increase by between 3 and 4 log cycles during the culture period. Cultures sampled at 
day 7 routinely yielded between 5.0 x 107 and 1.0 x 108 CFU mrl and were used as a 
source of inocula in the early studies. It was noted that continued incubation (> 2 weeks) 
in a rotary shaker-incubator produced clumping of mycobacteria and deposition of 
biomass at the liquid/air interface on the flask wall. 
3.1.2 RI23IPI labelling of cells cultured in broth 
Samples of M tuberculosis were taken from broth culture over the first week of growth 
and labelled with R123/PI. Due to the low cell density, samples taken early in broth 
culture were concentrated by centrifugation prior to staining. It was repeatedly observed 
that only between 20 and 40% of broth-cultured bacteria labelled with R123. No PI or 
R123 label was observed in the remaining (60-80%) cells. An example of M 
tuberculOSis culture sampled on day 7 and labelled with R123/PI is shown in Figure 3.2. 
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Figure 3.1: Growth curve of M. tuberculosis in Middlebrook 7H9 broth. 
The inoculum was prepared from a 7 day broth culture as described in Section 2.4.1. 
Cultures were incubated with constant agitation (180 rpm) in a rotary shaker-incubator at 
37°C. Growth was measured as CFU mrl (± 2 S.D.) and ODS80nm. 
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(a) 
(b) 
Figure 3.2: Broth-cultured M. tuberculosis dual labelled with RIl3 and PI. 
Phase-contrast and fluorescence images of the same field of view of broth-cultured M tuberculosis 
dual labelled with R123 (1 ~ and PI (3 ~. The organism was cultured in Middlebrook 7H9 
broth with constant agitation and sampled after 7 days growth. Cells were viewed at 1000 x 
magnification. Scale bar = 3 J..U1l. 
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Labelled and non-labelled bacteria were indistinguishable from each other by phase-
contrast microscopy (i.e. based on opacity, refractility or cell morphology). Fluorescence 
intensity of RI 23-labelled bacteria was heterogeneous and ranged from dull to brightly 
fluorescent cells. The total fluorescence associated with each cell may be quantified by 
image analysis; the example shown in Figure 3.3 displays this data in a scatter plot from 
which both heterogeneity of fluorescence intensity and cell size is evident. Although 
Tween 80 was included in the broth to prevent clumping of bacteria, many small clumps 
were nonetheless observed. It should be noted, that clumping did not appear to be 
associated with non-labelling, as cells found in clumps were as likely to be labelled as 
those not found in clumps. 
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Figure 3.3: Scatter plot demonstrating heterogeneity of fluorescence intensity in 
broth-cultured M. tuberculosis labelled with R123. 
Fluorescence is expressed as the integrated grey level (lGL) attributable to each cell. IGL is 
expressed in arbitrary units. 
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Cytochemical labelling of mycobacterial cells from shaken broth cultures was compared 
to that of cells produced by other methods of broth culture (Section 2.4.1). These 
methods included agitation and aeration of culture by magnetic stirrers (Wayne, 1994) 
and incubation of M tuberculosis without shaking (Herbert and Mitchison, 1996). 
Regardless of how broth culture was produced, there were more unlabelled than labelled 
cells when stained with R1231PI. 
Increased incubation times and concentrations of dye were investigated during 
optimisation of the mycobacterial R 123/PI cytochemical reaction. Figure 3.4 shows that 
longer incubation periods (> 15 min) had no effect on R123 labelling. Indeed, overnight 
incubations produced neither an increase in fluorescence intensity of individual labelled 
cells nor an increase in the proportion of labelled bacteria (results not shown). Similarly, 
increasing the concentration of R123 did not alter the observed labelling pattern with M 
tuberculosis. 
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Figure 3.4: Effect of incubation time on the R123 accumulation by M. tuberculosis. 
Accumulation is expressed as the percentage of bacteria in each of the fluorescence intensity 
ranges. The number of cells analysed for each incubation time was in the range of 100-150. 
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The non-labelled cells observed in the R123IPI assay were investigated for low-level 
fluorescence using prolonged integration times and increased electronic gain (analogous 
to longer exposure time and enhanced camera chip sensitivity respectively). However, 
under these conditions our general-purpose colour CCD camera produced high levels of 
background noise making it difficult to differentiate non-labelled cells. When a Peltier-
cooled CCD camera (Type KAF-0400, Wright Instruments Ltd., Enfield, England; array 
768H x 512V, pixel size 9 J.lm square, operating temperature 200 K) with 40% photon 
detection efficiency at 500 nm was used to examine these cells, no fluorescence signal 
above background was detected. 
Experiments designed to improve R123 labelling of potential low-activity non-labelled 
cells in M tuberculosis broth culture by valinomycin cytoplasmic membrane 
hyperpolarisation (Section 2.8.3) met with little success. In fact, rather than increasing 
dye uptake through the generation of a potassium ion gradient, treatment with 
valinomycin inhibited R 123 accumulation and reduced fluorescence even in the 
proportion of cells that were originally labelled. Valinomycin-treated bacteria did not 
stain with PI. 
In summary, between 20 and 40% of broth cultured M tuberculosis cells labelled with 
R123. The remainder did not label with either R123 or PI. It should be noted, that the 
presence of non-labelling bacteria would have been difficult to detect and quantify if 
brightfield illumination (the standard form of illumination on most microscopes) rather 
than phase contrast illumination had been used. 
3.1.3 Growth on agar 
Provided that the initial inoculum was well dispersed (e.g. 100 III of day 7 broth culture) 
and thoroughly spread on pre-dried agar plates, sub-confluent lawns of M tuberculosis 
were produced within a week. Bacteria were easily harvested and dispersed as single 
cells with a minimum of clumping using the glass rod homogenisation method described 
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in Section 2.4.4. When adjusted to an OD580nm of 0.2, bacterial suspensions prepared by 
this method yielded between 5.0 x 107 and 1.0 x 108 CFU mrl. However, with continued 
incubation (> 1 week), lawn cultures became confluent, dry and wrinkled. It was more 
difficult to prepare evenly dispersed suspensions from older cultures and they were not 
used in the cytochemical or antimycobacterial drug studies. 
3.1.4 R123IPI labelling of cells cultured on agar 
In contrast to broth culture, most M tuberculosis cells cultured on agar labelled with 
R123 (typically, 85-90%). The remainder were non-labelled and few bacteria in these 
preparations stained with PI. An example of R123/PI labelled M tuberculosis prepared 
from sub-confluent lawn culture as described in Section 2.4.4 is shown in Figure 3.5. 
Heterogeneity of fluorescence intensity in R123-labelled cells was also observed; an 
example of data from image analysis is displayed in scatter plot form in Figure 3.6. 
Apart from the difference in labelling with R123/PI, the most obvious difference in 
growth produced in broth and on agar was cell size. Broth cultured M tuberculosis 
bacilli were consistently larger than those grown on agar. Comparison of the length, 
breadth and area obtained by image analysis is shown below in Table 3.1. These 
differences were shown to be statistically significant (p < 0.05, Student's t-test). 
Table 3.1: Morphological properties of agar and broth cultured M. tuberculosis· 
length (/lm) breadth (/lm) area (/lm2) 
Agar 2.85 ± 0.01 1.39 ± 0.01 2.63 ± om 
Broth 3.71 ± 0.02 1.67 ± 0.01 4.02 ± 0.03 
*Data based on 13 independent experiments with analysis of 5364 bacteria and are expressed as means ± standard error of the means. 
Since the majority of agar cultured bacteria labelled, bacterial suspensions prepared from 
sub-confluent lawns were used as the standard inoculum for the remainder of the study. 
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(a) 
(b) 
Figure 3.5: Agar-cultured Mo tuberculosis dual labelled with R123 and PI. 
Phase-contrast and fluorescence images of the same field of view of agar-cultured M 
tuberculosis labelled with RI23 (1 ~ and PI (3 ~. The organism was cultured on 
Middlebrook 7HIO agar and sampled after one weeks growth. Cells were viewed at 1000 x 
magnification. Scale bar = 3 J.UIl. 
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Cell profile area (pixels) 
Figure 3.6: Scatter plot demonstrating heterogeneity of fluorescence intensity in 
agar-cultured M. tuberculosis labelled with R123. 
Fluorescence is expressed as the integrated grey level (IGL) attributable to each cell. 
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3.1.5 R123 Uncoupler sensitivity studies 
Labelling of M tuberculosis with R123 in the presence of the uncoupler agent CCCP was 
investigated, as described in Section 2.8.2, to demonstrate that the fluorescent dye was 
concentrated by the bacteria in an uncoupler-sensitive fashion. In the initial experiments, 
bacteria were treated for 15 min with 15 ).!M CCCP and labelled with 13 ).!M R 123. 
Under these conditions no detectable effect on the accumulation of R123 was produced. 
Consequently, a series of experiments were designed where different concentrations of 
cecp and R 123 were tested. 
eecp concentration: The effect of CCCP on R123 accumulation by M tuberculosis was 
negligible until concentrations greater than 15 ).!M were used. Thereafter, each increase 
in cecp concentration produced a concomitant decrease in bacterial fluorescence (Figure 
3. 7). Cytochemical labelling of bacteria treated with 150 ).!M CCCP produced almost 
complete inhibition of accumulation of RI23 and this concentration was used in all 
further experiments to demonstrate uncoupler-sensitive accumulation of dye. CCCP does 
not itself quench the fluorescence ofR123. 
Since eecp stocks were prepared in ethanol, the impact of ethanol on accumulation was 
assessed. The addition of 2% ethanol alone in labelling experiments had no effect on the 
accumulation ofR123. 
It was noted that, even at optimal concentrations of CCCP, complete inhibition of 
accumulation of RI23 by all bacteria was not observed. However, only low-level 
fluorescence was observed in these residual labelled cells. 
R123 concentration: The accumulation of R123 by M tuberculosis was uncoupler 
sensitive only when lower concentrations of dye (:::;; 1 ).!M) were used. Labelling with 13 
).!M R123 was not sensitive to CCCP, even when high concentration of the uncoupler 
agent was used. Results from M tuberculosis cell suspensions, labelled with 1 ).!M and 
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13 ~M R123 in the presence and absence ofCCCP are shown in Figure 3.8. In all further 
experiments R123 was added at a final concentration of 1 IlM. 
The uncoupler effect of CCCP on R123 accumulation was not permanent, as CCCP-
treated bacteria were able to accumulate the dye once the uncoupler was removed. It is 
shown in Figure 3.9 that an M tuberculosis cell suspension treated for 15 min with 
CCCP, washed and left to recover in fresh Middlebrook 7H9 broth for 15 min before 
labelling, demonstrated a return of fluorescence to a level similar to that detected in 
untreated bacteria. 
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Figure 3.7: Effect of carbonyl cyanide m-chlorophenyl hydrazone (CCCP) 
concentration on the accumulation of R123 by M. tuberculosis. 
Fluorescence is expressed as loglO of the average integrated grey level (IGL) produced by 
bacteria at each of concentrations tested. The number of cells analysed for each concentration 
was in the range of 70-120; symbols represent mean ± S .E.M. 
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Figure 3.9: Effect of CCCP on R123 accumulation by M. tuberculosis. 
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3.1.6 Heat, ethanol and formaldehyde treatments 
The effects of bactericidal treatments (defmed as treatments shown to be lethal to M 
tuberculosis as assessed by colony forming unit potential on Middlebrook 7HlO agar) on 
cytochemical labelling were assessed as described in Section 2.8.10. Each of the 
treatments was shown to significantly alter the accumulation of R123 and PI by M 
tuberculosis. 
Formaldehyde treatment produced uniform homogenous low-level labelling with R123 
that was not sensitive to uncoupler agent (Figure 3.10a & b). PI staining was not 
observed. Treatment with formaldehyde did not produce fluorescence without staining 
(Figure 3.lOc). 
Control F onnaldehyde treated 
Ca) R123-PI labelled 
(b) CCCP treated / R123-PI labelled 
Cc) Unstained 
Figure 3.10: Effect of formaldehyde treatment on R123 accumulation by M. 
tuberculosis. 
Phase-contrast and corresponding fluorescence microscopic images of Ca) R123 labelled, (b) 
R123 labelled CCCP-treated and, (c) unstained populations are shown. Cells were viewed at 
1000 x magnification. Scale bar = 2 J.1Ill. 
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Approximately 90% of heat-treated bacteria labelled with PI and fluoresced red. The 
remaining 10% retained the ability to accumulate R123 and fluoresced with similar 
intensity to bacteria in untreated populations. However, the accumulation ofR123 by the 
residuallabellers in heat-treated populations was not sensitive to CCCP. An example of 
R123IPI labelled heat-treated M. tuberculosis is shown in Figure 3.11. Heat-treated 
bacteria were not fluorescent without Rl231abelling. 
Control 
Heat treated 
Figure 3.11: Effect of heat treatment (70°C/30 min) on R123 accumulation by M. 
tuberculosis. 
Phase-contrast and fluorescence images of the same microscopic fields of view of treated and 
control populations are shown. Cells were viewed at 1000 x magnification. Scale bar = 3 J.1Dl. 
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The R123-labelled heat-treated cells were unexpected as previous work in this laboratory 
established that heat-treated mycobacteria labelled exclusively with PI (D.R. Walker and 
M.R. Barer, unpublished data). However, closer inspection of this work revealed that M 
tuberculosis was not among the mycobacterial species investigated. Heat treatment of M 
smegmatis and M aurum (organisms included in the previous study) produced results that 
agreed with the earlier findings, i.e. all bacteria identified by phase-contrast microscopy 
were PI stained and no R123 fluorescence was observed. An example of R123IPI 
labelled heat-treated M smegmatis is shown in Figure 3.12. Prior to heat treatment, 
almost all of M smegmatis cells accumulated R123 and fluoresced green. 
Control 
Heat treated 
Figure 3.12: Effect of beat treatment (70°C/30 min) on R123 accumulation by M. 
smegmatis. 
Phase-contrast and fluorescence images of the same microscopic fields of view of treated and 
control populations are shown. Cells were viewed at 1000 x magnification. Scale bar = 3 J1In. 
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Ethanol treatment produced the same pattern of RI 23/PI labelling as heat treatment in M 
tuberculosis (results not shown). In like manner, residual Rl23 accumulation was not 
uncoupler sensitive and ethanol-treated bacteria did not fluoresce without Rl23 labelling. 
Effects of the bactericidal treatments on colony counts are shown in Table 3.2. Each of 
the treatments produced a reduction in counts to levels below that detectable by the drop 
plate method used « 50 CFU mrl). 
Table 3.2: Effect of bactericidal treatments on colony counts of M. tuberculosis. 
Treatment 
Middlebrook 7H9 broth control 
4% fonnaJdehyde 
1 % fonnaldehyde 
Heat treatment at 70°C 
70% ethanol 
• Limit of detection of method is 50 CFU mrl. 
Time 
2 h or o/n 
2h or o/n 
30 min 
5 min 
CFU mr'a 
1.8 ± 0.4 x 107 
< 50 
< 50 
<50 
< 50 
In summary, although R 123/PI labelling of M tuberculosis cell suspenSIOns after 
bactericidal treatments was phenotypically different from untreated controls, none of the 
treatments completely abolished Rl23 fluorescence. However, in each case, residual 
labelling with Rl23 was not sensitive to uncoupler agent and, was therefore regarded as 
non-specific staining rather than evidence of physiological activity. 
3.1.7 Tetrazolium salt reactions 
Tetrazolium salt reduction was evaluated as an alternative cytochemical indicator of 
physiological activity in M tuberculosis (Section 2.8.4). Preliminary studies showed that 
both INT and CTC were reduced intracellularly by physiologically active cells to 
insoluble formazan and were detectable by microscopy. However, more cells remained 
non-labelled than labelled and deposits detected in many cells were small. Consequently, 
various reaction conditions were tested in order to improve tetrazolium reduction. 
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Initial experiments used short incubation times (5-10 min), high concentrations of INT (5 
mM), and test cells prepared in Middlebrook 7H9 broth. Although this resulted in some 
reduction of INT, formazan deposits were small and often difficult to detect. 
Deposits were found to increase in size with longer incubation times and lower 
concentrations of INT. The results of these experiments were quantified by image 
analysis and are shown in Figures 3.l3 and 3.l4 respectively. The most substantial 
deposits in M tuberculosis were observed with 1 mM INT incubated for 1 h. Examples 
of brightfield microscopy images of formazan deposits at each of the concentrations 
tested are included in Figure 3.14. With longer incubation times (> 1 h), deposits 
produced swollen cells with distorted morphology. Larger formazan deposits were 
observed in test cells prepared in PBS (PH 7.3) rather than Middlebrook 7H9 broth 
(results not shown). 
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Figure 3.13: Effect of incubation time on INT reduction by M. tuberculosis. 
Formazan deposits are expressed as the average integrated optical density (100) produced by bacteria at 
each of incubation times tested. INT was added at a final concentration of 5 mM. The number of cells 
analysed for each time point was in the range of 80-302; symbols represent mean ± S.E.M. 
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Figure 3.14: Eft'ect ofINT concentration on the production offormazan deposits by M. 
tuberculosis. 
(a) Formazan deposits produced at each of the concentrations tested expressed as the average 
integrated optical density (100). The number of cells analysed for each concentration was in the 
range of 50-100; symbols represent the mean ± S.E.M. Examples of brightfield images of 
bacteria at each of the concentrations are shown in (b). Cells were viewed at 1000 x 
magnification. Scale bar = 3 J.Ull. 
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Although, the addition of exogenous oxidisable substrates (aspartate, a-ketoglutarate, 
pyruvate, cellobiose, malate, serine, fumarate, citrate, succinate, glucose and glutamate) 
was shown to stimulate tetrazolium salt reduction with other bacterial species (Gribbon, 
1995; Whiteley, 1996), neither an increase in the number of M tuberculosis cells that 
produced formazan deposits or an increase in deposit size was observed in the present 
study. 
In summary, although optimisation of INT reduction in M tuberculosis produced larger 
formazan deposits, increase in the proportion of labelling to non-labelling bacteria was 
not observed. The number of cells that demonstrated cytological activity with the INT 
reduction assay was approximately the same as the number of cells that labelled with 
R123. 
Cells that reduced crc were easily identified by their bright red fluorescent deposits. 
However, non-labelling and inconsistent results were the norm. Some bacteria contained 
what appeared to be intracellular formazan deposits when observed by phase contrast 
microscopy, which, were not fluorescent when examined by fluorescence microscopy. 
Extracellular fluorescent formazan deposits were also observed. Extended incubation 
times and varying the concentration of CTC produced little improvement in labelling and 
consequently experiments with crc were discontinued. 
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3.1.8 Combined R123IPI labelling and INT reduction assays 
Both the R123-labelling and INT-reduction assays identified non-labelled cytologically 
inactive bacteria in M tuberculosis cell suspensions. In order to assess whether these 
populations were the same a combined assay was developed. 
Results of the combined assay indicated that more bacteria accumulated R 123 than 
produced measurable formazan deposits. Analysis of R123-labelled cells from broth 
culture revealed that approximately 10% of the fluorescent cells did not contain 
detectable formazan deposits (Figure 3.15a). This analysis was often difficult as R123 
fluorescence was obscured in bacteria that were filled with large formazan deposits 
(Figure 3 .I5b). It should be noted that INT deposits themselves are not fluorescent. 
In summary, although the non-labelling proportion was more or less the same, there were 
a higher number of cytologically inactive cells in the INT assay than the Rl23 assay. 
Bacteria that contained formazan deposits always accumulated R123 but cells that 
accumulated R123 did not always contain detectable deposits. 
The combined assay was also used to further investigate the residual R123-labelled cells 
produced by the bactericidal treatments described in Section 3.1.6. Examples of heat-
treated and control populations of M tuberculosis labelled using the combined assay are 
shown in Figure 3.16. Whereas formazan deposits were clearly observed in most R123 
labelled cells in control populations, none of the R123 labelled cells in heat-treated 
samples contained deposits. 
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Figure 3.1S: INT reduction in R123-labelled M. tuberculosis. 
R123 alone 
R123 + INT 
(a) Formazan deposits were quantified by integrated optical densities (lOD) and 
fluorescence intensities by integrated grey levels (lGL). Cells with IOD < 60 did not contain 
detectable formazan deposits. (b) Phase-contrast, brightfield and fluorescence images of 
R123-labelled bacteria with large formazan deposits demonstrating the quenching of 
fluorescence. Scale bar = 2 ~. 
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(a) 
(b) 
Figure 3.16: Combined INT reduction and RlZ3IPI aceomulatlon .... y. 
(a) Control and (b) heat-treated (70°Cl3Omin) populations of M. tuberculosis. Brightfield and 
fluorescence images of the same microscopic field of view are shown. Cells were viewed at 
1000 x magnification. Scale bar = 5 J.LDl. 
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3.1.9 Results of other cytological assays 
The other assays used to investigate cytological activity in M tuberculosis met with little 
success. Whereas the control organism Staphylococcus aureus labelled as expected in the 
oxonollabelling experiments (i.e. cells inactivated by heat-treatment were readily stained 
while untreated cells excluded oxonol and did not fluoresce), no difference in labelling 
between heat-treated M tuberculosis and untreated controls was observed. Mycobacteria 
inactivated by heat or ethanol treatment were expected to stain fluorescent red using the 
LivelDead BacLIGHT kit but a mixture of fluorescent red, green and orange bacteria was 
observed instead. Substantial background fluorescence was observed with both of these 
assays. Although, M avium stains successfully with the live cell nucleic acid SYT016 
(Ibrahim, 1996; 1997), the number of M tuberculosis cells stained with this dye in the 
present study was found to be less than the number labelled with R123 or INT. 
Since cytochemical labelling of M tuberculosis with oxonol, Live/Dead stains, SYT016 
and CTC proved unsatisfactory, they were not included in further work. 
3.1.10 Effect of labelling on colony counts 
The effects of treatment with R123, PI, CCCP and INT on colony counts of M 
tuberculosis are shown in Table 3.3. Treated bacteria produced approximately the same 
colony-forming ability as the controls. One notable observation was that sufficient INT 
was present in the undiluted and 10-1 diluted samples used to enumerate colony counts to 
produce dark red/purple coloured colonies. 
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Table 3.3: Effect of cytochemical assays on culture of M. tuberculosis 
Treatment 
Control 
I /lM RI23/ 3 /lM PI 15 min 
13 IlM R123/ 3 IlM PI 15 min 
15 IlM CCCP 15 min 
150 /lM CCCP 15 min 
5 mM INT 15 min 
CFU mr'· 
1.8 ± 0.4 x 107 
1.2 ± 0.2 x 107 
1.7±0.4x 107 
1.8 ± 0.2 x 107 
1.6 ± 0.4 x 107 
1.5 ± 0,5 x 107 
• Colony counts are expressed as means ± standard deviation of the means. 
3.1.11 Development of GFP reporter strain 
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The Aequorea victoria gfjJ gene was cloned into the E. coli-mycobacterium shuttle vector 
pMV261 using the unique BamHI and EcoRI sites downstream of the hsp60 promoter, 
and transformed into M tuberculosis as described in Section 2.10, However, none of the 
transformants selected by high-level kanamycin resistance produced fluorescence when 
examined at the single cell or colony level. Restriction digests of the gip constructs 
(Figure 3.17) revealed that a DNA fragment of the expected size was inserted into 
pMV26 1 and analysis of the DNA sequence demonstrated that the gfjJ gene was 
successfully cloned downstream of the promoter, Problems with this cloning strategy had 
apparently also occurred in other laboratories (Locht, personal communication I). At this 
time, Kremer et al., (1995) and Dhandayuthapani et al., (1995), described gfp expression 
in mycobacteria and the former group kindly provided their construct (pG FM 11) for use 
in this study. M tuberculosis was transformed with this construct as described. 
Gip-expressing M tuberculosis produced fluorescent colonies when illuminated by long-
wave UV light. At the single-cell level, GFP was brightly fluorescent and evenly 
distributed throughout the cell. Fluorescence was stable and did not fade quickly when 
illuminated, Apart from high-level kanamycin and streptomycin resistance, no obvious 
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difference in culture characteristics between transformants and the wild type strain was 
observed. 
kb 
23.1-
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6.6 -
4.4 -
2.3 -
2.0 -
0.6 -
1 2 3 4 
Figure 3.17: Restriction endonuclease digest of plasmids pGFM (lane 2), pMV26l (lane 
3) and pRPCI (lane 4). 
Plasmid maps are shown in Figure 2.4. Plasmids were digested with EcoRI and BamHI and analysed on 
0.8% agarose gel. DNA size markers (Hind ill digested lamba DNA) are shown in lane I. 
3.1.12 Total cell counts (TeC) 
Three different methods of direct microscopic enumeration of mycobacteria were 
assessed as described in Section 2.7. Although the specifications of the Thoma counting 
chamber are such that it's optical path with an ordinary coverslip is short enough so the 
chamber can be used under an oil-immersion objective at high power, it was both difficult 
and time consuming to use. Consequently, differentiating bacteria from debris or marks 
on the slide or coverslip and determining whether an object was a singJe large celJ or a 
group of small cells proved difficult. 
I c. Locht, Directeur de Recherche, Laboratoire de Microbiologie, Genetique et MoJeculaire, lnstitut 
Pasteur de Lille, / rue du Prof. Calmette, F-59019 Lille Cedex, France. 
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Direct counting of bacteria immobilised on APS-coated covers lips was more successful, 
as cells were clearly identified using phase-contrast microscopy and readily distinguished 
from debris present. As well as estimating the total number of bacteria it was possible to 
record information about their size and morphology. Although there was no need to stain 
the bacteria, the same preparation could be used for TCC enumeration and cytological 
assays (e.g. R123 labelling). As a result, the number of bacteria demonstrating activity or 
a particular phenotype could be determined. 
With the third method, DAPI-stained cells were brightly fluorescent on a black 
background. However, there was variation in the intensity of staining and background 
fluorescence was occasionally noted. Staining of amorphous shapes occurred but these 
were usually distinguishable from bacteria. Individual fluorescent cells were clearly 
labelled in small clumps. 
The three methods were used to calculate the number of bacteria in suspensions of M 
tuberculosis prepared as described in Section 2.4.4. Table 3.4 shows that there was little 
difference in the counts obtained. However, because of the straightforwardness of the 
techniques, direct counting of DAPI-stained bacteria on filters and bacteria immobilised 
on APS-coated coverslips were used for the remainder of the study. 
Table 3.4: Comparison of direct microscopic methods used in total cell counts of M. tuberculosis • 
Counting Method TCC mrl b 
Counting chamber 
Membrane filter sampled DAPI-stained 
Immobilised on APS-coated cover slip 
1.27 ± 0.34 x 108 
1.l4±0.S2x 108 
8.49±0.13x 107 
a Bacterial suspensions were prepared from agar culture as described in Section 2.4.4 and diluted to an OD580run of 0.2. 
b Data are expressed as means ± standard error of the mean. 
3.1.13 Development of mycobacteriopbage infectivity studies 
High titre lysates of mycobacteriophage D29 were obtained using the M smegmatis 
infection method described in Section 2.11.1. These lysates produced approximately 2 x 
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1010 PFU mr) on M smegmatis after 1-2 days incubation using the phage titres 
enumeration method described by Fullner and Hatfull (1997) (Section 2.11.2). Infection 
of mycobacterial cultures prepared in Tween-80 free media was essential for high titre 
lysates. Although 2 mM CaCh was reported to enhance productive infection by D29 
(David et al., 1980), phage titres were not substantially reduced by its absence. All 
plaques observed were discreet and clear, surrounded by confluent bacterial growth. 
Phage titres prepared from mycobacteriophage lysates stored aseptically either at 4°C or 
at -20°C for several months remained the same. 
M tuberculosis cultures were prepared for phage infectivity studies as described in 
Section 2.11.3. Overnight culture in Tween 80-free broth before incubation with phage 
was essential for successful infection. Cultures treated with a multiplicity of infection of 
between 10 and 100 did not produce colonies when subcultured. 
Effects of mycobacteriophage D29 infection on antimycobacterial drug treated M 
tuberculosis cultures and M tuberculosis broth culture were assessed using R123/PI 
cytochemical labelling and are presented in Section 3.2.10 and Section 3.3.2 respectively. 
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3.2 EFFECTS OF ANTIMYCOBACTERIAL DRUGS 
The suitability of M tuberculosis cell suspensions prepared from agar culture for 
cytochemical labelling and the development of R I 23IPI labelling, INT reduction, and gfp 
reporter strains as useful indicators of cytological activity in these populations were 
reported in Section 3.1. Here, the effects of clinically important antimycobacterial drugs 
on M tuberculosis cultures are assessed using these techniques and compared to those 
obtained with conventional culture methods. 
The experiments were done on many occasions during development and optimisation of 
the cytochemical assays using different inocula preparations, incubation conditions, 
sampling regimes, labelling procedures, recording and image analysis protocols. Bacteria 
in the early drug experiments were taken from the exponential growth phase of broth 
culture and consequently contained many unlabelled cells. These early experiments also 
used concentrations of R123 that were later shown to produce uncoupler-insensitive 
accumulation of dye, therefore it not known whether fluorescence reflected membrane 
potential or non-specific labelling. The results presented here are the culmination of this 
work and characterise the effects of the drugs with protocols that gave low numbers of 
non-labelling or ambiguous cells. 
The effect of antimycobacterial drugs on colony counts, total cell counts, cytochemical 
labelling and most probable number estimates are presented individually in this section. 
The results are not presented together because of the complexity of the data. 
3.2.1 Colony counts 
The colony counts of M tuberculosis cultures treated with single anti mycobacterial drugs 
over 7-day assay periods as described in Section 2.9.2 are shown in Figure 3.18a. 
Isoniazid and rifampicin produced between two and three log reductions in CFU mr). 
The effect of ethambutol was considerably less, and at most, a decline of one log cycle 
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was recorded. Although streptomycin initially produced reduction in colony counts 
comparable to isoniazid and rifampicin, the effect was transient as counts increased after 
day 4. Similar results were obtained with capreomycin (results not shown). Colony 
counts in drug-free controls increased by about one log over the assay period. 
The colony counts of M tuberculosis treated with isoniazid combinations and rifampicin 
combinations are shown in Figures 3 .18b and 3 .l8c respectively. In each case, the result 
produced when these drugs were used alone is included for comparison. The 
antimicrobial activity of drug combinations was almost always greater than that of single 
drugs, with greatest reduction in colony counts produced by isoniazid-rifampicin, 
isoniazid-streptomycin and rifampicin-streptomycin combinations (reductions of between 
five and six log CFU mrl). Colony counts continued to decline after the 7-day assay 
period, and few colonies were detected when cultures were sampled at 14 and 21 days 
(results not shown). Regrowth, such as that observed when streptomycin and 
capreomycin when used individually, was not observed when combinations of 
antimycobacterial drugs were used. 
It was noted that colonies of M tuberculosis treated with antimycobacterial drugs 
occasionally took longer to grow to visible size than those of drug-free controls. 
Consequently, plates for CFU enumeration were incubated for six weeks before being 
discarded to ensure detection of any slow-growing colonies. 
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Figure 3.18: Effect of antimycobacterial drugs on colony counts of M. tuberculosis. 
(a) single anti-mycobacterial drugs, (b) isoniazid combinations and, (c) rifampicin 
combinations. Colony counts are expressed as loglo CFU ml· l. 
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3.2.2 Total cell counts 
None of the antimycobacterial drugs tested, either singularly or in combination, produced 
more than a half log change in the total cell count of M tuberculosis cultures during the 
7-day assay periods. Total cell counts and colony counts before and after 7 days 
treatment are compared below in Figure 3.19. 
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Figure 3.19: Total cell counts and colony forming unit counts of Mo tuberculosis 
after 7 days treatment with antimycobacterial drugs. 
Cultures were treated for 7 days with antimycobacterial drugs (S, streptomycin; I, isoniazid; R, 
rifampicin; E, ethambutol) and sampled for TCC and colony counts. Day 0 represents the counts 
before drug treatment. Counts are expressed as means ± standard deviation of the means of data 
from independent experiments. Tee were by direct microscopic enumeration of DAPI-stained 
bacteria. 
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3.2.3 R123IPI labelling 
Prior to treatment with anti mycobacterial drugs, approximately 90% of bacteria labelled 
with R123, 1% stained with PI and the remainder were non-labelled. During the 7-day 
drug assays, there was a reduction in the proportion of Rl23-labelled bacteria and a 
concomitant increase in the number of PI-stained cells. The total number of R123-
labelled bacteria mr) was calculated from the number of green fluorescent cells in 
mono layers of bacteria immobilised on APS-coated coverslips, as described in Section 
2.7, and compared to the colony counts for each of the drugs tested (since it was 
necessary to process large number of images for these calculations, Rl23-labelIed cell 
counts were evaluated from fluorescent cells visible on recorded fields of view rather than 
from quantitative data obtained using image analysis). To simplify interpretation, the 
results of exposure to individual drugs are shown in Figure 3.20, isoniazid in combination 
with other drugs in Figure 3.21 and rifampicin in combination with other drugs in Figure 
3.22. 
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Figure 3.20: Comparison of colony counts and the number of R123-labelled bacteria in cultures of M. 
tuberculosis treated with single anti-mycobacterial agents. 
E 
<'(j 
.;:: 
Cl) 
-u <'(j 
..0 
"0 
~ 
Q) 
..0 
E 
<'(j 
-; 
:::l M 
'"'"' 
N 
U e::: 
0 0 
co co 
0 0 
......1 ......1 
1.00E+08 i 
1.00E+07 J... 
1.00E+06 
1.00E+05 
1.00E+04 
1.00E+03 
1.00E+02 Isoniazid 0.2 ~g ml-! 
1.00E+01 
0 2 3 4 5 6 
I.UV~"TVO I 
1.00E+07 i 
"- ~ 
1.00E+06 ~ -~ 
1.ooE+05 \ 
1.00E+04 
1.00E+03 
1 OOE+02 i Isoniazid 0.2 ~g ml-! 
. Ethambutol 6.0 ~g ml-! 
1.00E+01 
0 2 3 4 5 6 
1.00E+08 
1.00E+07 
1.00E+06 
1.00E+05 
1.00E+04 
1.00E+03 
1.00E+02 
1.00E+01 
7 
1.00E+08 
1.00E+07 
1.00E+06 
1.00E+05 
1.00E+04 
1.00E+03 
1.00E+02 
1.00E+01 
7 
0 
0 
Isoniazid 0.2 Ilg ml-! 
Rifampicin 1.0 Ilg ml-! 
2 3 
Isoniazid 0.2 Ilg ml-! 
Streptomycin 2.0 /lg mt-! 
2 3 
4 5 6 7 
4 5 6 7 
Time (days) - R123 ml·' -0- CFU ml-' 
Figure 3.21: Comparison of colony counts and the number of Rl23-labelled bacteria in cultures of M. 
tuberculosis treated with isoniazid combinations. 
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Figure 3.22: Comparison of colony counts and the number ofR123-labelled bacteria in cultures of M. 
tuberculosis treated with rifampicin combinations. 
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It is evident from these graphs that treatment with antimycobacterial drugs produced 
substantial dissociation between the number of RI 23-labelled bacteria and the number of 
colonies counted. In all cases, the number of RI 23-labelled cells exceeded the number of 
cells that produced colonies. Exposure to single drugs resulted in between half and two 
logs more R123-labelled bacteria than colonies. Treatment with drug combinations 
produced greater dissociation, in the cases of isoniazid-rifampicin, isoniazid-streptomycin 
and rifampicin-streptomycin combinations differences greater than three and four logs 
were observed. The discrepancies between the number of R123-labelled bacteria and 
colony forming units after 7 days treatment with antimycobacterial drugs are summarised 
in Table 3.5. 
Table 3.5: Comparison of R123-labelled cell counts (R123 mrl) and colony forming unit counts (CFU 
mrl) of M. tuberculosis culture after 7 days treatment with antimycobacterial drugs· 
Antimycobacterial drug(s) R123 mr' CFU mr' Log iO difference 
Isoniazid 1.4±0.5 x 107 3.0±0.5 x 104 2.8 
Rifampicin 2.2±0.4 x 106 9.6±3.2 x 104 1.5 
Ethambutol 1.1 ±0.4 x 107 3.1±0.6 X 106 0.7 
Streptomycin 3.3±0.7 x 106 l.3±0.7 x 106 0.6 
Isoniazid & Rifampicin 7.6±0.9 x 105 7.6±0.5 x 10' 4.2 
Isoniazid & Ethambutol 2.7±0.6 x 106 3.5±OA X 105 1.1 
Isoniazid & Streptomycin 5.7±2.8 x 105 5.9±3.3 x 102 3.1 
Rifampicin & Ethambutol 1.5±0.6 x 106 2.1±0.7x 104 2.0 
Rifampicin & Streptomycin 2.7±0.6 x 106 2.8±1.5 X 102 4.1 
• Counts are expressed as means ± standard deviation ofthe mean of data from replica experiments. 
The fluorescence intensity of R 123-labelled cells after drug treatment was heterogeneous 
and mixtures of bright, dull and non-fluorescent bacteria were seen. Image analysis was 
used to measure and quantify fluorescence intensities throughout the 7-day drug assays. 
Scatter plots of the integrated grey level and mean grey level of green fluorescence of 
individual bacteria from selected analyses are shown in Figures 3.23-3.29. From such 
data, the average daily fluorescence intensities for each of these drug assays were 
calculated and are shown in Figure 3.30. 
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Fluorescence is expressed both by integrated grey level and mean grey level. 
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Figure 3.25: Scatter plots of the fluorescence intensities of R123-labelled M. tuberculosis 
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Fluorescence is expressed both by integrated grey level and mean grey level. 
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Figure 3.27: Scatter plots ofthe fluorescence intensities of R123-labelled M. tuberculosis 
during treatment with a combination of isoniazid and streptomycin. 
Fluorescence is expressed both by integrated grey level and mean grey level. 
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Figure 3.28: Scatter plots of the fluorescence intensities of R123-labelled M. 
tuberculosis during treatment with a combination of rifampicin and ethambutol. 
Fluorescence is expressed both by integrated grey level and mean grey level. 
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during treatment with a combination of rifampicin and streptomycin. 
Fluorescence is expressed both by integrated grey level and mean grey level. 
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Two labelling trends with R123 were observed from the quantitative image analysis 
results. With the exception of treatments with isoniazid, and isoniazid-ethambutol 
combination, the scatter plots demonstrate the progressive reduction in the number of 
green fluorescent cells during the course of the 7-day treatments with antimycobacterial 
drugs already described. This reduction is reflected in the decrease of the average daily 
fluorescence intensities shown in Figure 3.30. Rifampicin treatment, for example, 
reduced the average green fluorescence intensity by a minimum of 30% within 24 hours 
and by at least 65% over the 7 days. 
250 
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Figure 3.30: Effect of antimycobacterial drugs on the average fluorescence intensity 
of M. tuberculosis. 
The average fluorescence intensity was calculated from the green fluorescence intensity 
attributable to each cell (MGL), including R123-1abelled and non-labelled cells. Symbols 
represent mean ± S.E.M of these values. 
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However, exposure of M tuberculosis culture to isoniazid or to a combination of 
isoniazid and ethambutol produced enhanced uptake of R 123 resulting in both increased 
fluorescence intensity per cell and an increase in the proportion of cells labelled. 
Increased average fluorescence intensities were observed within 24 hours of treatment 
(increases of 50% and 30% respectively) and were greatest after 3 days (increases of 85% 
and 55% respectively) (Figure 3.30). By this time, bacteria were almost exclusively 
labelled with R123 and few of the non-labelled proportion present before treatment were 
observed. By day 7, the average fluorescence intensity of isoniazid-treated cells remained 
higher than that measured in bacteria prior to treatment at day 0, whereas, the average 
fluorescence intensity of bacteria treated with isoniazid and ethambutol was reduced to 
less than 50% of that measured at day O. Although increased R123 fluorescence 
intensities were not observed when M tuberculosis cells were treated with isoniazid-
streptomycin or isoniazid-rifampicin combinations, declines in average fluorescence 
intensities were not as gradual as those produced by rifampicin and the other drug 
combinations. 
A noteworthy effect arising from the standardisation of image acquisition during 
experiments 0. e. using the same camera integration times and electronic gain for each 
image so that fluorescence intensities could be compared in meaningful way) can be 
observed in the scatter plots in Figure 3.23. The enhanced R123 fluorescence observed 
following isoniazid treatment meant that the brightest cells produced pixel saturation with 
the CCD camera. In such instance, quantitative fluorescence intensity data obtained using 
image analysis undervalues the total fluorescence produced by these cells and gives the 
inaccurate impression that they belong to distinct homogenous groups. 
In addition to increased fluorescence, many bacteria treated with isoniazid and 
combinations of isoniazid-ethambutol produced intense polar labelling when stained with 
R123 (Figure 3.31). The majority of cells in these bacterial populations were 
characterised by increased refractility when viewed by phase-contrast microscopy and 
many oddly shaped, small cells were observed. Although ethambutol-treated cells also 
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became more refractile and stunted, increased fluorescence intensity and polar labelling 
were not observed. The morphological changes produced by the cell wall active 
antimycobacterial drugs were associated with a lower frequency of clumps in the 
monolayer preparations. Enhanced R123 uptake and polar labelling was not produced by 
the other antimycobacterial drugs tested and treated cells gradually became less refractile 
when viewed using phase contrast microscopy. 
(a) Rl23-labelled cells at Day 0 Cb) R I 23-labelled cells after 3 days 
treatment with isoniazid 
Figure 3.31: R123 polar labelling of isoniazid-treated M. tuberculosis. 
Phase-contrast and fluorescence images of the same field of view of (a) bacteria before treatment 
and (b) bacteria treated with 0.2 f.lg mr' isoniazid for 3 days. 
When viewed using phase contrast microscopy, RI 23-1abelled and PI-labelled cells from 
M tuberculosis cultures treated with antimycobacterial drugs were indistinguishable from 
each other. In other words, groups of morphologically similar bacteria could contain 
RI23-labelled, PI-labelled and non-labelled cells. It was noted that a small number of 
bacteria labelled simultaneously with R123 and PI. In such cases, RI23 fluorescence was 
low-level and localised in one part of the cell. 
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3.2.4 R123 uncoupler sensitivity studies 
Cultures of M tuberculosis treated with antimycobacterial drugs were labelled with R123 
in the presence of CCCP (150 )lM) at intervals during the assays to demonstrate that 
accumulation of dye was uncoupler sensitive. Results of labelling experiments on 
cultures treated for 7 days with isoniazid, rifampicin and a combination of the two are 
shown in Figures 3.32-3.34 and demonstrate that fluorescence of cells was sensitive to 
uncoupler agent. Similar results were obtained with the other antimycobacterial drugs 
tested. 
In summary, the number of bacteria displaying phenotypes consistent with physiological 
activity in antimycobacterial drug-treated M tuberculosis cultures greatly exceeded the 
number of cells capable of producing propagules by culture on Middlebrook 7H 1 0 agar. 
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Figure 3.32: Uncoupler-sensitive accumulation of R123 by isoniazid-treated M. 
tuberculosis. 
Bacteria treated for 7 days with 0.2 /Jg ml- 1 isoniazid were (a) labelled with 1 /JM R123 
(b) treated with 150 /JM CCCP and labelled with R123 (c) treated with CCCP, washed 
in fresh broth and labelled with R123. 
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Figure 3.33: Uncoupler-sensitive accumulation of R123 by rifampicin-treated M. 
tuberculosis. 
Bacteria treated for 7 days with 2.0 Ilg ml- l rifampicin were (a) labelled with 1 IlM 
R123 (b) treated with 150 IlM CCCP and labelled with R123 (c) treated with CCCP, 
washed in fresh broth and labelled with R 123. 
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Figure 3.34: Un coupler-sensitive accumulation of R123 by M. tuberculosis treated 
with a combination of isoniazid and rifampicin. 
Bacteria treated for 7 days with a combination of 0.2 J..lg ml- i isoniazid and 2.0 )lg ml- i 
rifampicin were (a) labelled with 1 J..lM R123 (b) treated with 150 )lM CCCP and 
labelled with R123 (c) treated with CCCP, washed in fresh broth and labelled with 
R123. 
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3.2.5 MPN enumeration 
In light of the discrepancies between the number of cells with physiological activity and 
colony counts on Middlebrook 7H 1 0 agar, propagules of M tuberculosis in drug-treated 
cultures were also enumerated in Middlebrook 7H9 broth using the MPN method 
described in Section 2.9.3. The results from preliminary experiments revealed that 
sufficient active drug was present in the cultures at day 7 to prevent growth in the 
undiluted and least diluted tubes of the MPN assay. Consequently, bacteria were 
harvested at day 7 by centrifugation and washed in drug-free Middlebrook 7H9 broth for 
MPN enumeration. 
The transition from 5 positive to 5 negative tubes for all samples took place within two or 
three dilutions steps, thus indicating Poisson distribution of cells (Niemela, 1983). MPN 
estimates and colony counts of M tuberculosis at day 7 of the drug assays are compared 
in Figure 3.35. Although the MPN estimates for each of the antimycobacterial drugs and 
drug combinations tested were almost always greater than the colony counts, difference 
were usually about a half log and never more than one log. 
Whereas, results of colony counts changed little after 4 weeks incubation, MPN tubes 
were not discarded until after 6 weeks of continued incubation as turbidity in some of the 
dilutions was not observed until then. All randomly sampled positive MPN tubes 
contained acid-fast bacteria. 
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Figure 3.35: Comparison of colony forming unit (CFU) and most probable number 
(MPN) estimates of propagules of M. tuberculosis after 7 days treatment with 
antimycobacterial drugs. 
Cultures were treated for 7 days with antimycobacterial drugs (I - isoniazid, 0.2 /-lg mrl; 
R - rifampicin, 2.0 /-lg mrl; E - ethambutol, 6.0 /-lg mrl; S - streptomycin, 2.0 /-lg mrl and 
C - capreomycin, 10 /-lg mrl), washed in drug-free Middlebrook 7H9 broth and sampled 
for MPN and CFU counts. Con represents the counts before drug treatment. Colony 
counts are presented as CFU mrl ± S.D. and most probable numbers as MPN mrl ± S.D. 
of logloMPN as described by Niemela (1983). 
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3.2.6 Cell elongation and loss of R123 labelling in drug-free controls 
The effect of antimycobacterial drugs on R123/PI labelling of M tuberculosis was 
discussed in Section 3.2.3 (i.e. a decrease in the number of Rl23-labelled bacteria and a 
concomitant increase in the proportion of PI-labelled cells). In these experiments, 
changes in labelling were compared to labelling before drug treatment (i.e. at day 0) 
rather than labelling in drug-free controls. In the drug-free controls, morphological and 
labelling changes occurred which were later shown to be characteristic of M tuberculosis 
when transferred from agar to broth culture. These changes, summarised in Figure 3.36, 
were most obvious over the first three days and did not occur in the presence of any of the 
antimycobacterial drugs tested. In the absence of drugs, individual cells elongated and 
increased in length from an average of 3.0 to 4.1 /lm within 72 h. During this time 
bacteria became recalcitrant to labelling with R123 and the proportion of labelled cells 
decreased from approximately 80-90% to as low as 10%. The non-labelled cells did not 
stain with PI and were indistinguishable from labelled cells when viewed using phase-
contrast microscopy. Over the same period a four-fold increase in colony counts was 
observed (1.7 x 107 to 7.2 x 107 CFU mrl). 
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Figure 3.36: Changes in cell length, R123 labelling and colony counts of M. tuberculosis 
following transfer from Middlebrook 7010 agar to Middlebrook 709 broth. 
(a) Cell lengths are expressed as means ± S.E.M .. (b) R123 labelling as percentage labelled and 
(c) colony counts as means ± S.O. 
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3.2.7 INT reduction 
The effects of isoniazid and rifampicin on cultures of M tuberculosis were also assessed 
using INT reduction as an indicator of oxidative metabolism. Two trends were produced, 
comparable to the distinct trends produced with R123 accumulation. 
Enhanced reduction of INT was observed in isoniazid-treated cultures resulting both in 
larger formazan deposits and an increased proportion of labelled cells (Figures 3.37 and 
3.38). Analysis of these cells revealed that increased formazan deposits were produced 
within 24 hours of treatment and were greatest after 3 days (Figure 3.37a). Examples of 
formazan deposits in cells before treatment and at day 3 of treatment are shown in Figure 
3.37b. Although the deposits filled the cells at day 3, they appeared more concentrated at 
the bacterial poles. By day 7, the optical density measurements of isoniazid-treated cells 
had returned to a level close to that measured in untreated bacteria at day O. The 
proportion of cells labelled with INT increased from approximately 65% to 95% after 24 
hours treatment with isoniazid (Figure 3.38). This increase was followed by a gradual 
reduction in the proportion of labelled cells and by day 7 the number of cells containing 
formazan deposits was approximately the same as that observed at day 0 before drug 
treatment. Isoniazid treatment produced a 2.5 log reduction in colony counts over the 
assay period. 
Although a small increase in the proportion of labelled cells was produced in cultures 
treated with a combination of isoniazid and rifampicin after 24 hours (Figure 3.38), an 
increase in formazan deposit size was not observed (results not shown). This was 
followed by a rapid decrease in the number of labelled bacteria and by day 7 less than 
20% of the cells identified by phase contrast microscopy contained detectable deposits. 
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Figure 3.37: Effect of isoniazid treatment on colony counts and INT reduction by M. 
tuberculosis. 
Bacteria were treated with 0.2 J..Lg mr! isoniazid. (a) INT reduction is expressed as the 
average mean optical density (M.O.D. ± S.E.M.) of bacteria with formazan deposits, 
colony counts are expressed as lOglO CFU ml-! (± S.D.). (b) Phase-contrast and bright-
field microscopic images comparing formazan deposits in cells before treatment with 
those in cells after 3 days isoniazid treatment. Scale bar = 2 JlIIl. 
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In contrast, cultures of rifampicin-treated M tuberculosis demonstrated a gradual and 
progressive reduction in both the number and size of formazan deposits over the assay 
period (Figure 3.38). By day 7, less than 5% of cells identified by phase contrast 
microscopy reduced INT and many contained small formazan deposits that were difficult 
to detect. Over the same period colony counts fells by between 2 and 3 log units . 
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Figure 3.38: Effect of antimycobacterial drugs on INT reduction by M. tuberculosis 
Cell suspensions were treated with 0.2 ~g mr' isoniazid and 1.0 ~g mr' rifampicin. The 
percentages of INT labelled bacteria were calcuJated from the number of cells containing 
detectable formazan deposits counted directly from recorded phase contrast and brightfield 
microscopy images. The number of cells counted for each point was in the range of 450-1248. 
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3.2.8 Direct reduction of INT by isoniazid 
In light of the results observed in Section 3.2.7, investigations were undertaken to 
detennine whether or not isoniazid had sufficient intrinsic reducing power to directly 
reduce INT under the test conditions used to observe physiological activity in drug treated 
mycobacterial cell suspensions (i.e. I mM INT for 60 min at 37°C in the presence of 0.2 
).1g isoniazid mrl). Direct reduction was not observed in cell-free preparations under 
these conditions (Table 3.6). Reduction was observed only with higher concentrations of 
isoniazid (20 mg mrl compared to 0.2 ).1g mrl) and extended incubation times (24 h 
compared to 1 h). 
Table 3.6: Direct reduction of INT by isoniazid compared to that by M. tuberculosis cell suspension 
INT incubation times 
Cell-free preparations 
M tuberculosis cell 
suspension controlb 
INH concentration (J.lg mr') 
o 
0.2 
2 
20 
200 
2,000 
20,000 
0.2 
l.h 
0 
0 
0 
0 
0 
0 
(+) 
++++ 
INT reduction" 
24 h 36 h 
0 0 
0 0 
0 0 
0 0 
0 0 
(+) (+) 
++ ++ 
+++++ +++++ 
• Reactions were carried out in PBS (pH 7.3) at 37°C with 1.0 mM INT for 1,24 and 36 h. INT reduction was assessed visually and 
scored out of 5 depending on colour change. No colour change was recorded as 0; minimum colour change was recorded as (+), 
whereas maximum colour change was recorded as +++++. 
b M. tuberculosis bacterial suspension (ODssonm of 0.2) was prepared in PBS (pH 7.3) containing 0.2 ~g mr' INH. 
3.2.9 Effect of antimycobacterial drugs on GFP production 
The effects of antimycobacterial drugs on GFP production and colony counts of the M 
tuberculosis [pGFMII] reporter strain are shown in Figure 3.39. Reductions in colony 
counts over the 7-day assay period were similar to those already described for the wild 
type strain; greatest reductions were observed with isoniazid, rifampicin and a 
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combination of the two, whereas treatment with ethambutol produced the least reduction. 
Since M tuberculosis [pGFMlI] contained a streptomycin-resistance cassette, cultures 
were not affected by streptomycin treatment and an increase in colony count over the 7 
days was observed. 
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Figure 3.39: Effect of antimycobacterial drugs on colony counts and GFP 
fluorescence in g{p-expressing M. tuberculosis. 
Cultures were treated for 7 days with antimycobacterial drugs (S, streptomycin; I, isoniazid; R, 
rifampicin; E, ethambutol) and sampled for fluorescence and colony counts. Day 0 represents 
fluorescence and colony counts before drug treatments. Fluorescence intensity is expressed as the 
average of the mean grey levels (MGL ± S.E.M.) of analysed bacteria, colony counts are 
expressed as loglO CFU mr! (± S.D.). 
GFP fluorescence was expressed as mean grey levels per cell (i. e. the average 
fluorescence produced by each pixel of a cell) so that changes in morphology produced by 
different anti mycobacterial drugs would not interfere with comparisons. Treatment with 
isoniazid, rifampicin and a combination of the two produced the greatest decrease in GFP 
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fluorescence. Less than 3% of cells treated with these drugs had MOL values greater than 
the average MOL value (102) measured at day O. Ethambutol-treated cells produced least 
decrease in fluorescence. Curiously, even though OFP clones were resistant to the 
antibiotic, fluorescence in streptomycin-treated bacteria decreased to lower levels than 
those found in ethambutol-treated bacteria. 
Unfortunately, identification of membrane energisation and oxidative metabolism in cells 
with high OFP fluorescence intensity following antimycobacterial drug treatment using 
R123 and INT was hampered (results not shown). In the first instance, little information 
could be taken from cells co-labelled with R 123 and OFP because of the similar spectral 
characteristics of these fluorophores (Table 2.2). In the second instance, OFP 
fluorescence was obscured in cells containing formazan deposits. 
3.2.10 Mycobacteriopbage infectivity studies 
Overnight incubation of antimycobacterial drug treated M tuberculosis cultures with 
mycobacteriophage D29 produced no detectable effect on cytochemical labelling with 
R1231PI; i.e. drug-treated cell suspensions inoculated with D29 contained the same 
proportion of fluorescent green, fluorescent red and non-labelled cells as those incubated 
in phage buffer without D29 (results not shown). Although reductions in colony counts 
were noted in drug-treated cultures after incubation with D29, corresponding reductions 
were also observed in the phage buffer controls (Table 3.7) indicating that the decrease in 
culturability was not due to phage infection. 
It should be noted that the M tuberculosis cell suspension used in the drug studies (i.e. 
prepared from barely confluent agar culture) was less susceptible to D29 infection than 
the exponential phase broth culture described in Section 3.1.13, and at most a reduction 
of half a log in colony counts was observed. D29 infection of these cell suspensions also 
produced little detectable effect on R 123/PI labelling, unlike the changes observed in 
exponential phase broth culture cells reported in Section 3.3.2 below. Overnight 
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incubation in phage buffer was shown to have no effect on colony counts in control cell 
suspensions. 
Table 3.7: Effect of mycobacteriophage D29 infection on colony counts of antimycobacterial drug 
treated M. tuberculosis I 
Antimycobacterial drug 
Control cell suspension 
Isoniazid 
Rifampicin 
Isoniazid-rifampicin 
Isoniazid-streptomycin 
Rifampicin-streptomycin 
5.58 X 107 
2.05 X 105 
4.67 X 103 
8.50 X 103 
1.48 X 104 
2.33 X 103 
OIN Phage Buffer (CFU mrl) 
7.83 X 107 
1.53 X 104 
1.80 X 103 
1.17 X 102 
3.67 X 103 
1.25 X 102 
1.18xl07 
2.98 X 104 
0.58 X 103 
0.58 X 102 
4.33 X 103 
0.50 X 102 
I M. tuberculosiS cell suspension was prepared from barely confluent agar culture as described in Section 2.4.4 and treated with 
antimycobacterial drugs for 7 days as described in Section 2.9.2. Isoniazid was used at a final concentration of 0.2 I-lg mrl, 
rifampicin at 1.0 I-Ig mrl and streptomycin at 2.0 I-Ig mrl. After 7 days treatment, cultures were washed for 24 h in Tween 80 free 
broth (containing the appropriate antimycobacterial drugs) and infected with mycobacteriophage D29 as described in Section 2.11.3. 
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3.3 FURTHER STUDIES ON NON-LABELLING POPULATIONS AND 
DORMANCY MODELS 
The recalcitrance of cell suspensions prepared from M tuberculosis broth culture to 
cytochemical labelling was highlighted in Sections 3.1.2. The physiological status of 
these non-labelling cells was unknown with possible explanations including: 
physiologically active bacteria with low permeability properties to the cytochemical 
reagents; metabolically inactive or dormant sub-populations; empty cell husks devoid of 
nucleic acid, membrane potential and oxidative metabolism. Here, the results of 
experiments designed further investigate non-labelling populations are presented. These 
include observations from gfp reporter strains, mycobacteriophage D29 infection studies 
and the anaerobically induced dormancy model. 
3.3.1 Comparison of GFP production by bacteria cultured in broth and on agar 
Expression of gfp in M tuberculosis [pGFM 11] cells cultured in Middlebrook 7H9 broth 
was compared to that produced by cells grown on Middlebrook 7HIO agar. Scatter plots 
of fluorescence intensities obtained by image analysis and examples of microscopy 
images are shown in Figure 3.40. With each of the culture methods, most cells (> 90%) 
identified by microscopy produced sufficient GFP to be brightly fluorescent. Evidence of 
a predominantly cytologically inactive population in broth culture was not observed. 
Although detailed growth studies were not undertaken, expression of gfjJ by M 
tuberculosis did not appear to affect growth (assessed by OD and colony counts in broth 
culture and the time taken for growth to produce a barely confluent lawn on agar). Like 
the wild type strain, cells taken from M tuberculosis [pGFM 11] broth culture were 
greater in length than cells in suspensions prepared from agar (average cell lengths of 4.0 
and 3.5 Jlm respectively). 
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Figure 3.40: Expression of GFP in M. tuberculosis. 
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Scatter plots of fluorescence intensities, phase-contrast and corresponding fluorescence 
micrographs of gip-expressing M tuberculosis cultured (a) in Middlebrook 7H9 broth 
and (b) on Middlebrook 7HlO agar. Cells were viewed at lOOO x magnification. Scale 
bar = 3 JlIl1. 
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3.3.2 Mycobacteriopbage infectivity studies 
High titre lysates of mycobacteriophage D29 were obtained using the M smegmatis 
infection method described in Section 2.11.1. These lysates produced approximately 2 x 
1010 PFU mrl. 
The results of R123IPI labelling and colony counts of broth-cultured M tuberculosis 
infected with phage D29 and incubated overnight are shown in Table 3.8. 
Table 3.8: Effect of mycobacteriophage 029 infection on colony counts and R123IPI labelling of cells 
in M. tuberculosis broth culture" 
CFUmr' Non-labelled R123 PI & PIIR123 b 
Before treatment 3.52 x 107 73% 27% < 1% 
D29 treated <50 37% 12% 51% 
Phage buffer control 3.05 x 107 83% 17% < 1% 
• Results are expressed as the means of two independent experiments. M. tuberculosis broth culture was infected with 
mycobacteriophage D29 and incubated overnight prior to cytochemical labelling and colony count enumeration. 
b PlIR123 labelled cells stained with both dyes. 
The number of R123-labelled and non-labelled cells was reduced in D29-treated 
populations (from 27 to 12% and 73 to 37% respectively). The remaining 50% of 
bacteria were dual-stained cells, characterised by a green fluorescent periphery of variable 
thickness and a diffuse to well-defined red-orange fluorescent nuclear area. These cells 
were phase-light with dark regions at the poles when viewed using phase contrast 
microscopy. Examples of the different labelling patterns observed in D29-treated M 
tuberculosis are shown in Figure 3.41. No growth « 50 CFU mrl) was recorded in D29-
infected samples. 
Overnight incubation of broth-cultured M tuberculosis in phage buffer also produced a 
decrease in the number of RI 23-labelled bacteria (from 27 to 17%). However, unlike 
infected culture, the remaining bacteria were predominantly non-labelled and 
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indistinguishable by phase contrast microscopy. Incubation in phage buffer produced a 
small reduction in colony counts. 
In summary, the percentage of non-labelled cells in R123IPI stained M tuberculosis cell 
suspensions prepared from broth culture was reduced by infection with 
mycobacteriophage D29. 
(a) PI stained withR123-labelled pole 
(b) PI stained with R123-labelled poles 
(c) R123 labelled 
(d) Non-labelled 
Figure 3.41: Effect of mycobacteriophage D29 treatment on R123IPI labelling of M. 
tuberculosis. 
Phase-contrast and fluorescence images of the same fields of view of D29-treated M tuberculosis broth 
culture demonstrating the different R123IPI labelling patterns observed: (a & b) PI stained cells with R123 
labelled pole(s), (c) R123 labelled cells and, (d) non-labelled cells. Scale bar = 2 J.UD. 
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3.3.3 R123 labelling of dormant bacteria 
Two different methods were used to generate M tuberculosis cultures in a dormant phase 
by adaptation to anaerobiosis. Decolourisation of methylene blue in control tubes 
indicated when oxygen was used up and cells were sampled for labelling one week later. 
In the first method, unagitated broth culture was adapted to anaerobiosis by settling 
through a self-generated oxygen depleted gradient. Most of the cells found in the anoxic 
sediment had compromised cytoplasmic membranes and stained with PI. However, many 
cells labelled with R123 even with extended culture. R123 labelled cells present in the 
sediment 20 weeks after the oxygen was depleted are shown in Figure 3.42a. 
In the second method, cells were adapted to anaerobiosis in slowly stirred flask cultures 
by gradual depletion of oxygen. CytochemicalIy labelled cells in the anoxic stirred flask 
culture were indistinguishable from cells in aerobically aerated culture; between 20-40% 
accumulated R123, few stained with PI, and the remainder were non-labelled (Figure 
3.42b). 
In summary, cells in M tuberculosis culture adapted to a non-replicating dormant phase 
by anaerobiosis using the methods developed by Wayne and colleagues (Wayne and Lin, 
1982; Wayne and Hayes, 1996) could be labelled with R123. 
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(a) 
(b) 
Figure 3.42: R1231PI labelled M. tuberculosis celh adapted to anaerobiosis 
Paired phase contrast and fluorescence microscopic images of: 
(a) Cells in the sediment ofunagitated broth culture adapted to anaerobiosis by settling through a self-
generated oxygen depleted gradient as described by Wayne and Sramek (1994). Cells were sampled 
and labelled after 20 weeks of culture. 
(b) Cells adapted to anaerobiosis in slowly stirred flask cultures by gradual depletion of oxygen as 
described by Wayne and Hayes (1996). Cells were sampled 7 days after complete decolourisation of 
lllethylene blue (0.5 Ilg ml- t ) indicated depletion of oxygen. 
Cells were viewed at 1000 x magnification. Scale bar = 3 Ilm. 
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4. DISCUSSION 
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4.1 METHODOLOGICAL STUDIES 
Different methods of cultivating M tuberculosis are available; the choice of medium and 
conditions of incubation used in investigations has generally depended on the aspect of 
the organism to be studied. In the present study, cytological assays were being used to 
assess the physiology of bacteria at the single cell level and therefore, considerable effort 
was invested in establishing a culture method to produce consistent defined popuIations 
of M tuberculosis suitable for these assays. 
4.1.1 Growth characteristics in broth 
Culture in liquid media was originally investigated as it is generally considered to 
produce bacterial cells in a defined state of growth with minimum heterogeneity of 
physiology. As stated in Section 3.1.1, continuously agitated culture exhibited 
logarithmic growth over the first week with daily increases in colony counts and OD 
consistent with expected generation times of M tuberculosis (16 to 18 h). During the 
second week growth slowed, cultures entered the stationary phase, small clumps appeared 
and biomass was deposited at the liquid/air interface on the flask wall. Mycobacteria, by 
virtue of their hydrophobicity, tend to accumulate at the triphasic interface of air, glass 
and culture medium where, the wave motion produced from centrifugal forces deposit 
cells on the flask wall out of the reach of fresh medium. This effect may be exaggerated 
by the cord factor (6,6'-dimycolate) produced which tends to aggregate in veils that 
naturally "climb" container walls (Wayne, 1994). It has been suggested that deposition 
on the flask wall may be the cause of inhibition of growth reported by many workers 
when M tuberculosis is cultured in flasks aerated on rotary shaker incubators. However, 
inhibition of growth was not observed in the present study, possibly because 
polycarbonate baft1ed flasks were used, to which cells adsorb less than to glass. 
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4.1.2 R123/PI labelling of cells cultured in broth 
It soon became evident that although broth culture was considered appropriate for 
producing defined populations of M tuberculosis, it was unsuitable as a starting point for 
the cytochemical labelling reactions. Regardless of when bacteria were sampled during 
the growth curve, more cells were non-labelled than labelled (Section 3.1.2). From the 
results obtained with R123/PI dual labelling, few PI stained cells were observed 
indicating that although the majority of the cells did not fluoresce with R 123, they had 
intact cytoplasmic membranes. The lack of staining in cells sampled during the 
exponential phase of growth is difficult to explain since it seems unlikely that actively 
growing bacteria exist without a detectable membrane potential. It is more likely that the 
dye cannot penetrate the mycobacterial cell wal1 and in such cases, membrane potential 
cannot be measured using R 123. A more detailed discussion of the non-Iabel1ed cel1s 
found in broth culture is given in Section 4.3 including observations from other 
experiments used to investigate this sub-population. In addition, although the detergent 
Tween 80 was included in media to disperse the hydrophobic mycobacteria during 
growth, much clumping was observed on the bacterial monolayers making image analysis 
and interpretation difficult. 
4.1.3 Growth on agar 
Some of the problems faced when cells from broth culture of M tuberculosis were used 
for cytochemical labelling were highlighted in the previous section. Mycobacterial 
culture on agar media was investigated as an alternative source of cell suspension for 
these studies. Mature colonial growth was not used because this can be expected to 
include a wide range of environments, from an abundance of oxygen and nutrients at the 
edge, to almost no oxygen or nutrients available to those cells in the centre. All phases of 
growth are probably represented, and therefore cellular heterogeneity is likely. 
Consequently, bacterial suspensions prepared from growth on agar were from barely 
confluent spread plate cultures as described in Section 2.4.4. 
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4.1.4 R123IPI labelling of cells cultured on agar 
The results obtained with these cell suspensions demonstrated that approximately 90% of 
individual bacteria accumulated R 123. In addition, bacterial monolayers prepared from 
culture on agar showed little evidence of clumping on slide preparations and more 
uniform cell morphology was observed. This made microscopy, image recording and 
subsequent image analysis more straightforward than with cell suspensions from broth 
culture. Therefore, it was decided to use bacterial suspensions prepared from culture on 
solid medium for the remainder of the study. The inherent morphological differences 
between M tuberculosis cells prepared from culture in broth and on agar presented in 
Table 3.1 will be discussed in more detail in Section 4.2.6. 
Interestingly, apart from a report by Ibrahim (1996), other workers who used R123 to 
label mycobacteria (Matsuyama, 1984; Bercovier, 1987; Walker (O.R. Walker and M.R. 
Barer, unpublished observations); and Sayles, 1994) did not comment on non-labelled 
cells. Ibrahim observed substantial non-labelling in M avium cultured in liquid media. 
As in the present study, this proportion was reduced in suspensions prepared from culture 
grown on solid medium. Matsuyama, Walker and Sayles prepared cell suspensions from 
culture grown on solid medium in their studies and therefore probably did not observe 
large unlabelled sub-populations. Although, Bercovier and colleagues prepared their 
cultures in liquid media, fluorescence was measured using spectrophotofluorometry and 
therefore non-Iabellers in their experiments would have been overlooked. 
4.1.5 R123 Uncoupler sensitivity studies 
The accumulation of R123 across the energised mycobacterial cytoplasmic membrane 
was demonstrated by showing that uptake of dye was sensitive to dissipation of the 
membrane potential by the uncoupler agent CCCP (Section 3.1.5). The mechanism of 
uncoupling by CCCP is demonstrated schematically below in Figure 4.1 (Mitchell, 1966; 
Lewis et al., 1994). 
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OUTSIDE INSIDE 
Figure 4.1: Dissipation of the cytoplasmic membrane potential by the uncoupler 
agent carbonyl cyanide m-chlorophenyl hyrazone (Lewis et al., 1994). 
It was established during this study that both the concentration of R123 used to label M 
tuberculosis cell suspensions and the concentration of CCCP used to dissipate the 
membrane potential were decisive when demonstrating uncoupler-sensitive accumulation. 
Whereas other workers successfully labelled mycobacteria with 13 J.LM R123 
(Matsuyama, 1984; Bercovier, 1987; D.R. Walker and M.R. Barer, unpublished 
observations; Sayles, 1994; and Ibrahim, 1996), the evidence presented here shows that 
uncoupler-sensitive accumulation of R123 can only be demonstrated at lower dye 
concentrations (e.g. 1 J.LM). Kaprelyants and Kell (1992) made similar observations with 
their studies on Micrococcus luteus and also concluded that uptake was fully uncoupler 
sensitive only at low R123 concentrations. At higher concentrations R123 may bind non-
specifically and produce fluorescence independent of membrane energisation. 
Whereas, uncoupler-sensitive accumulation of R123 was reported with 5 J.LM CCCP for 
S. aureus (Matsuyama, 1984) and 15 J.LM CCCP for M luteus (Kaprelyants and Kell, 
1992), almost ten-fold higher concentrations were required in the present study to 
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produce the same effect in M tuberculosis. The action of uncoupler agents on whole 
cells depends on cell wall permeability (Lewis et al. , 1994). The effect of uncoupler 
agents is reported to be less with Gram-negative bacteria than Gram-positive bacteria 
because the outer membrane acts as an effective barrier to CCCP uptake (Nikaido, 1994). 
The low permeability of the mycobacterial cell wall is also well documented (Nikaido 
and larlier, 1991), and higher concentrations of uncoupler agent are probably required to 
achieve effective dissipation of the membrane potential. 
Previous studies in this laboratory have shown that estimation of the hydrophobicity of 
compounds based on their octonal:water partition coefficients (logP Qct) may be calculated 
using the semi-empirical algorithms of Hansch and Leo (1979) and used to predict the 
likelihood of a compound crossing the mycobacterial cell membranes (Christensen et al., 
1999). Extremely hydrophobic compounds (logP QC! > 8) are likely to localise in the 
mycobacterial cell wall lipids where they become trapped, weakly hydrophobic 
compounds (8 > 10gP QC! > 0) are likely to be membrane permeant and diffuse into the 
cytoplasm, while hydrophillic compounds (logP Qct < 0) do not pass through membranes 
by passive diffusion. Calculation of the 10gP Qcl values of non-ionised and ionised CCCP 
(+ 0.7 and < 0 respectively) suggest that although the non-ionised compound is readily 
membrane permeant, once ionised it is much less so (RW. Horobin, personal 
communication l ). The rate of uncoupling may therefore be limited by the rate of 
diffusion of the anionic species across the cytoplasmic membrane. 
4.1.6 Heat, ethanol and formaldehyde treatments 
Interestingly, none of the bactericidal methods used to produce defined cytologically 
inactive populations of M tuberculosis, produced populations that exclusively stained 
with PI. As stated in Section 3.1.6, heat, ethanol and formaldehyde treated cultures 
contained cells that labelled with R123 . However, in each case, this residual labelling 
I R. W. Horobin, Department of Biomedical Science, University of Sheffield, Sheffield S 10 2TN, UK. 
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was shown to be uncoupler-insensitive and was therefore not specifically attributable to 
membrane energisation. 
Several workers have commented on non-specific R123 fluorescence produced by 
bactericidal treatments. Mason et al. , (1995) repolied that heat-treated E. coli, 
Salmonella typhimurium and S. aureus showed increased fluorescence compared to 
controls when labelled with R123 whereas low-level R123 fluorescence was observed in 
formaldehyde-fixed cells of E. coli and S. aureus by Diaper et al., (1992) and Comas and 
Vives-Rego (1997). Suggested mechanisms for non-specific binding include cell surface 
changes produced by increases in surface hydrophobicity or exposure of negatively 
charged components resulting in increased R123 adsorption and binding of the dye to 
alternative cellular binding sites, possibly within the hydrophobic regions of the 
membrane. 
However, it remams unclear why small sub-populations of M tuberculosis cells 
consistently demonstrated uncoupler-insensitive R123 fluorescence after heat or ethanol 
treatment while the majority labelled intensely with PI. Much variability has been 
reported in the outermost layer of the M tuberculosis cell wall. These include thickness, 
electron density and appearance (fibrillar, granular or homogeneous) when viewed using 
electron microscopy (Rastogi et al., 1986). Whereas, the outer layer tends to be thin for 
the majority of the population, a small proportion of M tuberculosis cells have a wide 
electron transparent zone around individual cells (Frehel et aI., 1986; 1988). Cell wall 
variation may account for residual uncoupler-insensitive labelling observed after heat or 
ethanol treatment should binding of dye to non-specific binding sites found only in a 
small proportion of the population occur. 
Curiously, R123 labelling was not observed in heat or ethanol treated M smegmatis or M 
aurum, or in previous studies with M gordonae (D.R. Walker and M.R. Barer, 
unpublished results). Brennan and Draper (1994) report that although M tuberculosis 
shares many ultrastructural features with other mycobacteria, the various species differ 
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considerably in their complement of lipids, glycolipids and proteins resulting in important 
differences in wall structure and properties. Disruption of the M tuberculosis cell wall 
might well expose non-specific binding sites for the cationic R123, e.g. LAM, that are 
absent in the rapidly growing species. 
Thus while there were significant differences between M tuberculosis cells treated with 
formaldehyde, heat and ethanol and untreated controls, presence of R123 labelling was 
not consistently correlated with the ability of cells to form colonies. However, loss of 
CCCP suppressible R123 labelling was strongly correlated with the bactericidal (CFU 
reducing) activity of these treatments. 
4.1.7 Tetrazolium salt reactions 
Initially, formazan deposits were small and difficult to detect in cells but optimisation of 
reactions, increased incubation time and decreased tetrazolium salt concentration resulted 
in greater deposition ( ection 3.1.7). The effect of INT concentration was not expected 
as previous work in this laboratory using a variety of bacteria suggested that higher 
concentrations of tetrazolium salt resulted in optimal reduction. Concentrations of 10 
mM were routinely used with the environmental bacteria Vibrio vulnificus and 
Pseudomonas putida (Whiteley et al., 1996), and 5 mM with M avium (Ibrahim, 1996) 
and the enteric pathogen Helicobacter pylori (Gribbon and Barer, 1995). However, at 
these concentrations, tetrazolium salt reduction was inhibited in M tuberculosis. 
Exposure to INT was shown not to be tuberculocidal (Table 3.3) and therefore some form 
of inhibitory effect must be attributed to INT. 
Larger deposits occurred with longer incubation times in M tuberculosis and continued to 
grow intracellular1y as more INT diffused into bacteria. Indeed, formazan deposits often 
completely filled and distorted cells, raising the possibility of cell lysis. However, phase 
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contrast microscopy showed that although cells tended to swell in association with large 
formazan deposits, there was no evidence of lysis and cell envelopes appeared 
morphologically intact with continuous smooth surfaces around the swollen deposits. 
Although reaction optimisation improved labelling, marked cell-to-cell variation In 
staining remained, ranging from some cells that were filled with beads of deposits to 
others with no detectable formazan. As reported with R 123/PI labelling, this variation 
was more obvious with M tuherculosis cells cultured in liquid media. Other workers 
have shown that addition of oxidisable substrates to the incubation medium enhanced 
both the intensity and proportion of cells yielding positive INT reactions in a variety of 
microbial species (Gribbon and Barer, 1995; Whiteley et al., 1996). These included E. 
coli, H. pylori, V vulnificus and P. putida. However, attempts at substrate enhanced 
tetrazolium salt reduction in the present study with M. tuberculosis, and previously by 
Ibrahim (1996) with A1. avium, indicated that none of the substrates tested (aspartate, (X-
ketoglutarate, pyruvate, cellobiose, malate, serine, fumarate, citrate, succinate, glucose 
and glutamate) had any effect on formazan deposition. It is possible that the exogenous 
substrates selected in both these studies were inappropriate for demonstrating activity in 
mycobacterial species. In addition, there is substantial evidence in the literature to show 
that mycobacteria produce intracellular storage bodies (Garton, 1998) and therefore the 
addition of exogenous substrates would not be expected to show any effect until these 
endogenous pools of substrates were exhausted. 
Since !NT detects the overall rate of production of reducting equivalents within cells, one 
interpretation of the results would be that many cells demonstrate little evidence of 
oxidative metabolism even when exogenous energy sources are supplied. This seems 
unlikely especially in cells sampled during the exponential phase of growth. It seems 
more probable that the cell-to-cell variation in !NT reduction, like the previously 
described variation in R 123 accumulation, reflects heterogeneity of cell envelope 
permeability in M tuberculosis cells. 
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As stated in Section 3.1. 7, the fluorogenic tetrazolium salt CTC was investigated as an 
alternative determination of oxidative metabolism in M. tuherculosis since this would 
facilitate rapid analysis by fluorescence microscopy. However, in these studies CTC was 
found to be less sensitive to reduction than INT. There are several explanations for this 
observation. Firstly, mycobacterial cells may be more permeable to INT than CTC 
resulting in greater diffusion and/or transport to the site of reduction. Secondly, 
mycobacterial cells may be more permeable to CTC formazan deposit than INT formazan 
deposit resulting in the former leaching out of the cell. This possibility could explain the 
presence of the extracellular fluorescent deposits seen in M. tuherculosis cell suspensions. 
Thirdly, INT may be reduced more readily than CTC and hence produce more detectable 
amounts of formazan within the reaction period. Regardless, reaction with CTC did not 
produce useful results with M tuberculosis and consequently only 1NT was used in the 
remaining experiments involving tetrazolium salt reduction. 
4.1.8 Combined R123/PI labelling and INT reduction assays 
The development of a combined INT reduction and R123 accumulation assay was 
pursued to provide simultaneous determination of oxidative potential and membrane 
potential in individual cells. One application of this approach was to investigate whether 
the same cytologically active population was being identified by the separate assays. The 
general observation was that most R 123 labelled cells also contained detectable formazan 
deposits (Section 3.1.8). Unfortunately, simultaneous measurement ofRl23 fluorescence 
intensity and formazan optical weight was difficult because cells that contained large 
deposits obscured or quenched fluorescence. Therefore, it wasn't possible to establish a 
quantitative relationship between R 123 accumulation and INT reduction in individual 
cells. However, approximately 10% of R 123 labelled cells did not contain detectable 
deposits. Whether this reflects differences in the physiological status or the permeability 
of those cells compared to the dual-labelled population remains uncertain. 
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None of the cells that demonstrated uncoupler-insensitive R 123 labelling after 
bactericidal treatment with heat, ethanol or formaldehyde reduced INT. The absence of 
oxidative metabolism in these cells was not unexpected. since it was speculated in 
Section 4.1.6 that this fluorescence was not evidence of membrane energisation but of 
non-specific staining produced by the treatments. 
4.1.9 Results of other cytological assays 
Although there are many reports of oxonol and the Live/Dead BacLIGHT stains being 
used to differentiate physiologically active and inactive cells, neither was shown to label 
M tuberculosis in a satisfactory manner (Section 3.1.9). Oxonol labelled cell 
preparations were always poorly stained, most likely because of dye exclusion by the 
impermeant mycobacterial cell wall. The myriad of labelling obtained with the 
Live/Dead BacLIGHT stain made interpretation difficult and suggested that much of the 
staining was non-specific. Although the' live cell' nucleic acid stain S YTO 16 was shown 
to label M tuberculosis cell preparations, the low number stained in control populations 
precluded useful application. 
4.1.10 Effect of labelling on colony counts 
Previous workers have reported that some of the cytochemical reagents used to 
demonstrate bacterial physiological activity were toxic and inhibited the cell functions 
they were supposed to measure (Nebe-Von Caron and Badley. 1995; Diaper et al., 1992; 
Mason et al., 1993). In the present study. none of the cytochemical procedures used were 
shown to be bactericidal (as assessed by colony forming unit counts) with M. 
tuberculosis. 
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4.1.11 Development of GFP reporter strain 
A major drawback in monitoring the cytological activity of intact live bacteria USIng 
cytochemical reagents is cell wall permeability. For example, it was suggested in Section 
4.1.9 that oxonol was excluded from labelling M tuberculosis cells because of poor 
permeability. Similarly, it was highlighted in Sections 4.1.2 and 4.1.7 that as few as 20% 
of M tuberculosis cells found in the exponential phase of growth in broth labelled with 
Rl23 and INT respectively. The absence of membrane potential and oxidative 
metabolism seems unlikely in rapidly dividing cells; it seems more likely that the reagents 
cannot enter the cell and therefore activity cannot be assessed. A OFP reporter strain of 
M tuberculosis was developed to look for cytological activity in such populations 
recalcitrant to labelling since OFP is produced intracellularly and does not require 
external substrates or co factors due to the intrinsically fluorescent nature of the protein. 
It is difficult to explain why attempts to clone the OFP gene downstream of the HSP60 
promoter in the E. coli-mycobacterial shuttle vector pMV261 failed since there are many 
reports of this exact cloning strategy being used for recombinant protein expression in a 
variety of mycobacterial species (Stover et al., 1991; Andrew and Roberts, 1993; 
Cooksey et aI., 1993). Regardless, transformation of M tuberculosis with the OF? 
construct pOFM-ll (Kremer et al., 1995) produced expression that was readily detected 
both at colony and single cell level. Comparison of OFP production by M tuberculosis 
cells cultured in broth and on agar is discussed in Section 3.3.1. The effects of 
antimycobacterial drugs on OFP production are discussed in Section 3.2.9. 
4.1.12 Total cell counts (Tee) 
The results of the three direct microscopic methods of enumeration used to obtain total 
cell counts of mycobacterial cell suspensions (immobilisation of bacteria on APS-coated 
coverslips, membrane filtration of OAPI stained cells and the Thoma counting chamber 
method) were compared in Section 3.1.12. Little ditTerence was found between the 
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counts obtained by the different methods. Direct counting of cells immobilised on APS-
coated coverslips by phase contrast microscopy had a number of advantages over the 
other methods. Firstly, cell suspensions did not have to be formalin fixed prior to 
counting since the microchamber system is suitable for pathogens requiring level 3 
containment. Secondly, the same preparation used for counting could be used for 
cytochemical labelling and thus the number of cells displaying certain phenotypes could 
be calculated. Thirdly, the size and morphology of the cells being counted were readily 
recorded for analysis. Fourthly, where clumping did occur it was usually possible to 
identify individual bacteria. Consequently, most of the total cell counts were evaluated 
using this method. 
4.1.13 Development of mycobacteriophage infectivity studies 
Results of the development of mycobacteriophage infectivity studies for investigation of 
effects on cytochemical labelling of M. tuberculosis were presented in Section 3.1. I 3. 
The results corroborate previous reports that although Ca2+ may enhance productive 
infection by D29 it is not essential for productive infection (Sellers et al., 1962; David et 
aI., 1980). The inhibitory effect of Tween 80 on phage infection was highlighted. 
Although this effect has been known for some time (White and Knight. 1958), culture of 
M tuberculosis in liquid media necessitates the use of the detergent to prevent clumping. 
To prevent inhibition, cultures were washed and incubated for 24 h in detergent-free 
broth before infection. However, it is known that Tween 80 extracts lipids, glycolipids 
and carbohydrates from the mycobacterial cell wall (Dam~ and Draper, 1998) and 
consequently phage binding sites may have been removed from many of the cells. 
Nonetheless, high titre Iysates of mycobacteriophage D29 were obtained and infection of 
M tuherculosis culture was shown to be cidal. 
The effects of mycobacteriophage 029 infection on anti mycobacterial drug treated M 
tuberculosis cultures and Iv! tuberculosis broth culture assessed using R 123/PI 
cytochemical labelling are described in Section 4.2.10 and Section 4.3.2 respectively. 
153 
CHAPTER 4 DISCUSSION 
4.2 EFFECTS OF ANTIMYCOBACTERIAL DRUGS 
The resurgence of tuberculosis has caused considerable effort to be focused on the 
development of rapid methods for determining the susceptibility of M. tuherclI/osis to 
antimycobacterial agents. Firstly, there is a clinical need for a quicker turnaround time in 
susceptibility testing because of the slow growth of the organism, especially with the 
diagnosis and management of MDR-TB. Secondly, little is known about the 
physiological properties of M. tuberculosis whieh render it refractory to eradication and 
produce the characteristic slow response to chemotherapy. In Section 4.1 the 
development of physiologically validated procedures for determining cytological activity 
in M tuberculosis was discussed. The results demonstrated that cytological activity 
could be detected in M tuberculosis at the single cell level using a variety of 
cytochemical assays. Uncoupler sensitive accumulation of R 123 and reduction of the 
tetrazolium salt INT readily demonstrated membrane energisation and oxidative 
metabolism in cytologically active cells. The effects of antimycobacterial drugs on M 
tuberculosis at the single cell level using these cytochemical assays are discussed here. 
4.2.1 Colony counts 
The effects of antimycobacterial drugs are most often assessed using colony counts. In 
Section 3.2.1, the individual antimycobacterial drugs tested were shown to produce 
different bactericidal activity in vitro. The reduction in colony counts following 
treatment with rifampicin or isoniazid was greatest and demonstrated the high level of 
bactericidal activity observed by other workers with these drugs (Herbert et at.. 1996). 
There was much less reduction with ethambutol. even though this agent is reported to 
show substantial early bactericidal activity in vivo (lower than isoniazid but higher than 
rifampicin) (Jindani et al., 1980). However, ethambutol was also reported to be less 
bactericidal in vitro than isoniazid and rifampicin (Dickinson et al., 1977). 
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After initial declines in culturability, cultures treated with streptomycin or capreomycin 
demonstrated increases in colony counts. It seems unlikely that resistance in the 
previously sensitive M tuberculosis H37Rv strain would arise so quickly since wild-type 
resistance is reported at 1 in 107 and the rate of mutation per cell division leading to drug 
resistance is 10-8 (Evans. 1998; WHO, 1997). It seems more likely that loss of drug 
activity occurred through deterioration which allowed cell division to resume, yet reports 
show that deterioration of streptomycin and capreomycin in Middlebrook media at 37°C 
was minimal and indeed less than that of isoniazid, rifampicin and ethambutol (Griffith 
and Bodily, 1992). Mitchison and colleagues reported that many of the antimycobacterial 
drugs they investigated (e.g novel rifamycins) were unstable in Middlebrook 7H9 media 
and to compensate for potential loss of activity routinely added additional drug during 
susceptibility assays so that inhibitory concentrations were constantly maintained 
(Dickinson and Mitchison, 1990; Herbert et al., 1996). However, since treatments with 
combinations of antimycobacterial drugs were shown to produce enhanced and permanent 
reduction in colony counts few further studies were designed where streptomycin or 
capreomycin were used in isolation. 
The antimicrobial activities of isoniazid-rifampicin, isoniazid-streptomycin, isoniazid-
capreomycin, rifampicin-streptomycin and rifampicin-capreomycin combinations were 
greater than those observed with individual drugs. Although there is well-documented 
synergy between ethambutol and other antimycobacterial drugs in the treatment of disease 
caused by mycobacteria-other-than-tuberculosis (i. e. where the antimicrobial effect 
produced by the drug combinations is significantly greater than the expected result based 
on their independent effects, probably as a result of increased permeability of the 
ethambutol-induced damage to the mycobacterial cell wall) (Heifets, 1994), synergy was 
absent with M tuberculosis in the present study. It should be noted that, even though 
drug combinations produced increased bactericidal activity, with reductions of up to 5 
loglo in colony counts over the 7-day assay periods, none of the treatments resulted in 
complete bactericidal activity. 
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4.2.2 Total cell counts 
No substantial change in TCe over the 7-day assays was observed with any of the drugs 
or drug combinations used in this study (Section 3.2.2). This was interesting because 
lysis and an associated reduction in TCe were expected, especially following treatment 
with the cell wall active drugs isoniazid and ethambutol. There is surprisingly little 
specific information in the literature regarding what eventually happens to mycobacterial 
cells following treatment with antimycobacterial drugs. Scanning electron microscopy 
studies on isoniazid-treated M tuberculosis suggest that extensive fragmentation of the 
mycobacterial cell wall should occur within 24 h (Takayama et al., 1973). However, the 
results presented here show that although treatment was bactericidal (assessed by 
reduction in colony counts), exposure to isoniazid does not immediately lead to cc)) lysis 
since the layers of peptidoglycan, arabinogalactan, mycolic acids and associated 
components in the sturdy mycobacterial cell envelope retains structural integrity for some 
time after wall synthesis is halted. 
Although it was highlighted in Section 3. 1.3 that preparation of M. tuberculosis cell 
suspensions from barely confluent lawn produced mono layers of bacteria largely free 
from clumping, some clumping was nonetheless observed. Treatment of culture with 
isoniazid or ethambutol resulted in noticeably lower levels of clumping and development 
of bacillus-shaped cells to shorter and broader forms with increased refractility when 
viewed by phase contrast microscopy (Section 3.2.3). Loss of clumping, however, did 
not result in greater total cell counts since individual bacteria in small clumps observed 
prior to drug treatment were easily identified using phase contrast microscopy and 
accurately enumerated. Other workers have commented on loss of clumping of 
mycobacteria after treatment with ethambutol (Kilburn and Greenberg, 1977). This was 
associated with an initial rapid rise in colony-forming units following exposure of M. 
smegmatis to an inhibitory concentration of ethambutol along with a change in cell shape 
to shorter and broader forms. Early increases in colony counts of M tuberculosis were 
not observed following treatment with any of the drugs in the present study. 
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4.2.3 R123/Pllabelling 
It was reported in Section 3.2.3, that treatment of M tuberculosis culture with 
antimycobacterial drugs produced two patterns of R123/PI labelling. The first trend was 
produced by treatment with isoniazid and was shown to be unique to this drug, while, the 
second trend was characterised by treatment with rifampicin and was produced by the 
other drugs tested. 
Treatment of M. tuberculosis culture with isoniazid produced enhanced accumulation of 
R 123 in cells, which was observed within 24 hours and peaked at day 3. This was 
unexpected since the bactericidal effect of isoniazid was shown to be rapid; on day 3 
colony counts were already reduced by 2 log cycles indicating that approximately 99% of 
the cells identified by microscopy were unable to divide and produce detectable colonies. 
These cells were expected to show reduced cytological activity and accumulate less R 123. 
As cell death ensued it was expected that isoniazid treated cells would loose the integrity 
of their cytoplasmic membranes and stain with PI. 
In addition to increased fluorescence intensity many of these R123 labelled cells 
displayed intense staining at their poles. It has been firmly established that isoniazid 
inhibits mycolic acid synthesis at a very early stage of the action and produces profound 
changes in the mycobacterial cell envelope (Bardou el al., 1996). One of the earliest 
effects of subinhibitory concentrations of isoniazid on the ultrastructure of mycobacteria, 
produced within one generation time after the addition of the drug, was alteration of the 
bacterial poles accompanied by release of intracellular material. These workers suggest 
that as well as morphological changes induced by the inhibition of mycolic acids, the 
drug produced change in the permeability of the mycobacterial cell envelope, affecting 
both the influx and efflux of compounds. Based on these observations, it is likely that 
isoniazid treatment increases the permeability of the mycobacterial cell wall and allows 
greater intlux of R 123. especially at the poles where earliest weakening was shown to 
occur. Similarly. many \vorkers have reported increased R123 labelling of many Gram-
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negative organIsms following permeabilization of their outer membrane with 
ethylenediaminetetraacetic acid (EDTA) (Kaprelyants and Kell, 1992; Diaper el (1/., 1992; 
Mason et (1/., 1995). However, interpretation of the increase in fluorescence in M 
tuberculosis cells based on the physiological understanding of R 123 uptake would 
suggest that greater influx of dye implies greater electrochemical gradient rather than 
greater cell wall permeability. Indeed, one of the early changes in mycobacteria 
following treatment with isoniazid is an increase in respiration associated with a change 
in cell envelope permeability (Schaefer, 1960). An increase in cellular respiration may 
produce an increase in the electrochemical gradient across the mycobacterial cytoplasmic 
membrane resulting in a greater influx of R123. This increase in respiration may also be 
responsible for the unexpected increase in INT reduction produced by isoniazid (Section 
3.2.7) and discussed in further detail below in Section 4.2.7. 
Although leakage of cell material undoubtedly occurs following treatment with isoniazid, 
most cells actually became more refractile when viewed using phase contrast microscopy 
(Section 3.2.3). Increased refractility was also observed with ethambutol treatment but 
not with the other antimycobacterial drugs tested and could be produced by accumulation 
of polysaccharides and other cell wall precursors in the cytoplasm that would ordinarily 
be incorporated into the cell wall. Increases in protoplasmic viscosity in isoniazid-treated 
cells were also observed by Takayama et al., (1975). 
In contrast, the average fluorescence intensity produced by R 123 accumulation gradually 
declined following treatment with rifampicin so that by day 7 fluorescence was 
approximately one third of that measured at day O. Similarly, Bercovier et a/., (1987) 
observed that cultures of !v! luberculosis H37Ra treated with rifampicin for 6 days yielded 
between 20-30% of total fluorescence measured at day O. However, it was unknown from 
their study whether 70-80% of individual cells no longer accumulated R 123 following 
treatment or if the average fluorescence per cell was reduced by 70-80% in all the cells 
since fluorescence was measured at the population level using spectofluorometry. The 
results in the present study clearly show that as many as one third of cells in rifampicin-
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treated M tuberculosis culture could be labelled with RI23. The fluorescence intensities 
of these cells were mostly indistinguishable from those measured before treatment. 
However, the vast majority of these cells were not expected to label with R 123 since less 
than 1 in 100 of them were able to produce detectable colonies. 
Cells treated with rifampicin gradually became less refractile when viewed using phase 
contrast microscopy suggesting a decrease of intracellular contents. According to Konno 
et al. (1973), exposure of M bovis to rifampicin for as little as 12 hours produced 
extensive changes in cell ultrastructure including fragmented mesosomes, less defined 
ribosomes, loosening of the cytoplasmic structure and shrinking of the cytoplasm. It 
seems that lack of freshly synthesised RNA eventually initiates secondary changes in cell 
structure as the cell dies. 
Although combinations of isoniazid-rifampicin, isoniazid-streptomycin and rifampicin-
streptomycin produced synergistic reduction in colony counts, a corresponding synergistic 
reduction in the number of R 123 labelled cells was not observed. Rather, the discrepancy 
between the number of cells demonstrating cytological activity and the number of these 
cells that produced colonies increased (Table 3.6). For example, approximately 1 in 10 
cells treated with rifampicin-streptomycin labelled with R123 whereas less than I in 
10,000 produced colonies. 
The central observation in the present study, regardless of which antimycobacterial drug 
was used, "vas that cytochemical phenotypes consistent with viability far exceed the 
number of cells capable of forming colonies. Retained cytological activity in 
mycobacteria treated with antimycobacterial drugs is by no means restricted to the present 
study. The application of various cytochemical assays as rapid assessment of viability in 
mycobacteria indicate that the total number of cytologically active cells demonstrable by 
mlcroscopy greatly exceeds the number capable of growth by several orders of 
magnitude. Retained activity in non-culturable drug-treated mycobacterial cell 
suspensions was reported in studies with FDA (Norden et a!., 1995; Bownds et al., 1996; 
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Tsukiyama et al., 1985), MTT (Mshana et al., 1998) and as already discussed with R 123 
(Bercovier et af.. 1987). Indeed the general subject of bacterial viability, cytological 
activity and culturability has recently received renewed attention (Kell et al., 1998). 
These authors reject the vievv· advanced in many publications that demonstrable cellular 
activity can be used as an operational definition of viability (i. e. activity == viability). 
They propose that these assays are indicators of (metabolic) activity since they 
demonstrate important aspects of cellular physiology and that a positive result should lead 
to classitication of the cell as active rather than viable. 
Evidence of cytological activity in M tuberculosis cells unable or electing not to divide 
and produce colonies provides a substantial opportunity for speculation. This may be no 
more than residual activity in cells without the potential to divide and therefore these celIs 
should only be considered as slowly degrading packages of pre-existing enzymes. For 
instance, it is not known how long enzymes involved in oxidative metabolism, esterases 
or cytoplasmic membrane energisation persist for after the death of the cell (i.e. after it 
looses division potential). With the exception ofnonculturable cells of pathogens capable 
of expressing virulence factors such as toxins and invasins in response to exogenous 
stimuli, activity in such bags of enzymes is not important so long as the cells cannot 
divide and grow. 
However, evidence of cytological activity 111 nonculturable cells of M. tuberculosis 
following treatment with antimycobacterial drugs could be important in elucidating many 
unanswered problems in the clinical treatment of tuberculosis. As stated already, little is 
known about the physiological properties of M tuberculosis which render it refractory to 
eradication and produce the characteristic slow response to chemotherapy (6-9 months). 
It is generally considered that the tubercle bacillus is susceptible to the bactericidal effects 
of antimycobacterial drugs only when it is actively dividing and growing (Mitchison, 
1985). The results presented here show that there are many individual cells in M 
tuberculosis cultures which cannot be grown but remain cytologicalIy active either 
160 
CHAPTER 4 DISCUSSION 
because non-replicating sub-populations always exist In large populations or sub-
populations convert to a non-growing state after exposure to antimycobacterial drugs. 
Phenotypic adaptations that enable pathogenic bacteria to resist the action of drugs in 
response to prolonged exposure have been reported (Handwerger and Tomasz, 1985). S. 
aureus and Salmonella enteritidis can enter physiological states in which normally 
bactericidal antibiotics produce only a bacteriostatic effect, thus enabling the 
microorganisms to outdistance the course of antibiotic therapy and produce recurrent 
infections. Parrish et aI., (1998) suggest that phenotypic adaptation might explain the 
unusually long treatment duration required for successful chemotherapy of active 
tuberculosis. Whereas bacteriological cultures of M tuberculosis are sterilised in a 
matter of days with anti mycobacterial drug treatment, it is essential to treat patients for at 
least 6 months with multiple drugs to eradicate the infection. It is possible that actively 
growing M. IlIherclIlosis cells adapt to the administration of anti mycobacterial drugs by 
moving into a physiological state that is associated with increased drug resistance. 
Identifying the means to rapidly eliminate this population in vitro with novel 
combinations of known drugs or novel drugs could lead to development of regimens that 
could accelerate chemotherapy in vivo. 
Indeed, the endogenous reactivation of tuberculosis in humans is generally considered to 
be the result of reactivation of dormant tubercle bacilli that persisted, sequestered in 
tubercles after the initial infection. The putative mycobacterial dormancy phase adopted 
to survive this Icngthy persistence may well be responsible for the recalcitrance of M 
tuberculosis cells to killing by antimycobacterial drugs. 
4.2.4 Rl23 uncoupler sensitivity studies 
The inhibitory effect of the uncoupling agent CCCP was used to show that R123 
accumulation in antimycobacterial drug treated cell suspensions was attributable to 
membrane energisation and to discount the possibility that labelling unrelated to 
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membrane energisation might be concealing genuine inhibitory and bactericidal effects 
(Section 3.2.4). The results of quantitative image analysis show clearly that R 123 
labelling was uncoupler sensitive with all the anti mycobacterial agents tested. In 
accordance with previous observations CCCP-inhibited cells were capahle of 
regenerating memhrane potential when washed and re-labelled with R123. 
In previous work where R123 was used to monitor mycobacterial cytological activity, 
decisive uncoupler sensitivity studies were not included (D.R. Walker and M.R. Barer, 
unpublished data: Bercovier, 1987: Sayles, 1994; Ibrahim, 1996). Indeed the results 
presented in Section 3.1.5 clearly show that inhibition would not have been observed in 
these studies, since the high concentration of R123 (13 ~lM) used would have produced 
non-specific staining. Consequently, there is considerable doubt concerning the 
significance of R 123 labelling observed in these studies. 
4.2.5 MPN enumeration 
The numbers of culturable cells following treatment with antimycobacterial drugs were 
assessed using the MPN method and compared to the colony counts obtained by 
conventional agar plate dilution (Section 3.2.5). Improved recovery and enumeration of 
surviving bacteria using the MPN assay could help explain the significant difference 
observed between the number of cytochemically labelled cells detected by microscopy 
and the number which can form colonies highlighted in Section 4.2.3. Although greater 
numbers of propagules were detected with the MPN method, differences of at least 1.5-2 
orders of magnitude are needed before considering significant improvement over 
conventional plate counts (Kell el aI., 1998). It is worth noting that a major disadvantage 
to enumeration of culturable cells using the MPN approach is the inherent low precision 
of the procedure; the coefficient of variation is about 40% for 10 parallel tubes (Koch, 
1994). 
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Recently, Sun and Zhang (1999) have shown that early-stationary-phase culture 
supernatant improved the viability of aged cultures of M tuberculosis H37Ra by allowing 
the formation of 20-fold more colonies on plates and allowed small inocula to initiate 
growth in liquid culture. They speculate that an acid labile and heat stable resuscitation 
factor with a mass of less than 1.375 Da was probably responsible for this effect. It 
would be interesting to assess the effect of such a resuscitation factor in the recovery of 
antimycobacterial drug treated M. tuberculosis cells in the model established in the 
present study. 
4.2.6 Cell elongation and loss of R123 labelling in drug-free controls 
It was reported in Section 3.2.6 that cells in the drug-free controls quickly elongated and 
became recalcitrant to labelling. In contrast, cells exposed to drugs did not grow and the 
number of cells stained with PI gradually increased concomitantly with a reciprocal 
decrease in the number of R 123 labelled cells. This was interesting because it was 
observed that the most obvious morphological difference between M tuberculosis cells 
cultured in liquid and on solid media was cell size, the former being approximately 25% 
longer and 20% wider (Section 3.1.4). Further studies revealed that this appears to be a 
general phenomenon with M. tuberculosis and that cell suspensions prepared in broth 
from agar cultures quickly elongate and by day 3 resemble cells maintained in broth 
culture. 
References to morphological differences between M tuberculosis cells cultured in broth 
and on agar are scanty. Wayne and Hayes (1996) commented on cell elongation in their 
anaerobic adaptation model for dormancy. They observed that the length of bacilli 
increased by 32%. from a median length of 2.23 ~lm during active aerobic growth to 2.94 
).1m during the period of O2 depletion, which lasted over 150 hours. However, inocula for 
their expaiments were prepared in broth culture. Ingraham et al., (1983) comment that 
stationary-phase cells are al\vays smaller than those in the exponential phase as cell 
division continues after the synthesis of most macromolecules has slowed. These 
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observations provide little basis for interpreting the morphological changes reported here. 
Nonetheless, they identify trends that may be relevant. Most importantly, however, the 
changes clearly signify shifts in the physiological status of the cells, the basis of which 
has yet to be established. 
4.2.7 INT reduction 
The eftects of isoniazid and rifampicin on M tuberculosis culture were also assessed 
using INT reduction as an indicator of oxidative metabolism (Section 3.2.7). The results 
were comparable to those reported with R 123 in that two trends were observed. Isoniazid 
treatment produced enhanced reduction of INT in almost every cell, which was apparent 
after 24 hours and greatest after 3 days, whereas rifampicin treatment produced a gradual 
and progressive reduction in both the number and size of formazan deposits over the 
assay period. 
The simplest interpretation of the increase in INT reduction in isoniazid-treated cells is 
that isoniazid treatment increased the permeability of the mycobacterial cell wall resulting 
in a greater influx of tetrazolium salt where it was reduced to INT formazan. This would 
explain both the increase in deposit size and the increase in the proportion of labelled 
cells. However, it is also likely that increased INT reduction reflects an increase in the 
oxidative metabolism of isoniazid-treated M tuberculosis cells and is associated with the 
increase in respiration reported by Schaefer (1960) as one of the early changes in 
mycobacteria following treatment. Indeed, activation of isoniazid by crude extracts of M 
tuberculosis and purified hydrogen peroxidase is known to be accompanied by a burst of 
toxic oxygen species (including superoxide and hydroxy radicals) (Shoeb et a\., 1985a; 
1985b) leading to speculation that oxidative stress contributes to the bactericidal action of 
isoniazid (Barry el af., 1998). 
Other workers have also observed enhanced tetrazolium reduction with isoniazid. 
Ibrahim ( 1996) reported enhanced reduction of INT by isoniazid-treated M avium, larger 
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formazan deposits were produced and the proportion of cells that reduced INT increased 
to almost 100%. More recently, Mshana et al., (1998) reported difficulties detecting 
isoniazid resistance in M tuberculosis using an MTT (3-( 4,5-dimethylthiazol-2-yl)-2.5-
diphenyl tetrazolium bromide) reduction assay because formazan production remained 
high despite inhibition of mycobacterial proliferation. 
Curiously, the enhanced reduction of INT (or increased R123 fluorescence intensity) 
produced by isoniazid was minimal in cells treated with combinations of isoniazid and 
rifampicin. In addition, the distinctive cellular morphological characteristics (stunted 
cells, bulging poles and increased refractility) produced by isoniazid treatment were 
absent. These observations suggest that the inhibitory effects of rifampicin start very 
quickly, before isoniazid produces gross cell wall changes and/or an increase in oxidative 
metabolism. Indeed, the progressive reduction in both the number and size of formazan 
deposits in rifampicin-treated cultures reflects the expected reduction of oxidative 
metabolism in cells treated with bactericidal concentrations of the antibiotic and mirrors 
the reduction in colony counts. 
4.2.8 Direct reduction of INT by isoniazid 
An alternative explanation for the enhanced reduction of INT during treatment with 
isoniazid is that the anti mycobacterial drug itself has sufficient intrinsic reducing power 
to reduce tetrazolium salts. Indeed, Issopoulos and Economou (1992) reported that both 
neotetrazolium chloride and tetrazolium violet chloride could be used in the 
spectrophotometric determination of microquantities of isoniazid as demonstrated by the 
redox reaction in Figure 4.2. 
The results presented in Section 3.2.8 clearly demonstrate that direct reduction of INT by 
isoniazid in vitro only occurs at levels well above those used in the biological 
experiments (20 mg mrl vs. 0.2 pg mrl) and after much longer exposure times (overnight 
vs. 10-60 min). Thus, it is unlikely that the direct reducing capacity of isoniazid reported 
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by Issopoulos and Economou (1992) was contributing to the enhanced 1Nl reduction 
observed in mycobacterial cells. 
+ 2 
Isoniazid Tetrazolium salt 
- 2HCI 
+ 2 
Formazan 
Figure 4.2: Reduction oftetrazolium salt by isoniazid (Issopoulos and Economou, 1992) 
4.2.9 Effect of antimycobacterial drugs on GFP production 
The effect of antimycobacterial drugs on GFP expression in M tuherculosis reporter 
strains was assessed (Section 3.2.9). Unlike cytochemical labelling with R123 and INT, 
GFP expression could be analysed directly without fluorescent probe or substrate 
addition, thus bypassing problems associated with heterogeneity of permeability in the 
mycobacterial population. As stated, GFP fluorescence intensity decreased following 
drug treatment. with the greatest decrease in treatments that produced the greatest 
reduction in colony counts. 
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Along with detecting the decline in average intensity fluorescence, image analysis of cells 
treated with antimycobacterial drugs identified sub-populations with GFP fluorescence 
intensity comparable to that measured before treatment (approximately 3% of drug-
treated bacteria had fluorescence intensities greater than the average fluorescence 
intensity measured before treatment). However, these results should be interpreted with 
caution as once formed GFP seems to be very stable (Tombolini et al., 1997; Andcrsen et 
al., 1998). Therefore, fluorescence may be detected in cells that are no longer capable of 
protein production. Recently, new unstable variants of GFP with reduced half-life (40 
min to a few hours) compared to that of the wild-type protein have been produced 
(Andersen et af., 1998). The effect of antimycobacterial drugs on reporter strains of M 
tuherculosis expressing such variants might be more revealing concerning real-time gene 
expression. 
Unfortunately, as stated in Section 3.2.9, identification of membrane energisation and 
oxidative metabolism in cells with high GFP fluorescence intensity following 
anti mycobacterial drug treatment using R 123 and INT was hampered due to the similar 
spectral characteristics R 123 and GFP and the obscuring of GFP fluorescence in cells 
containing formazan deposits. However, spectrally shifted GFP variants have been 
produced recently (e.g. Clontech's enhanced blue fluorescent protein which has an 
emission maximum of 440 nm) which could be used in conjunction with RI23 labelling 
and provide information on the energy status of any brightly fluorescing GFP cells. 
4.2.10 Mycobacteriophage infectivity studies 
Mycobacteriophage D29 was also used to investigate whether the R 123 labelled 
proportion of cells observed in cultures of M tuberculosis treated with anti mycobacterial 
drugs could be infected and support viral replication. However, as stated in Section 
3.2.10, treatment with D29 did not reduce the number of RI23 labelled bacteria and 
unlike D29-treated broth culture (Section 3.3.3), cells partially labelled with R 123 and PI 
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were not observed suggesting that the R 123 labelled cells in the drug-treated cultures did 
not support lytic development. 
It should be noted that, although the antimycobacterial drug treated cultures were washed 
in Tween 80-free media and incubated overnight before infection, these media were 
prepared with antimycobacterial drugs that may have affected the outcome of these 
experiments. Firstly, although the effect of addition of fresh drug to drug-treated cell 
suspensions was not studied, it is possible that this contributed to the reduction in colony 
counts observed following incubation in 029-free phage buffer contols (Table 3.7). 
Secondly, in the case of rifampicin it has been reported that development of 029 can be 
inhibited in AI smegmatis at concentrations below the MIC (lones and Oavid, 1971) 
suggesting that phage transcription is more sensitive to the drug than the host. In 
hindsight, phage development in cell suspensions containing rifampicin would probably 
not have been produced. Unfortunately, time constraints precluded the repetition of these 
experiments such that the etTects of 029 on drug-treated cells washed in drug-free media 
prior to infection could be investigated. 
However, under the experimental conditions established in this study, little effect was 
observed in cells in drug-treated M tuberculosis cultures suggesting that although 
membrane energisation may be demonstrated in many of these cells, they do not seem to 
support phage development. 
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4.3 FURTHER STUDIES ON NON-LABELLING POPULATIONS AND 
DORMANCY MODELS 
It was highlighted in Section 4.1.2 that most M tuberculosis cells cultured in broth did 
not label with R123 or the other cytochemical stains used in the study (e.g TNT, PI or 
SYTO 16). The physiological nature of these cells, therefore, remained undefined. Non-
labellers could be: (1) active bacteria that were impermeable to cytochemical stains; (2) 
active bacteria with a low energy status; or (3) empty bacterial remnants devoid of 
intracellular material. 
Heterogeneity of R 123 labelling in other bacterial species has been reported and even in 
species that stained well, R123 did not label 100% of the cells detected, e.g. S aureus 
(96%), E. coli (91 %), Salmonella pullorum (89%) and Aeromonas hydrophilia (77%) 
(Diaper et a/" I 992). Most reports agree that the uptake of R123 and other fluorogenic 
probes that measure membrane potential is dependent on the age of culture, with 
accumulation greatest during the exponential phase and decreasing during the stationary 
phase. They suggest that variations in uptake reflect differences in the cell surface 
physiology and/or permeability of the bacteria. (Jepras et al., 1995; Monfort and Baleux, 
1996 and Comas and Vives-Rego, 1997). Indeed, it has long been reported that the 
concentration of lipids in mycobacteria increases with age and bacteria in older cultures 
often have two or three layered cell walls when observed using electron microscopy 
(Imaeda et af.. 1969). On this basis older cultures with thickened cell walls and lower 
permeability properties might be expected to show recalcitrance to cytochemical 
labelling. However. poor labelling with R123 was observed regardless of when cells 
were sampled from M tuberculosis broth culture; there was little difference between 
bacteria stained early in the exponential phase or late in the stationary phase of growth. 
According to Kaprelyants and Kell (1992, 1993), the extent by which individual cells 
accumulate R 123 depends on their energetic status and physiological state. They suggest 
that fluorescent cells have high metabolic activity, whereas non-labelled cells are 
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metabolically inert or dormant. For example, starvation of Micrococcus !uleus culture 
produces a gradual decrease in the number of cells exhibiting Rl23 fluorescence until few 
can be detected, whereas resuscitation in fresh liquid medium results in most of these 
cells reverting to accumulating RI23. Similarly, Porter et al., (1995) observed non-
staining sub-populations in Pseudomonas fluorescens cultures stressed hy starvation and 
suggested that they were low-activity bacteria with insufficient membrane potential to 
accumulate sufficient R123 for detection. The addition of the ionophore valinomycin to 
these cells was shown to increase the uptake of R123. Valinomycin is a potassium-
selective ionopore and under conditions of high concentrations of sodium ions, but low 
concentrations of potassium ions produces hyperpolarisation hy selective transport of 
potassium until the membrane potential is almost entirely due to the potassi um ion 
gradient. Using this interpretative framework, the non-labelled cells observed in M. 
tuberculosis broth culture could be metabolically inert or dormant. However, attempts to 
hyperpolarise the plasma membrane in these cells with valinomycin produced inhibition 
of fluorescence even in the original1y labelled portion. Explanation of this inhibition by 
valinomycin in M tuberculosis under conditions where the cell membrane should be 
hyperpolarised remains unclear. 
Heterogeneity of labelling with R 123 was also reported with other mycobacteria. A 
recent investigation in this laboratory which characterised the morphological changes 
during the life cycle of M avium, demonstrated that culture in liquid media produced an 
abundance of cell-like particles that did not label with either R 123 or PI (Ibrahim, 1996). 
Ibrahim postulated that this non-staining proportion consisted of lipid bodies rather than 
bacteria, which were made from sloughed off mycobacterial lipids produced from 
culturing these extremely hydrophobic organisms in broth. However, the particles 
observed with M avium were generally small and spherical, and should not be confused 
with the non-staining cells observed with M. tuberculosis which were bacillus shaped and 
morphologically indistinguishable from their staining counterparts. 
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Other workers have commented on persistent low-level lysis of M. tuherculosis in broth 
culture (Wayne, 1994; Cole et al., 1998). Non-labelled cells could well be bacteria that 
had undergone disintegration/lysis leaving behind ghost cells or empty mycobacterial 
husks devoid of cellular contents. Such remnants would not accumulate R 123 since they 
lack membrane potential, would not reduce INT due to the absence of oxidative 
metabolism and would not contain nucleic acid to stain with PI or S YTO 16. However. 
labelled and non-labelled cells had similar morphological and refractile properties when 
viewed using phase contrast microscopy, evidence that lysis had not occurred and that 
husks devoid of cellular contents were not present. 
The results of further investigations into the cytochemically non-labelled cells found 
principally in broth culture were presented in Section 3.3 and are discussed below. 
4.3.1 Comparison of GFP production by bacteria cultured in broth and on agar 
The growth and morphological characteristics of wild type H37Rv differed little from KijJ-
expressing strains of M tuberculosis (Section 3.1.1), suggesting that although KijJ was 
being expressed constitutively by cells and presumably reaching substantial 
concentrations, it was not toxic. 
Regardless of culture method, most M. tuberculosis cells transformed with the Kip-
expression cassette p-OFM 11 produced OFP and were brightly t1uorescent green. 
Therefore, the majority of bacteria had at some stage been able to produce intact OFP. 
This evidence that the majority of cells supported protein synthesis favours the view that 
the high numbers of cytochemically non-labelled cells observed in broth culture were 
cytologically active but had decreased cell wall permeability properties. 
As stated in Section 4.1.11, this highlights one advantage of using OFP as a reporter 
molecule to demonstrate cellular activity in M tuberculosis since it requires neither 
substrate nor cofactor due to the intrinsically fluorescent nature of the protein. However, 
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as discussed in Section 4.2.9 a major drawback of GFP is that once formed it is very 
stable and the half-life in M tuberculosis is not really known. Hence, while fluorescence 
may be detected in cytologically inactive cells in broth culture that are no longer capable 
of protein synthesis or division, these cells may not label with cytochemical reagents such 
as R123 and INT. Real-time gene expression studies using unstable variants oUiFP with 
reduced half-lives would help solve this problem. 
4.3.2 Mycobacteriophage infectivity studies 
Mycobacteriophage 029 was used to determine whether the non-labelling suh-
populations observed in M tuberculosis broth culture could be infected and support viral 
replication. D29 is a lytic phage and is reported to cause rapid bacterial cell lysis (Oavid 
et al., 1980; Donnelly-Wu et al., 1993; Hatfull and Jacobs, 1994; Carriere et al., 1997). It 
was hypothesised that Rl23-labelled cells being cytologically active would be infected, 
support phage replication and lyse during lytic development whereas the cytologically 
inactive non-labelled cells would not be infected and/or support replication and would not 
lyse. If this had been the case, the proportion of Rl23-labelled cells should have 
decreased following phage infection and the proportion of non-labelled cells should have 
increased. 
In contrast, the results presented in Section 3.3.2 show that the proportion of non-labelled 
cells was greatly reduced after overnight incubation with 029, suggesting that these cells 
had become infected, supported viral replication and during phage lytic development had 
lost their intact cell membrane and become permeable to PI or lysed completely. Many of 
the PI-stained cells showed evidence of shrunken cytoplasm when viewed by phase 
contrast microscopy (e.g. Figure 3.39a) suggestive of plasmolysis. It appears that 
although most M tuberculosis cells in broth culture are recalcitrant to cytochemical 
labelling, many of these cells can be infected by mycobacteriophage and support 
replication. 
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Although the proportion of cells that accumulated R123 was reduced alter infection with 
phage, many still accumulated the dye. There are several possible reasons for this. (I) 
David et al., (1980) demonstrated that the timing of D29 replication was rclated to thc 
average division time of the host, and therefore, one would expect that only cells which 
underwent replication during the time fame of the experiment would show evidence of 
lytic development. (2) Longer phage development may take place in slowly dividing cells 
and probably does not occur in non-dividing or resting cells. (3) Although Twecn 80 is 
known to inhibit D29 infection (White and Knight, 1958), culture of M tuherculosis in 
liquid media necessitates the use of detergent to prevent clumping. Consequently. 
cultures were washed and incubated for 24 h in detergent-free broth before infection. 
However, Tween 80 extracts lipids, glycolipids and carbohydrates from the mycobacterial 
cell wall (Daffe and Draper, 1998) and may have removed phage binding sites from many 
cells. Another important effect resulting from the addition of Tween 80 to mycobacterial 
cells is insertion of the detergent into the outer lipid layer of the wall (Christensen el al., 
1999). Such accumulation might well mask the D29 specific receptors in many of these 
cells. 
4.3.3 R123 labelling of dormant bacteria 
There has been renewed interest in mycobacterial dormancy to explain both the capacity 
of M tuberculosis cells in tissues to survive in the presence of antimycobacterial drugs 
and the endogenous reactivation of tuberculosis years or even decades after primary 
infection (Gangadharam, 1995; Grange, 1992; Wayne, 1994). Wayne and colleagucs 
have investigated nonreplicating persistence produced by adaptation to anaerobiosis as an 
in vitro model to study this phenomenon (Wayne and Lin, 1982; Waync and Hayes, 
1996). Cells adapted to anaerobiosis in liquid culture remain viable for long periods but 
do not replicate. Adaptation involved changes in oxygen-dependent metabolic pathways. 
which may facilitate the phenomenon of dormancy in vivo. Recently Cunningham and 
Spread bury (1998) observed that under these low-oxygen conditions M tuberculosis 
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develops a thickened cell wall possibly for protection and produces an a-crystallin 
homo log that may play a role in stabilising cell structures during long-term survival. 
It was reported in Section 3.3.3 that M. tuberculosis cells adapted to anaerobiosis using 
either of Wayne's models could be labelled using the Rl23/PI assay. In the first model, 
the slow settling of bacilli through a self-generated oxygen gradient, most of the cells 
found in the anoxic region at the bottom of the tube had not adapted to anaerobiosis as 
they were stained with PI. The PI stained cells must have succumbed to the lethal shock 
of oxygen depletion. Wayne (1996) found that this model yielded erratic results and that 
slight changes in the growth or settling rate was sufficient to upset the equilibrium 
between replication and settling that is required to maintain the oxygen gradient and 
support the orderly shift down to dormancy. Nonetheless, many R123 labelled cells were 
found in the anoxic sediment as long as 6 months after oxygen was depleted. 
In the second model, which was based on controlled agitation of sealed liquid cultures 
exposed to limited headspace volumes of air, few PI labelled cells were found. Ilere, it 
appears that the transition to anaerobiosis was more gradual, allowing the bacilli to adapt 
to the gradual depletion of oxygen producing an orderly shift down to dormancy. 
In summary, cytological activity in M tuberculosis cells adapted to anaerobiosis using 
Wayne's in vitro model could be monitored using Rl23/PI labelling. Unfortunately, time 
constraints precluded assessment of the effects of anti mycobacterial drugs on these cells. 
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4.4 GENERAL DISCUSSION 
The central aim of this project was to develop cytochemical indicators of cell activity to 
investigate the effect of antimycobacterial drugs on M. tuberculosis. It was hoped that 
these techniques would contribute to our understanding of the physiological properties of 
M tuberculosis that render it refractory to eradication and produce the characteristic slow 
response to chemotherapy (6-9 months). 
A principal feature of the early work was to establish a culture method that would 
produce consistent defined populations of M tuberculosis that was suitable for both the 
cytochemical labelling and in vitro antimycobacterial drugs studies. It was clear f)·om 
these results that there were substantial differences between cells grown in broth and 
those grown on agar. While culture in liquid media was expected to produce bacterial 
cells in a defined state of growth with minimum of heterogeneity, it proved unsuitable for 
cytochemical labelling due to the large number of cells (up to 70%) at any time of 
observation that were recalcitrant to staining. These cells were unlabelled and therefore 
undefined. In contrast, most bacteria (approximately 90%) in cell suspensions prepared 
from growth on agar were readily labelled with the cytochemical stains evaluated and 
consequently this source was used as the standard M tuberculosis cell suspension for the 
study. 
Not all the cytochemical methods evaluated demonstrated activity in M tuherculosis, e.g. 
poor labelling was observed with the membrane potential indicator oxonal (DiBAC.)), 
extracellular formazan with the tetrazolium salt CTe and non-specific labelling with the 
Molecular Probes Live/Dead BacLIGHT reagents. The most consistent results were 
obtained with R123/PI dual labelling and INT reduction, which demonstrate 
transmembrane electrochemical potential in cells with intact plasma membranes and 
oxidative metabolism respectively. 
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The accumulation of R123 was shown to be energy dependent as dissipation of the 
electrochemical gradient with the uncoupler agent CCCP abolished uptake. Ilowever. 
this was only demonstrable in M tuberculosis with low concentrations of dye and high 
concentrations of uncoupler reagent. CCCP-inhibited cells were capable of regenerating 
membrane potential when washed and re-labelled. The requirement for a physiologically 
validated procedure where cellular labelling could be unambiguously attributed to 
membrane energisation was highlighted when the effects of a range of tuberculocidal 
treatments on M tuberculosis cell suspensions were assessed. Several of the treatments 
(70°C for 30 min, 70% ethanol and 4% formaldehyde) lead to development of uncouplcr-
insensitive R 123 labelling of 'dead' cells. This identified non-specific labelling of dye 
that was unrelated to membrane energisation, which would have concealed the genuine 
bactericidal effects of the treatments at the single cell level. 
All of the cytochemical stains evaluated identified heterogeneity in labelling among the 
M tuberculosis cell population irrespective of growth stage and growth conditions. It is 
clear that all the cells in a mycobacterial culture are not identical and that all stages of the 
growth and division cycle are probably represented. With each labelling reaction, 
heterogeneity may reflect either the level of the physical or chemical activity available to 
be demonstrated in each cell (e.g. high versus low oxidative metabolism, high versus low 
electrochemical gradient) or the access of the label to that activity (e.g. variation in cell 
permeability). The heterogeneity of physiological phenotypes in M tuberculosis cell 
populations no doubt produces cell-to-cell variation in antimycobacterial drug 
susceptibility. 
Once the suitability of M tuberculosis cell suspensions prepared trom agar culture tor 
cytochemical labelling with R123/PI and INT was established, the effects of clinically 
important antimycobacterial drugs on cytological activity were assessed in parallel with 
conventional growth based techniques. Prior to drug treatment approximately 90% of 
cells labelled with R 123, 1 % stained with PI and the remainder were non-labelled. The 
general observation during the 7-day drug treatments was, with the exception of isoniazid 
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(and isoniazid-ethambutol combination), that there was a reduction in the proportion or 
R123-labelled bacteria and a concomitant increase in the number of PI-stained cclls. 
Although substantial bactericidal effects were achieved with single drug treatmcnts (I to 
3 log reductions in CFU mr'), drug combinations (e.g. isoniazid-rifampicin, isoniazid-
streptomycin and rifampicin-streptomycin) produced the greatest reduction in colony 
counts (3 to 5 log reductions in CFU mr'). However, the central feature of the 
anti mycobacterial drug treatments was that the number of cells with cytochemical 
phenotypes consistent with viability (i. e. energy-dependent uptake of R 123 or INT 
reduction) far exceeded the number of cells capable of forming colonies. Typically, an 
excess of between 1 and 4 orders of magnitude of uncoupler sensitive RI23 labelling 
cells over culturable units was observed. Increased recovery of M luherclI/osis 
propagules in drug-treated cultures was not observed with the MPN enumeration method. 
Thus, large populations of active but nonculturable (ABNC) cells were produced by 
antimycobacterial drugs commonly used in the treatment of tuberculosis. 
Isoniazid (and isoniazid-ethambutol combinations) caused enhancement in the labelling 
properties of cells during the first 3 days of treatment, producing both an increase in the 
proportion of labelled cells and an increase in the intensity of fluorescence and size of 
formazan deposit. This was associated with gross morphological changes characterised 
by a transformation from bacillus-shaped cells to smaller stunted cells with intense polar 
labelling. The simplest interpretation of these observations is that isoniazid treatment 
increased the permeability of the mycobacterial cell walls to the cytochemical stains 
resulting in greater influx ofRI23 and INT. However, it is possible that isoniazid causes 
an increase in cell respiration, thus producing greater activity in the electron transport 
system, an increased rate of production of reducing equivalents and therefore greater 
labelling with INT and R123. 
Non-labelling cells and ABNC cells were further investigated using a OFP reporter strain 
and by exposure to the lytic mycobacteriophage D29. Regardless of culture method, the 
majority of bacteria (> 90%) in cell suspensions prepared using the reporter strain 
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produced GFP and were brightly fluorescent. Evidence of the predominant non-labelling 
population identified by cytochemical labelling in broth culture was not observed. [n 
addition, the results of studies with 029 revealed that some non-labelled cells in broth 
culture were readily infected with 029, supported viral replication and during lytic 
development were permeabilised to PI or lysed completely. It seems likely that the non-
labelled cells identified in M tuberculosis broth culture are cytologically active cells with 
low permeability properties to the cytochemical reagents rather than empty cell husks. 
The identification of large numbers of cells with low permeability properties in M. 
tuberculosis cell populations has significance with regard to antimycobacterial drug 
susceptibility and needs to be investigated further. 
Treatment with antimycobacterial drugs caused a reduction in the expression of GFP in 
the reporter strain; the greatest reductions were seen with drugs that produced the greatest 
reduction in colony counts. It was disappointing that the membrane potential and 
oxidative metabolism in drug-treated GFP expressing cells could not be assessed using 
the cytochemical assays developed during the study since the spectral characteristics of 
R123 and GFP overlapped and formazan deposits obscured GFP fluorescence. Although 
the results made clear that many drug-treated cells contained sutJicient GFP to brightly 
fluoresce, they should be taken with caution as GFP seems to be very stable once formed 
and it's half-life in M tuberculosis is not known. Exposure of antimycobacterial drug 
treated cultures to 029 did not appear to have any effect on the ABNC cells identified by 
R123 labelling. It was hoped that the mycobacteriophage would infect these cells and 
lyse them during lytic development demonstrating that these cells contained the necessary 
machinery for replication. 
In addition to demonstrating ABNC in antimycobacterial drug treated M. tuberculosis 
culture, cytological activity was demonstrated in non-replicating cells adapted to 
anaerobiosis using Wayne's in vitro model of dormancy. Cells in the anoxic sediment 
generated accumulated R123 months after the oxygen was depleted. Unfortunately, time 
constraints precluded assessment of the effects of antimycobacterial drugs on these cells 
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since it is known that M tuberculosis derived from the Wayne model reveals a different 
drug susceptibility pattern. 
The presence of large numbers of ABNC bacteria in antimycobacterial drug treated 
cultures offers much opportunity for speculation. Since anti mycobacterial agents arc 
generally considered to affect M tuberculosis only when the bacilli are actively growing, 
phenotypic adaptation to ABNC forms in response to chemotherapy may produce drug-
resistant phenotypes in which normally bactericidal drugs produce only a bacteriostatic 
effect. Such phenotypes would have the capacity to outdistance the course of 
chemotherapy, which might explain both the unusually long treatment required for 
successful chemotherapy of tuberculosis and reactivation tuberculosis. Indeed, by 
adopting the rapid elimination of ABNC cells as a determinant for the outcome of 
chemotherapy, novel drugs or novel combinations of known drugs might be discovered 
that could produce more rapid treatment of disease. 
Although many publications implicitly or explicitly state that viability can be assayed at 
the cellular level by a variety of cytological methods, it should be stressed that viability 
implies the capacity for replication and growth and that methods that can predict these 
properties have not been found. Direct demonstration of growth and replication by 
culture remains the only unambiguous operational definition of culturability applicable to 
bacteria. Although we have demonstrated R123 accumulation, INT reduction and g/iJ 
expression in nonculturable M tuberculosis cells on many occasions, the viability of 
these cells is indeterminate at present. The significance of the non-labelling and ABNC 
cells observed remains to be established, but it is speculated that these populations may 
have implications for the chemotherapy of tuberculosis. 
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4.5 CONCLUSIONS 
The following conclusions can be drawn from this study 
I. There are substantial differences between cells grown in broth and those grown on 
agar with regard to morphology and physiology. The majority of cells grown in broth 
are recalcitrant to labelling with cytochemical stains. 
2. Of the cytochemical indicators of cell activity evaluated, R 123/PI dual labelling and 
INT reduction give the most consistent results with M tuberculosis. 
3. All of the cytochemical stains evaluated identified heterogeneity in M tuberculosis 
cell population irrespective of growth stage and growth conditions. It is clear that all 
the cells in a mycobacterial culture are not identical. 
4. All anti mycobacterial drug treatments produce an excess of between 1 and 4 orders of 
magnitude of uncoupler sensitive RI23 labelling cells over culturable units aftcr 7 
days exposure. Activity in ABNC cells can also be detected using INT reduction and 
GFP reporter strains. 
5. Isoniazid produces enhanced cytochemical labelling with RI23 and INT early 111 
treatment that is associated with gross morphological cell changes. 
6. Non-replicating cells adapted to anaerobiosis using Wayne's in vitro model of 
dormancy can be labelled with R123. 
7. Non-labelled cells identified by cytochemical staining techniques seem to be 
cytologically active cells with low permeability properties. Some of them can be 
infected and lysed by the lytic mycobacteriophage D29. All cells in OFP reporter 
strains of j\1 tuberculosis produce GFP. 
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